Section 52

EurekaMag PDF full texts Chapter 51,385


Pollithy, S.; Celik, N.; Höh, H.; Dithmar, S. 2013: Adjuvant stereotactic low energy radiation therapy of exudative age-dependent macular degeneration (Oraya system). Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 110(5): 460-463
Kano, H.; Niranjan, A.; Kondziolka, D.; Flickinger, J.C.; Lunsford, L.Dade. 2008: Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas. International Journal of Radiation Oncology Biology Physics 72(5): 1333-1339
Shafiq, M.; Mansoor, M.S.; Khan, A.A.; Sohail, M.R.; Murad, M.H. 2013: Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. Journal of Hospital Medicine 8(2): 68-75
Pieren, M.; Tigges, M. 2012: Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance. Current Opinion in Pharmacology 12(5): 551-555
Russo, S.; Jain, A.K.; Saif, M.W. 2012: Adjuvant strategies for resectable pancreatic cancer: have we made progress?. Jop: Journal of the Pancreas 13(2): 139-142
Cinieri, S.; Orlando, L.; Fedele, P.; Cusmai, A.; D'Amico, M.; Rizzo, P.; Chetri, M.C. 2007: Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18 Suppl. 6: Vi63-Vi65
Ferro, V.A.; Pérez, O. 2009: Adjuvant strategies required for targeting mucosal tissues. Methods 49(4): 299-300
Veronesi, G.; Scanagatta, P.; Leo, F.; De Pas, T.; Pelosi, G.; Catalano, G.; Gandini, S.; De Braud, F.; Spaggiari, L. 2007: Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2(2): 131-134
Oshiro, Y.; Takahashi, K.; Sasaki, R.; Kondo, T.; Sakashita, S.; Ohkohchi, N. 2013: Adjuvant surgery for advanced extrahepatic cholangiocarcinoma. World Journal of Gastroenterology 19(40): 6934-6938
Taomoto, J.; Tanabe, K.; Suzuki, T.; Hamai, Y.; Emi, M.; Hihara, J.; Yoshida, K.; Okada, M. 2010: Adjuvant surgery for advanced gastric cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(2): 263-266
Mordant, P.; Henry, B.; Morel, S.; Robert, J.; Veziris, N.; Le Dû, D.; Frechet-Jachym, M.; Similowski, T.; Caumes, É.; Riquet, M.; Le Pimpec-Barthes, F. 2014: Adjuvant surgical resection for multidrug-resistant tuberculosis: A review. Revue des Maladies Respiratoires 31(6): 511-524
Kato, K.; Kondo, S.; Hirano, S.; Tanaka, E.; Shichinohe, T.; Tsuchikawa, T.; Matsumoto, J. 2011: Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. Journal of Hepato-Biliary-Pancreatic Sciences 18(5): 712-716
Shiraishi, Y.; Katsuragi, N.; Kita, H.; Hyogotani, A.; Saito, M.H.; Shimoda, K. 2013: Adjuvant surgical treatment of nontuberculous mycobacterial lung disease. Annals of Thoracic Surgery 96(1): 287-291
Leroux-Roels, I.; Devaster, J.-M.; Leroux-Roels, G.; Verlant, V.; Henckaerts, I.; Moris, P.; Hermand, P.; Van Belle, P.; Poolman, J.T.; Vandepapelière, P.; Horsmans, Y. 2015: Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. Vaccine 33(4): 577-584
Jonker, D.J.; Spithoff, K.; Maroun, J. 2011: Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline. Clinical Oncology ) 23(5): 314-322
Turan, N.; Benekli, M.; Koca, D.; Ustaalioglu, B.O.; Dane, F.; Ozdemir, N.; Ulas, A.; Oztop, I.; Gumus, M.; Ozturk, M.A.; Berk, V.; Kucukoner, M.; Uner, A.; Balakan, O.; Helvaci, K.; Ozkan, S.; Yilmaz, U.; Buyukberber, S. 2013: Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer. Oncology 84(1): 14-21
Zhong, Y.; Liu, B.; Deng, M.; Xu, R. 2013: Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection. Drug Discoveries and Therapeutics 7(4): 164-166
Hernandez-Aya, L.F.; Gonzalez-Angulo, A.M. 2013: Adjuvant systemic therapies in breast cancer. Surgical Clinics of North America 93(2): 473-491
Reding, K.W.; Bernstein, J.L.; Langholz, B.M.; Bernstein, L.; Haile, R.W.; Begg, C.B.; Lynch, C.F.; Concannon, P.; Borg, A.; Teraoka, S.N.; Törngren, T.; Diep, A.; Xue, S.; Bertelsen, L.; Liang, X.; Reiner, A.S.; Capanu, M.; Malone, K.E.; Bernstein, J.L.; Begg, C.B.; Capanu, M.; Reiner, A.S.; Liang, X.; Orlow, I.; Layne, T.M.; Bernstein, L.; Donnelly-Allen, L.; Olsen, J.ør.H.; Andersson, M.; Bertelsen, L.; Guldberg, P.; Mellemkjaer, L.; Malone, K.E.; Epstein, N.; Boice, J.D.; Borg, A.; Torngren, T.; Shore, R.E.; Anton-Culver, H.; Largent, J.; Lynch, C.F.; DeWall, J.; Haile, R.W.; Langholz, B.M.; Thomas, D.C.; Diep, A.T.; Xue, S.; Zhou, N.; Ter-Karapetova, E.; Thompson, W.D.; Stovall, M.; Smith, S.; Concannon, P.; Teraoka, S.; Olson, E.R.; 2010: Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Research and Treatment 123(2): 491-498
Henry, N.L.; Diehl, K.M.; Hayes, D.F. 2006: Adjuvant systemic therapy for elderly women with breast cancer. Women's Health 2(1): 75-87
Pal, S.K.; Mortimer, J. 2009: Adjuvant systemic therapy for older adults with early-stage breast cancer. Women's Health 5(3): 251-262
Abdel-Rahman, O.; ElHalawani, H. 2014: Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns. Expert Opinion on Drug Safety 13(11): 1443-1467
Oakman, C.; Moretti, E.; Galardi, F.; Biagioni, C.; Santarpia, L.; Biganzoli, L.; Di Leo, A. 2011: Adjuvant systemic treatment for individual patients with triple negative breast cancer. Breast 20(Suppl 3): S135-S141
Kähler, K.C.; Egberts, F.; Hauschild, A.; Mohr, P. 2011: Adjuvant systemic treatment of melanoma. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 62(6): 414; 416-422
Ciconte, G.; Conti, M.; Evangelista, M.; Pappone, C. 2018: Atrial Fibrillation in Autoimmune Rheumatic Diseases: from Pathogenesis to Treatment. Reviews on Recent Clinical Trials 13(3): 170-175
Van de Velde, C.J.H.; Rea, D.; Seynaeve, C.; Putter, H.; Hasenburg, A.; Vannetzel, J.-M.; Paridaens, R.; Markopoulos, C.; Hozumi, Y.; Hille, E.T.M.; Kieback, D.G.; Asmar, L.; Smeets, J.; Nortier, J.W.R.; Hadji, P.; Bartlett, J.M.S.; Jones, S.E. 2011: Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet 377(9762): 321-331
Cutuli, B.; Petit, J.; Fricker, J.; Jung, G.; Schumacher, C.; Velten, M.; Abecassis, J. 1994: Adjuvant tamoxifen in breast-cancer-treatment in postmenopausal women - occurrence of thromboembolic complications. Oncology Reports 1(1): 59-63
Lin, C.; Chen, L.-S.; Kuo, S.-J.; Chen, D.-R. 2014: Adjuvant tamoxifen influences the lipid profile in breast cancer patients. Breast Care 9(1): 35-39
Ko, K.L.; Shin, I.S.; You, J.Y.; Jung, S.-Y.; Ro, J.; Lee, E.S. 2013: Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Breast Cancer Research and Treatment 142(3): 559-567
Vicentini, F.C.; Mazzucchi, E.; Brito, A.H.; Chedid Neto, E.A.; Danilovic, A.; Srougi, M. 2011: Adjuvant tamsulosin or nifedipine after extracorporeal shock wave lithotripsy for renal stones: a double blind, randomized, placebo-controlled trial. Urology 78(5): 1016-1021
Mackey, J.; McLeod, D.; Ragaz, J.; Gelmon, K.; Verma, S.; Pritchard, K.; Laing, K.; Provencher, L.; Charbonneau, L.F. 2009: Adjuvant targeted therapy in early breast cancer. Cancer 115(6): 1154-1168
Gajria, D.; Seidman, A.; Dang, C. 2010: Adjuvant taxanes: more to the story. Clinical Breast Cancer 10 Suppl. 2: S41-S49
Lorenzetti, M.; Motta, F.; Campanella, R.; Bauer, D.; Assi, A.; Arienta, C.; Gaini, S.M.; Caroli, M. 2011: Adjuvant temozolomide chemotherapy for treatment of papillary tumor of the pineal region. World Neurosurgery 76(1-2): 160-163
Franceschi, E.; Tosoni, A.; Brandes, A.A. 2008: Adjuvant temozolomide: how long and how much?. Expert Review of Anticancer Therapy 8(5): 663-665
Bektas, M.; Idilman, R.; Soykan, I.; Soydan, E.; Arat, M.; Cinar, K.; Coban, S.; Tuzun, A.; Bozkaya, H.; Ormeci, N.; Ozden, A. 2008: Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. Journal of Clinical Gastroenterology 42(5): 517-521
Rüttinger, D.; van den Engel, N.K.; Winter, H.; Schlemmer, M.; Pohla, H.; Grützner, S.; Wagner, B.; Schendel, D.J.; Fox, B.A.; Jauch, K-W.; Hatz, R.A. 2007: Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response. Journal of Translational Medicine 5: 43
Else, T.; Williams, A.R.; Sabolch, A.; Jolly, S.; Miller, B.S.; Hammer, G.D. 2014: Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. Journal of Clinical Endocrinology and Metabolism 99(2): 455-461
Kosmider, S.; Lipton, L. 2007: Adjuvant therapies for colorectal cancer. World Journal of Gastroenterology 13(28): 3799-3805
Colleoni, M.; Russo, L.; Dellapasqua, S. 2011: Adjuvant therapies for special types of breast cancer. Breast 20(Suppl 3): S153-S157
Freedman, R.A.; Partridge, A.H. 2011: Adjuvant therapies for very young women with early stage breast cancer. Breast 20(Suppl 3): S146-S149
Gutzmer, R.; Jäger, E.; Vordermark, D. 2011: Adjuvant therapies in oncology: a critical benefit-risk assessment. Onkologie 34(Suppl 2): 10-12
Scarupa, M.D.; Kaliner, M.A. 2007: Adjuvant therapies in the treatment of acute and chronic rhinosinusitis. Clinical Allergy and Immunology 20: 251-262
Baas, J.ør. 2008: Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs. Acta Orthopaedica. Suppl 79(330): 1-43
Bachelot, T.; Guastalla, J.-P.; Ray-Coquard, I. 2008: Adjuvant therapies: the example of breast cancer. La Revue du Praticien 58(8): 817-819
Poli de Figueiredo, C.E.; Barros, E. 2014: Adjuvant therapy. Jornal Brasileiro de Nefrologia: 'orgao Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 36(1 Suppl 1: 27-28
Kubo, S.; Takemura, S.; Sakata, C.; Urata, Y.; Uenishi, T. 2013: Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus. Liver Cancer 2(1): 40-46
Markelis, R.; Endzinas, Z.; Kiudelis, M.; Grizas, S.; Pundzius, J.; Saladzinskas, Z.; Juozaityte, E.; Inciūra, A.; Pranys, D.; Maleckas, A. 2009: Adjuvant therapy after curative resection with D2 lymphadenectomy for gastric cancer: results of a prospective clinical trial. Medicina 45(6): 460-468
Kudo, M. 2011: Adjuvant therapy after curative treatment for hepatocellular carcinoma. Oncology 81(Suppl 1): 50-55
Fong, Y. 2014: Adjuvant therapy after hepatectomy for colorectal metastases. LANCET. Oncology 15(6): 544-545
Mitra, A.; Khoo, V. 2009: Adjuvant therapy after radical prostatectomy: clinical considerations. Surgical Oncology 18(3): 247-254
Kukura, V.; Ciglar, S.ćk.; Markulin-Grgić, L.; Santek, F. 2007: Adjuvant therapy after radical surgery of cervical cancer: Zagreb experience. Collegium Antropologicum 31(Suppl 2): 155-158
Broemme, J.; Abu-Isa, J.; Kottke, R.; Beck, J.; Wiest, R.; Malthaner, M.; Schmidhalter, D.; Raabe, A.; Aebersold, D.M.; Pica, A. 2013: Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 189(9): 765-770
Rahbari, N.N.; Reissfelder, C.; Schulze-Bergkamen, H.; Jäger, D.; Büchler, M.W.; Weitz, Jürgen.; Koch, M. 2014: Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy. Bmc Cancer 14: 174
Sandoval, B.; Fong, Y. 2008: Adjuvant therapy after resection of hepatic colorectal metastases. Annals of Surgical Oncology 15(1): 9-10
Ferrandino, M.N.; Monga, M.; Preminger, G.M. 2009: Adjuvant therapy after surgical stone management. Advances in Chronic Kidney Disease 16(1): 52-59
Kasai, K.; Kuroda, H.; Suzuki, K. 2008: Adjuvant therapy after treatment of hepatocellular carcinoma. Nihon Shokakibyo Gakkai Zasshi 105(6): 787-794
Haie-Meder, C.; Paumier, A.; Lessard, N.; Morice, P.; Pautier, P.; Touboul, C. 2008: Adjuvant therapy and role of radiation therapy in advanced endometrial cancers. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 12(6-7): 630-632
Mayo, S.C.; Austin, D.F.; Sheppard, B.C.; Mori, M.; Shipley, D.K.; Billingsley, K.G. 2010: Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis. Cancer 116(12): 2932-2940
Chand, M.; Swift, R.I.; Chau, I.; Heald, R.J.; Tekkis, P.P.; Brown, G. 2014: Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Annals of the Royal College of Surgeons of England 96(7): 543-546
Castrellon, A.B.; Glück, S. 2008: Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?. Clinical Advances in Hematology and Oncology: H&o 6(9): 666-672
Zhu, J.; Xu, Y.; Gu, W.; Peng, J.; Cai, G.; Cai, G.; Sun, W.; Shen, W.; Cai, S.; Zhang, Z. 2010: Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients. Radiation Oncology 5: 118
Heist, R.; Azzoli, C.G. 2013: Adjuvant therapy for a 3.9-cm adenocarcinoma of the lung. Oncologist 18(12): 1258-1261
Wolff, R.A.; Varadhachary, G.R.; Evans, D.B. 2008: Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. Annals of Surgical Oncology 15(10): 2773-2786
Tsuburaya, A. 2012: Adjuvant therapy for advanced gastric cancer. Nihon Geka Gakkai Zasshi 113(1): 8-11
Mohammed, K.S.; Kowey, P.R.; Musco, S. 2010: Adjuvant therapy for atrial fibrillation. Future Cardiology 6(1): 67-81
Pritchard, K.I. 2007: Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing. Journal of the National Cancer Institute 99(7): 494-495
Saltz, L.B. 2010: Adjuvant therapy for colon cancer. Surgical Oncology Clinics of North America 19(4): 819-827
Sargent, D.; Grothey, A. 2010: Adjuvant therapy for colon cancer: learning from the past to inform the future. Annals of Surgical Oncology 17(4): 947-949
De Dosso, S.; Sessa, C.; Saletti, P. 2009: Adjuvant therapy for colon cancer: present and perspectives. Cancer Treatment Reviews 35(2): 160-166
Sanoff, H.K.; O'Neil, B.H. 2009: Adjuvant therapy for colorectal cancer: increasingly complex as patients age. Oncology 23(2): 173-174
Figueredo, A.; Coombes, M.E.; Mukherjee, S. 2008: Adjuvant therapy for completely resected stage Ii colon cancer. Cochrane Database of Systematic Reviews 3: Cd005390
Costa, S-Dan.; Bischoff, J. 2007: Adjuvant therapy for early breast cancer. New England Journal of Medicine 356(12): 1268-1269
Stein, A.; Hiemer, S.; Schmoll, H.-J. 2011: Adjuvant therapy for early colon cancer: current status. Drugs 71(17): 2257-2275
Hoffman, K.E.; Neville, B.A.; Mamon, H.J.; Kachnic, L.A.; Katz, M.S.; Earle, C.C.; Punglia, R.S. 2012: Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer 118(1): 248-257
Deleon, M.C.; Ammakkanavar, N.R.; Matei, D. 2014: Adjuvant therapy for endometrial cancer. Journal of Gynecologic Oncology 25(2): 136-147
Tugba Kos, F.; Aksoy, S.; Odabas, H.; Ozdemir, N.; Oksuzoglu, B.; Uncu, D.; Zengin, N. 2011: Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study. Journal of BUON: Official Journal of the Balkan Union of Oncology 16(3): 464-468
Gold, D.G.; Miller, R.C.; Haddock, M.G.; Gunderson, L.L.; Quevedo, F.; Donohue, J.H.; Bhatia, S.; Nagorney, D.M. 2009: Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. International Journal of Radiation Oncology Biology Physics 75(1): 150-155
Coit, D. 2007: Adjuvant therapy for gastric cancer. Journal of the American College of Surgeons 205(4 Suppl): S54-S58
Nishida, T. 2012: Adjuvant therapy for gastric cancer after D2 gastrectomy. Lancet 379(9813): 291-292
Foo, M.; Leong, T. 2014: Adjuvant therapy for gastric cancer: current and future directions. World Journal of Gastroenterology 20(38): 13718-13727
Ellenberg, S.S.; Sun, W. 2007: Adjuvant therapy for gastric cancer: how negative results can help patients. Journal of the National Cancer Institute 99(8): 580-582
Brooks, G.A.; Enzinger, P.C.; Fuchs, C.S. 2012: Adjuvant therapy for gastric cancer: revisiting the past to clarify the future. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(19): 2297-2299
Leong, T. 2014: Adjuvant therapy for gastric cancer; more questions than answers. Journal of Medical Imaging and Radiation Oncology 58(4): 481-482
Hong, T.S.; Kwak, E.L. 2014: Adjuvant therapy for gastric cancers: more answers or more questions?. Annals of Surgical Oncology 21(11): 3367-3368
Jeng, W.-J.; Lin, C.-C.; Chen, W.-T.; Sheen, I.-S.; Lin, C.-Y.; Lin, S.-M. 2014: Adjuvant therapy for hepatocellular carcinoma after curative treatment. Digestive Diseases 32(6): 747-754
Wang, Z.; Zhang, G.; Wu, J.; Jia, M. 2013: Adjuvant therapy for hepatocellular carcinoma: current situation and prospect. Drug Discoveries and Therapeutics 7(4): 137-143
Hensley, M.L.; Wathen, J.K.; Maki, R.G.; Araujo, D.M.; Sutton, G.; Priebat, D.A.; George, S.; Soslow, R.A.; Baker, L.H. 2013: Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Cancer 119(8): 1555-1561
Joensuu, H. 2012: Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management. Drugs 72(15): 1953-1963
Gronchi, A.; Casali, P.G. 2013: Adjuvant therapy for high-risk soft tissue sarcoma in the adult. Current Treatment Options in Oncology 14(3): 415-424
Boltežar, I.H.če.; Bahar, M.S.; Zargi, M.; Gale, N.; Matičič, M.; Poljak, M. 2011: Adjuvant therapy for laryngeal papillomatosis. Acta Dermatovenerologica Alpina Pannonica et Adriatica 20(3): 175-180
Scherr, A.J.O.; Lima, J.P.S.N.; Sasse, E.C.; Lima, C.S.P.; Sasse, A.é D. 2011: Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis. Bmc Cancer 11: 115
Merk, J.; Leschber, G. 2009: Adjuvant therapy for lung cancer. Minerva Chirurgica 64(6): 599-609
Davar, D.; Tarhini, A.A.; Kirkwood, J.M. 2012: Adjuvant therapy for melanoma. Cancer Journal 18(2): 192-202
Sondak, V.K.; Gonzalez, R.J.; Kudchadkar, R. 2011: Adjuvant therapy for melanoma: a surgical perspective. Surgical Oncology Clinics of North America 20(1): 105-114
Sanborn, R.E.; Lally, B.E. 2008: Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvement. Thoracic Surgery Clinics 18(4): 423-435
Kalemkerian, G.P. 2010: Adjuvant therapy for non-small-cell lung cancer. Lancet 375(9722): 1230-1231
Owusu, C.; Hurria, A.; Muss, H. 2012: Adjuvant therapy for older women with early-stage breast cancer: treatment selection in a complex population. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2012: 3-9
O'Reilly, E.M. 2011: Adjuvant therapy for pancreas adenocarcinoma: where are we going?. Expert Review of Anticancer Therapy 11(2): 173-177
Mulcahy, M.F. 2007: Adjuvant therapy for pancreas cancer: advances and controversies. Seminars in Oncology 34(4): 321-326
Aung, K.L.; Smith, D.B.; Neoptolemos, J.P. 2007: Adjuvant therapy for pancreatic cancer. Expert Opinion on PharmacoTherapy 8(15): 2533-2541
Sultana, A.; Cox, T.; Ghaneh, P.; Neoptolemos, J.P. 2012: Adjuvant therapy for pancreatic cancer. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 196: 65-88
Evans, D.B.; Wolff, R.A. 2011: Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. Annals of Surgical Oncology 18(5): 1224-1228
Berlin, J.D. 2007: Adjuvant therapy for pancreatic cancer: to treat or not to treat?. Oncology 21(6): 712-718; Discussion 720: 725-726, 730
Freedman, R.A.; Winer, E.P. 2010: Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer. Breast 19(2): 69-75
Kurebayashi, J. 2008: Adjuvant therapy for premenopausal patients with early breast cancer. Current Opinion in Obstetrics and Gynecology 20(1): 51-54
Haas, N.B.; Uzzo, R. 2008: Adjuvant therapy for renal cell carcinoma. Current Oncology Reports 10(3): 245-252
Pinto, A. 2014: Adjuvant therapy for renal cell carcinoma. Clinical Genitourinary Cancer 12(6): 408-412
Pal, S.K.; Haas, N.B. 2014: Adjuvant therapy for renal cell carcinoma: past, present, and future. Oncologist 19(8): 851-859
Brandts, C.H.; Schulz, C.; Willich, N.; Steffen, B.ör.; Hardes, J.; Gosheger, G.; Winkelmann, W.; Serve, H.; Heinecke, A.; Berdel, W.E.; Thomas, M. 2012: Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy. Cancer ChemoTherapy and Pharmacology 69(3): 613-620
Anderson, C.; Kim, R. 2009: Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treatment Reviews 35(4): 322-327
Gill, S. 2014: Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 35(3): 197-202
Wozniak, A.J.; Gadgeel, S.M. 2009: Adjuvant therapy for resected non-small cell lung cancer. Therapeutic Advances in Medical Oncology 1(2): 109-118
Rami-Porta, R.ón. 2013: Adjuvant therapy for resected non-small-cell lung cancer with lymphovascular invasion. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 8(1): E9-10
Minutilli, E.; Feliciani, C. 2012: Adjuvant therapy for resected stage IIi melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors. Tumori 98(2): 185-190
Schuetze, S.M.; Ray, M.E. 2005: Adjuvant therapy for soft tissue sarcoma. Journal of the National Comprehensive Cancer Network: Jnccn 3(2): 207-213
Meyerhardt, J.A. 2010: Adjuvant therapy for stage Ii and IIi colon cancer. Clinical Advances in Hematology and Oncology: H&o 8(11): 772-774
De Gramont, A.; Tournigand, C.; André, T.; Larsen, A.K.; Louvet, C. 2007: Adjuvant therapy for stage Ii and IIi colorectal cancer. Seminars in Oncology 34(2 Suppl 1: S37-S40
Vicuna, B.; Benson, A.B. 2007: Adjuvant therapy for stage Ii colon cancer: prognostic and predictive markers. Journal of the National Comprehensive Cancer Network: Jnccn 5(9): 927-936
Abbruzzese, J.L. 2008: Adjuvant therapy for surgically resected pancreatic adenocarcinoma. JAMA 299(9): 1066-1067
Cheung, J.P.Y.; Tsang, H.H.L.; Cheung, J.J.C.; Yu, H.H.Y.; Leung, G.K.K.; Law, W.L. 2009: Adjuvant therapy for the reduction of postoperative intra-abdominal adhesion formation. Asian Journal of Surgery 32(3): 180-186
Chen, T.C.; Chamberlain, M.C. 2007: Adjuvant therapy for unresectable meningiomas: benign and malignant. Neurosurgical Focus 23(4): 1
Sautter-Bihl, M.-L.; Souchon, R.; Gerber, B. 2011: Adjuvant therapy for women over age 65 with breast cancer. Deutsches Arzteblatt International 108(21): 365-371
Janni, W. 2014: Adjuvant therapy in breast cancer - have we already learned the entire lesson?. Breast Care 9(3): 153
Mandalà, M.; Tondini, C. 2012: Adjuvant therapy in breast cancer and venous thromboembolism. Thrombosis Research 130(Suppl 1): S66-S70
Graham, J.S.; Cassidy, J. 2012: Adjuvant therapy in colon cancer. Expert Review of Anticancer Therapy 12(1): 99-109
Latif, N.A.; Haggerty, A.; Jean, S.; Lin, L.; Ko, E. 2014: Adjuvant therapy in early-stage endometrial cancer: a systematic review of the evidence, guidelines, and clinical practice in the U.S. Oncologist 19(6): 645-653
Serke, M. 2010: Adjuvant therapy in early-stage non-small cell lung cancer. Frontiers of Radiation Therapy and Oncology 42: 135-144
Ku, G.Y.; Ilson, D.H. 2012: Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus. Gastrointestinal Cancer Research: Gcr 5(3): 85-92
Brandes, A.A.; Tosoni, A.; Franceschi, E. 2007: Adjuvant therapy in glioblastomas: false steps and real advances. Expert Review of Anticancer Therapy 7(5): 607-608
Kim, J.Hwi.; Lee, S.Jong.; Bae, J.Hoon.; Lee, S.Ha.; Bae, S.Nyeon.; Namkoong, S.Eun.; Park, J.Sup. 2008: Adjuvant therapy in high-risk early endometrial carcinoma: a retrospective analysis of 46 cases. Journal of Gynecologic Oncology 19(4): 236-240
Mahner, S.; Trillsch, F.; Kock, L.; Rohsbach, D.; Petersen, C.; Kruell, A.; Harter, P.; Jaenicke, F.; Woelber, L. 2013: Adjuvant therapy in node-positive vulvar cancer. Expert Review of Anticancer Therapy 13(7): 839-844
Rusch, V.W. 2007: Adjuvant therapy in non-small cell lung cancer. Annals of Thoracic Surgery 84(5): 1793-1794
Sangha, R.; Price, J.; Butts, C.A. 2010: Adjuvant therapy in non-small cell lung cancer: current and future directions. Oncologist 15(8): 862-872
Carbone, D.P.; Felip, E. 2011: Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms. Clinical Lung Cancer 12(5): 261-271
Thomas, A.; Dajani, K.; Neoptolemos, J.P.; Ghaneh, P. 2010: Adjuvant therapy in pancreatic cancer. Digestive Diseases 28(4-5): 684-692
Jones, O.P.; Melling, J.D.; Ghaneh, P. 2014: Adjuvant therapy in pancreatic cancer. World Journal of Gastroenterology 20(40): 14733-14746
Oettle, H.; Neuhaus, P. 2007: Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 67(16): 2293-2310
Berruti, A.; Fassnacht, M.; Baudin, E.; Hammer, G.; Haak, H.; Leboulleux, S.; Skogseid, B.; Allolio, B.; Terzolo, M. 2010: Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(23): E401
Loibl, S. 2009: Adjuvant therapy in patients with breast cancer during pregnancy. Cancer Treatment and Research 151: 317-328
Roll, L. 2008: Adjuvant therapy in patients with pancreatic cancer. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 177: 49-56
Janowitz, T.; Welsh, S.J.; Zaki, K.; Mulders, P.; Eisen, T. 2013: Adjuvant therapy in renal cell carcinoma-past, present, and future. Seminars in Oncology 40(4): 482-491
Schwartz, G.F.; Bartelink, H.; Burstein, H.J.; Cady, B.; Cataliotti, L.; Fentiman, I.S.; Holland, R.; Hughes, K.S.; Masood, S.; McCormick, B.; Palazzo, J.A.; Pressman, P.I.; Reis-Filho, J.; Pusztai, L.; Rutgers, E.J.T.; Seidman, A.D.; Solin, L.J.; Sparano, J.A. 2012: Adjuvant therapy in stage i carcinoma of the breast: the influence of multigene analyses and molecular phenotyping. Breast Journal 18(4): 303-311
Song, Z.; Zhang, Y. 2014: Adjuvant therapy in stage Ii thymic carcinoma. Journal of Cancer Research and Clinical Oncology 140(2): 349-352
Kuku, S.; Williams, M.; McCormack, M. 2013: Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23(6): 1056-1064
Muss, H.B.; Biganzoli, L.; Sargent, D.J.; Aapro, M. 2007: Adjuvant therapy in the elderly: making the right decision. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(14): 1870-1875
Matuev, K.B. 2012: Adjuvant therapy of brain tumors in young infants. Review article (Part two). Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 76(4): 69-73
Saarto, T. 2009: Adjuvant therapy of breast cancer - bisphosphonates. Cancer Treatment and Research 151: 163-177
Jones, E.L.; Leak, A.; Muss, H.B. 2012: Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes. Oncology 26(9): 793-801
Beneder, C.; Marth, C. 2008: Adjuvant therapy of breast cancer with trastuzumab. Gynakologisch-Geburtshilfliche Rundschau 48(3): 138-142
Trarbach, T.; Kubicka, S.; Hacker, U.; Ridwelski, K.; Reinacher-Schick, A. 2008: Adjuvant therapy of colon carcinoma. Onkologie 31(Suppl 5): 19-23
Koshenkov, V.P.; Rodgers, S.E. 2012: Adjuvant therapy of gastrointestinal stromal tumors. Current Opinion in Oncology 24(4): 414-418
Lindenmeir, T.; Ulrich, M.; Rau, O.; Reiher, F.; Allhoff, E.P. 2007: Adjuvant therapy of locally advanced prostate carcinoma with ibandronate. Der Urologe. Ausg. a 46(9): 1287
Ascierto, P.A.; Kirkwood, J.M. 2008: Adjuvant therapy of melanoma with interferon: lessons of the past decade. Journal of Translational Medicine 6: 62
Sondak, V.K.; Flaherty, L.E. 2008: Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?. Lancet 372(9633): 89-90
Hilbig, A.; Oettle, H. 2010: Adjuvant therapy of pancreatic cancer. Expert Review of Anticancer Therapy 10(4): 485-491
Chaulagain, C.P.; Ng, J.; Wazer, D.; Saif, M.W. 2012: Adjuvant therapy of pancreatic cancer. Jop: Journal of the Pancreas 13(4): 349-353
Saif, M.Wasif. 2011: Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. JOP: Journal of the pancreas 12(2): 106-109
Perez, E.A.; Moreno-Aspitia, A.; Aubrey Thompson, E.; Andorfer, C.A. 2010: Adjuvant therapy of triple negative breast cancer. Breast Cancer Research and Treatment 120(2): 285-291
Glimelius, B.; Lind, P.; Lundell, L. 2007: Adjuvant therapy of ventricular cancer tested in Sweden. Lakartidningen 104(43): 3214-3215; Discussion: 3215-3216
Kleeberg, U.R.; Fink, M.; Tessen, H-Werner.; Nennecke, A.; Hentschel, S.; Bartels, S. 2013: Adjuvant therapy reduces the benefit of palliative treatment in disseminated breast cancer - own findings and review of the literature. Onkologie 36(6): 348-356
García-Albéniz, X.; Gallego, R.; Hofheinz, R.D.; Fernández-Esparrach, G.; Ayuso-Colella, J.R.ón.; Bombí, J.A.; Conill, C.; Cuatrecasas, M.; Delgado, S.; Ginés, A.; Miquel, R.; Pagés, M.; Pineda, E.; Pereira, V.ón.; Sosa, A.ón.; Reig, O.; Victoria, I.án.; Feliz, L.; María de Lacy, A.; Castells, A.; Burkholder, I.; Hochhaus, A.; Maurel, J. 2014: Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World Journal of Gastroenterology 20(42): 15820-15829
Cash, W.J.; Patterson, K.; Callender, M.E.; McDougall, N.I. 2010: Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients. Journal of Viral Hepatitis 17(4): 269-273
Rosario, P.W.; Mourão, G.F.; Siman, T.L.; Calsolari, M.R. 2015: Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases. Endocrine 49(1): 279-282
Hashimoto, K.; Tono, T.; Abe, H.; Nishida, K.; Yanagawa, T.; Fujie, Y.; Fujita, S.; Fujita, J.; Yoshida, T.; Ohnishi, T.; Imaoka, S.; Monden, T. 2014: Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(10): 1298-1300
Gough, M.J.; Crittenden, M.R.; Sarff, M.; Pang, P.; Seung, S.K.; Vetto, J.T.; Hu, H.-M.; Redmond, W.L.; Holland, J.; Weinberg, A.D. 2010: Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. Journal of ImmunoTherapy 33(8): 798-809
Lecumberri, R.; López Vivanco, G.; Font, A.; González Billalabeitia, E.; Gúrpide, A.; Gómez Codina, J.; Isla, D.; Galán, A.; Bover, I.; Domine, M.; Vicente, V.; Rosell, R.; Rocha, E. 2013: Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study. Thrombosis Research 132(6): 666-670
Panahi, Y.; Saadat, A.; Beiraghdar, F.; Sahebkar, A. 2014: Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. PhytoTherapy Research: Ptr 28(10): 1461-1467
Wilson, C.; Coleman, R.E. 2011: Adjuvant therapy with bone-targeted agents. Current Opinion in Supportive and Palliative Care 5(3): 241-250
Xia, Y.; Qiu, Y.; Li, J.; Shi, L.; Wang, K.; Xi, T.; Shen, F.; Yan, Z.; Wu, M. 2010: Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Annals of Surgical Oncology 17(12): 3137-3144
Tournigand, C.; André, T.; Bonnetain, F.; Chibaudel, B.; Lledo, Gérard.; Hickish, T.; Tabernero, J.; Boni, C.; Bachet, J-Baptiste.; Teixeira, L.; de Gramont, A. 2012: Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(27): 3353-3360
Thakar, A.; Gupta, G.; Bhalla, A.S.; Jain, V.; Sharma, S.C.; Sharma, R.; Bahadur, S.; Deka, R.C. 2011: Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma. Head and Neck 33(12): 1747-1753
Saw, R.P.M.; Armstrong, B.K.; Mason, R.S.; Morton, R.L.; Shannon, K.F.; Spillane, A.J.; Stretch, J.R.; Thompson, J.F. 2014: Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase Ii trial (ANZMTG 02.09 Mel-D). Bmc Cancer 14: 780
Nader, N.D.; Li, C.M.; Dosluoglu, H.H.; Ignatowski, T.A.; Spengler, R.N. 2009: Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft. Clinical Journal of Pain 25(2): 101-106
Raikhelkar, J.K.; Weiss, A.J.; Maysick, L.; Scurlock, C. 2012: Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement. Journal of Cardiothoracic and Vascular Anesthesia 26(5): 878-879
Raikhelkar, J.K.; Milla, F.; Darrow, B.; Scurlock, C. 2011: Adjuvant therapy with methylene blue in the treatment of right ventricular failure after pulmonary embolectomy. Heart Lung and Circulation 20(4): 234-236
Fekadu, A.; Mesfin, M.; Medhin, G.; Alem, A.; Teferra, S.; Gebre-Eyesus, T.; Seboxa, T.; Assefa, A.; Hussein, J.; Lemma, M.T.; Borba, C.; Henderson, D.C.; Hanlon, C.; Shibre, T. 2013: Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial. Trials 14: 406
Dearnaley, D.P.; Mason, M.D.; Parmar, M.K.B.; Sanders, K.; Sydes, M.R. 2009: Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials. LANCET. Oncology 10(9): 872-876
Grob, J.Jacques.; Jouary, T.; Dréno, B.; Asselineau, J.; Gutzmer, R.; Hauschild, A.; Leccia, M.Thérèse.; Landthaler, M.; Garbe, C.; Sassolas, B.; Herbst, R.A.; Guillot, B.; Chene, G.; Pehamberger, H. 2013: Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study. European Journal of Cancer 49(1): 166-174
Bottomley, A.; Coens, C.; Suciu, S.; Santinami, M.; Kruit, W.; Testori, A.; Marsden, J.; Punt, C.; Salès, F.ço.; Gore, M.; Mackie, R.; Kusic, Z.; Dummer, R.; Patel, P.; Schadendorf, D.; Spatz, A.; Keilholz, U.; Eggermont, A. 2009: Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage IIi melanoma: a phase IIi randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(18): 2916-2923
Anonymous 2009: Adjuvant therapy with steroids or immunoglobulins. Respirology 14 Suppl. 2: S65-S67
Eggemann, H.; Ignatov, A.; Smith, B.J.; Altmann, U.; von Minckwitz, G.; Röhl, F.W.; Jahn, M.; Costa, S.-D. 2013: Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Research and Treatment 137(2): 465-470
Fields, A.L.A.; Keller, A.; Schwartzberg, L.; Bernard, S.; Kardinal, C.; Cohen, A.; Schulz, J.; Eisenberg, P.; Forster, J.; Wissel, P. 2009: Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage IIi colon cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(12): 1941-1947
Zheng, Y.Y.; Zhu, J.H. 2013: Adjuvant therapy with zoledronic Acid and menopausal status. Oncologist 18(8): E24
Burton, R.C.; Bell, R.J.; Thiagarajah, G.; Stevenson, C. 2012: Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Research and Treatment 131(3): 949-955
Phan, N.Q.; Siepmann, D.; Gralow, I.; Ständer, S. 2010: Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia. Journal der Deutschen Dermatologischen Gesellschaft 8(2): 88-91
Gentile, M.; Bianchi, P.; Sesti, F.; Sopracordevole, F.; Biamonti, A.; Scirpa, P.; Schimberni, M.; Cozza, G.; Marziani, R.; Di Martino, G.; Catalano, A.; Milazzo, G.N.; Zinna, M.; Caserta, D.; Frega, A. 2014: Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3. European Review for Medical and Pharmacological Sciences 18(19): 2949-2952
Xi, T.; Lai, E.C.H.; Min, A-ru.; Shi, L-hua.; Wu, D.; Xue, F.; Wang, K.; Yan, Z.; Xia, Y.; Shen, F.; Lau, W.Yee.; Wu, M-chao. 2012: Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. Hepato-Gastroenterology 59(116): 1198-1203
Peng, B.-G.; He, Q.; Li, J.-P.; Zhou, F. 2009: Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. American Journal of Surgery 198(3): 313-318
Abe, H.; Umeda, T.; Kawai, Y.; Tanaka, M.; Mori, T.; Cho, H.; Kubota, Y.; Mekata, E.; Kurumi, Y.; Tani, T. 2010: Adjuvant trastuzumab can be infused safely over 30 minutes. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1887-1891
Tarantini, L.; Gori, S.; Faggiano, P.; Pulignano, G.; Simoncini, E.; Tuccia, F.; Ceccherini, R.; Bovelli, D.; Lestuzzi, C.; Cioffi, G. 2012: Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis. Annals of Oncology: Official Journal of the European Society for Medical Oncology 23(12): 3058-3063
Tai, C.-J.; Pan, C.-K.; Chen, C.-S.; Hung, C.-S.; Wu, C.-H.; Chiou, H.-Y. 2013: Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage Ii or IIi breast cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 14(3): 1981-1984
Palmieri, F.M.; Myatt, C.V.; Perez, E.A. 2010: Adjuvant trastuzumab for HER2-positive early breast cancer. Clinical Journal of Oncology Nursing 14(3): 326-336
Anonymous 2012: Adjuvant trastuzumab for breast cancer. A second look. Longer follow-up confirms improved overall survival. Prescrire international 21(133): 285-287
Younis, T.; Skedgel, C. 2011: Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial. Pharmacoeconomics 29(5): 361-365
Kaji, D.; Miura, Y.; Takano, T. 2012: Adjuvant trastuzumab in HER2-positive breast cancer. New England Journal of Medicine 366(7): 663; Author Reply 664-666
Mortimer, J. 2012: Adjuvant trastuzumab in HER2-positive breast cancer. New England Journal of Medicine 366(7): 663
Livi, L.; Borghesi, S.; Meattini, I.; Saieva, C.; De Luca Cardillo, C.; Scotti, V.; Mangoni, M.; Galardi, A.; Cataliotti, L.; Paiar, F.; Bianchi, S.; Biti, G. 2010: Adjuvant trastuzumab in breast cancer: experience from the University of Florence. Journal of ChemoTherapy 22(2): 115-118
Murray, L.J.; Ramakrishnan, S.; O'Toole, L.; Manifold, I.H.; Purohit, O.P.; Coleman, R.E. 2010: Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery. Breast 19(5): 339-344
Viani, G.A.; Afonso, S.L.; Stefano, E.J.; De Fendi, L.I.; Soares, F.V. 2007: Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials. Bmc Cancer 7: 153
Haykowsky, M.J.; Mackey, J.R.; Thompson, R.B.; Jones, L.W.; Paterson, D.I. 2009: Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(15): 4963-4967
Kiess, A.P.; McArthur, H.L.; Mahoney, K.; Patil, S.; Morris, P.G.; Ho, A.; Hudis, C.A.; McCormick, B. 2012: Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer 118(8): 1982-1988
Jahanzeb, M. 2008: Adjuvant trastuzumab therapy for HER2-positive breast cancer. Clinical Breast Cancer 8(4): 324-333
McArthur, H.L.; Mahoney, K.M.; Morris, P.G.; Patil, S.; Jacks, L.M.; Howard, J.; Norton, L.; Hudis, C.A. 2011: Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer 117(24): 5461-5468
Swain, S.M. 2013: Adjuvant trastuzumab: does time really matter?. Oncologist 18(5): 490-492
Joy, A.A.; Mackey, J.R. 2006: Adjuvant trastuzumab: progress, controversies, and the steps ahead. Current Oncology 13(1): 8-13
Sultana, A.; Neoptolemos, J.; Ghaneh, P. 2006: Adjuvant treatment. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 8(5): 352-364
Kim, R.; Tan, A.; Estfan, B.; Aucejo, F. 2009: Adjuvant treatment after orthotopic liver transplantation: is it really necessary?. Oncology 23(14): 1276-1281
Richaud, P. 2007: Adjuvant treatment after total prostatectomy. Annales d'Urologie 41(Suppl 3): S69-S72
Gadducci, A.; Cosio, S.; Landoni, F.; Maggino, T.; Zola, P.; Sostegni, B.; Bellicini, A.; Fuso, L.; Cristofani, R.; Sartori, E. 2014: Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). Gynecologic Oncology 134(1): 29-35
Rackley, T.; Palaniappan, N.; Owens, D.; Evans, M. 2014: Adjuvant treatment decisions for oropharyngeal cancer - is it time for a change?. Clinical Otolaryngology: Official Journal of Ent-Uk ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology and Cervico-Facial Surgery 39(5): 316-321
Battista, M.J.; Schmidt, M.; Rieks, N.; Sicking, I.; Albrich, S.; Eichbaum, M.; Koelbl, H.; Mallmann, P.; Hoffmann, G.; Steiner, E. 2015: Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006. Journal of Cancer Research and Clinical Oncology 141(3): 555-562
Kim, R.; Chabot, J.; Saif, M.Wasif. 2011: Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. JOP: Journal of the pancreas 12(4): 362-363
Zighelboim, I.; Powell, M.A. 2011: Adjuvant treatment for early-stage endometrial cancer. Clinical Obstetrics and Gynecology 54(2): 245-255
Pasetto, L.M.; Falci, C.; Basso, U.; Gasparini, G.; D'Andrea, M.; Bonginelli, P.; Bajetta, E.; Platania, M.; Alabiso, O.; Miraglia, S.; Bertona, E.; Oniga, F.; Biason, R.; Chetrì, M.C.; Fedele, P.; Massara, G.; Romaniello, I.; Negru, M.E.; Luchena, G.; Giordano, M.; Buzzi, F.; Ricottao, R.; Sienao, S.; Monfardini, S. 2008: Adjuvant treatment for elderly patients with colon cancer. An observational study. Anticancer Research 28(4c): 2513-2518
Veluswamy, R.R.; Mhango, G.; Bonomi, M.; Neugut, A.I.; Hershman, D.L.; Aldridge, M.D.; Wisnivesky, J.P. 2013: Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection. Annals of the American Thoracic Society 10(6): 622-628
Morneau, Mélanie.; Foster, W.; Lalancette, M.; Van Nguyen-Huynh, T.; Renaud, M-Claude.; Samouëlian, V.; Letarte, N.; Almanric, K.; Boily, G.; Bouchard, P.; Boulanger, J.; Cournoyer, G.; Couture, Félix.; Gervais, N.; Goulet, Séphanie.; Guay, M-Pascale.; Kavanagh, Mélanie.; Lemieux, J.; Lespérance, B.; Letarte, N.; Morneau, Mélanie.; Ouellet, J-François.; Pineau, G.; Rajan, R.; Roy, I.; Samson, Bît.; Sidéris, L.; Vincent, Fçois.; Almanric, K.; Boily, G.; Bouchard, P.; Boulanger, J.; Cournoyer, G.; Couture, Félix.; Gervais, N.; Goulet, Séphanie.; Guay, M-Pascale.; Kavanagh, Mélanie.; Lemi 2013: Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO). Gynecologic Oncology 131(1): 231-240
Ashraf, N.; Hoffe, S.; Kim, R. 2013: Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist 18(9): 1013-1021
Ilson, D.H. 2014: Adjuvant treatment for gastric cancer: too much is not enough. LANCET. Oncology 15(8): 788-789
De Stefano, A.; Moretto, R.; Bucci, L.; Pepe, S.; Romano, F.J.; Cella, A.C.; Attademo, L.; Rosanova, M.; De Falco, S.; Fiore, G.; Raimondo, L.; De Placido, S.; Carlomagno, C. 2014: Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?. Clinical Colorectal Cancer 13(3): 185-191
Daoud, V.; Saif, M.W.; Goodman, M. 2014: Adjuvant treatment for pancreatic cancer. Jop: Journal of the Pancreas 15(4): 348-350
Kiyota, N.; Tahara, M.; Fujii, M. 2015: Adjuvant treatment for post-operative head and neck squamous cell carcinoma. Japanese Journal of Clinical Oncology 45(1): 2-6
Leung, J. 2013: Adjuvant treatment for resected pancreatic adenocarcinoma-still an unresolved issue. LANCET. Oncology 14(13): E583-E584
Lakomý, R.; Poprach, A.; Nēmecek, R.; Vyskocil, J.; Ondrová, B.; Kocák, I.; Kocáková, I.; Rehák, Z.; Vyzula, R. 2009: Adjuvant treatment for stage i of testicular germ cell tumours. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 22(1): 22-26
Akers, S.N.; Groman, A.; Odunsi, K.; Lele, S.; Frederick, P.J. 2013: Adjuvant treatment for uterine leiomyosarcoma. European Journal of Gynaecological Oncology 34(5): 409-414
Balduzzi, A.; Cardillo, A.; D'Alessandro, C.; Colleoni, M. 2007: Adjuvant treatment for young women with early breast cancer. Minerva Ginecologica 59(5): 513-527
Cereda, S.; Belli, C.; Reni, M. 2012: Adjuvant treatment in biliary tract cancer: to treat or not to treat?. World Journal of Gastroenterology 18(21): 2591-2596
Streng, H. 2010: Adjuvant treatment in hormone receptor positive breast cancer. MMW Fortschritte der Medizin 152(41): 37-39
Remon, J.; Lianes, P.; Martínez, S.; Velasco, M.; Querol, R.; Zanui, M. 2013: Adjuvant treatment in resected non-small cell lung cancer: current and future issues. Critical Reviews in Oncology/Hematology 88(2): 375-386
Cetin, E.N.; Yıldırım, C. 2013: Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery. International Ophthalmology 33(5): 605-610
Gungorduk, K.; Ozdemir, A.; Ertas, I.E.; Gokcu, M.; Telli, E.; Oge, T.; Sahbaz, A.; Sayhan, S.; Sanci, M.; Harma, M.; Ozalp, S. 2015: Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas. Cancer Research and Treatment 47(2): 282-289
Mlodawska, E.; Lopatowska, P.; Malyszko, J.; Banach, M.; Sobkowicz, B.że.; Covic, A.; Tomaszuk-Kazberuk, A. 2018: Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?. International Urology and Nephrology 50(9): 1633-1642
Lee, N.K. 2011: Adjuvant treatment of advanced-stage endometrial cancer. Clinical Obstetrics and Gynecology 54(2): 256-265
Lecavalier-Barsoum, M.; Quon, H.; Abdulkarim, B. 2014: Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas. Cochrane Database of Systematic Reviews 5: Cd007104
Eberlein, B.; Eicke, C.; Reinhardt, H.-W.; Ring, J. 2008: Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). Journal of the European Academy of Dermatology and Venereology: Jeadv 22(1): 73-82
Macpherson, I.R.; Lindsay, C.; Canney, P. 2010: Adjuvant treatment of breast cancer in postmenopausal women: role of exemestane. Breast Cancer 2: 59-70
Downey, L.B. 2008: Adjuvant treatment of breast cancer in the elderly. Understanding and addressing the challenges. Oncology 22(3): 286-93; Discussion 297-8
Mouridsen, H.T.; Andersen, J.ør. 2007: Adjuvant treatment of breast cancer. Endocrine therapy. Ugeskrift for Laeger 169(37): 3072-3076
Simonds, H.M.; Miles, D. 2007: Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor. Expert Opinion on Biological Therapy 7(4): 487-491
Van Loon, K.; Venook, A.P. 2011: Adjuvant treatment of colon cancer: what is next?. Current Opinion in Oncology 23(4): 403-409
Wils, J. 1994: Adjuvant treatment of colon-cancer - a plea for a large-scale European trial. Oncology Reports 1(1): 225-226
Lo Pardo, D.; Pezzuti, G.; Selleri, C.; Pepe, S.; Esposito, S. 2012: Adjuvant treatment of diabetic foot. Le Infezioni in Medicina 20(Suppl 1): 35-41
Cazzaniga, M.E.; Mustacchi, G.; Pronzato, P.; De Matteis, A.; Di Costanzo, F.; Floriani, I. 2007: Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(12): 1976-1980
Short, S.S.; Stojadinovic, A.; Nissan, A.; Wainberg, Z.; Dhall, D.; Yao, K.; Bilchik, A. 2012: Adjuvant treatment of early colon cancer with micrometastases: results of a national survey. Journal of Surgical Oncology 106(2): 119-122
Eichbaum, M.H.R.; Sohn, C. 2008: Adjuvant treatment of early-stage endometrial cancer: which patient can benefit from chemotherapy?. Gynecologic Oncology 109(3): 434; Author Reply 434-6
Verweij, J. 2012: Adjuvant treatment of gastrointestinal stromal tumor: the proof, the pro, and the practice. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2012: 659-662
Loveless, M.H. 1948: Adjuvant treatment of hay fever with emulsions of pollen extract. Acta Allergologica 1(2): 226
Bernier, J. 2007: Adjuvant treatment of head and neck cancers: advances and challenges. Bulletin du Cancer 94(9): 823-827
Yossi, S.; Krhili, S.; Mesgouez-Nebout, N.; Vinchon-Petit, S.; Jadaud, E.; Tuchais, C.; Cellier, P.; Autret, D.; Rio, E.; Fernandez, L.; Poirier, A.-L.; Mahé, M.A.; Paumier, A. 2013: Adjuvant treatment of keloid scars: electrons or brachytherapy?. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 17(1): 21-25
Wozniak, A.J.; Gadgeel, S.M. 2007: Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?. Oncology 21(2): 163-171; Discussion 171 174 179-182
Crawford, J. 2012: Adjuvant treatment of older patients with lung cancer. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2012: 315-319
Khosravi Shahi, P.; Izarzugaza Perón, Y.; Encinas García, S.; Díaz Muñoz de la Espada, V.M.; Pérez Manga, G. 2008: Adjuvant treatment of operable breast cancer. Anales de Medicina Interna 25(1): 36-40
Neoptolemos, J.P. 2011: Adjuvant treatment of pancreatic cancer. European Journal of Cancer 47(Suppl 3): S378-S380
Saif, M.Wasif. 2009: Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. JOP: Journal of the pancreas 10(4): 373-377
Regan, M.M.; Pagani, O.; Fleming, G.F.; Walley, B.A.; Price, K.N.; Rabaglio, M.; Maibach, R.; Ruepp, B.; Coates, A.S.; Goldhirsch, A.; Colleoni, M.; Gelber, R.D.; Francis, P.A. 2013: Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast 22(6): 1094-1100
Kim, S.J.; Kim, J.; Park, J.-H.; Lee, A.-R.; Lee, J.-K.; Kim, T.M.; Park, Y.S. 2013: Adjuvant treatment of proper endobronchial management in leiomyosarcoma. Tuberculosis and Respiratory Diseases 75(6): 250-255
Müller, P.A.; Bröcker, E.B.; Klinker, E.; Stoevesandt, J.; Benoit, S. 2012: Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption. Dermatology 224(3): 224-227
Bosset, J-François. 2008: Adjuvant treatment of rectal cancer: improving patient selection. Gastrointestinal cancer research: GCR 2(1): 37-38
Chhatwani, L.; Cabebe, E.; Wakelee, H.A. 2009: Adjuvant treatment of resected lung cancer. Proceedings of the American Thoracic Society 6(2): 194-200
Felip, E.; Martinez-Marti, A.; Martinez, P.; Cedres, S.; Navarro, A. 2013: Adjuvant treatment of resected nonsmall cell lung cancer: state of the art and new potential developments. Current Opinion in Oncology 25(2): 115-120
Wiedermann, C.J. 2014: Adjuvant treatment of sepsis: what is known?. Medizinische Klinik Intensivmedizin und Notfallmedizin 109(8): 583-590
Calhoun, R.; Jablons, D.; Lau, D.; Gandara, D.R. 2008: Adjuvant treatment of stage IB NSCLC: the problem of stage subset heterogeneity. Oncology 22(5): 511-516; Discussion 516: 521-523
Gao, X.; Ding, G.; Wang, Z.; Fu, H.; Ni, Z.; Ma, J.; Song, S.; Liu, F.; Fu, Z. 2010: Adjuvant treatment suppresses IL-17 production by T cell-independent myeloid sources in nonobese diabetic mice. Molecular Immunology 47(14): 2397-2404
Wang, C.-H.; Chung, F.-T.; Lin, S.-M.; Huang, S.-Y.; Chou, C.-L.; Lee, K.-Y.; Lin, T.-Y.; Kuo, H.-P. 2014: Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Critical Care Medicine 42(2): 313-321
De Marzi, P.; Frigerio, L.; Cipriani, S.; Parazzini, F.; Busci, L.; Carlini, L.; Viganò, R.; Mangili, G. 2010: Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience. Gynecologic Oncology 116(3): 408-412
Gok, B.; McGirt, M.J.; Sciubba, D.M.; Garces-Ambrossi, G.; Nelson, C.; Noggle, J.; Bydon, A.; Witham, T.F.; Wolinsky, J-Paul.; Gokaslan, Z.L. 2009: Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis. Neurosurgery 65(1): 193-9; Discussion 199-200
Vaquerizo, V.; Abril, J.C.; Ramírez, A.; Montes, E. 2012: Adjuvant treatment with phenol of aggressive benign and low grade malignant bone tumors in patients with immature skeleton. Acta Ortopedica Mexicana 26(2): 107-111
Biondi, B.; Pulcrano, M.; Pagano, L.; Lombardi, G. 2009: Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer. Biologics: Targets and Therapy 3: 9-13
Tiodorovic-Zivkovic, D.; Argenziano, G.; Catricalà, C.; Ferrara, G.; Giorgio, C.M.; Moscarella, E.; Zalaudek, I. 2011: Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma. European Journal of Dermatology: Ejd 21(3): 410-411
Yerushalmi, R.; Sulkes, A. 2012: Adjuvant treatment with trastuzumab in early breast cancer. Harefuah 151(1): 34-36; 61
Retsas, S.; Quigley, M.; Pectasides, D.; Henry, K. 2009: Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008). Melanoma Research 19(2): 123-124
Eigentler, T.K.; Radny, P.; Hauschild, A.; Gutzmer, R.; Linse, R.; Pföhler, C.; Wagner, S.N.; Schadendorf, D.; Ellwanger, U.; Garbe, C.; Hermes, B.; Kohl, P.; Mohr, P.; Breitbart, E.W.; Koch, H.J.; Schreiter, K.; Stein, A.; Sebastian, G.; Meurer, M.; Kellner, I.; Linse, R.; Wagner, S.; Goos, M.; Neuber, K.; Moll, I.; Gutzmer, R.; Kapp, A.; Jess, P.; Näher, H.; Petzoldt, D.; Djawari, D.; Petzold, O.; Pföhler, C.; Reinhold, U.; Tilgen, W.; Kaatz, M.; Elsner, P.; Möller, M.; Hauschild, A.; Jöckel, A.; Mauch, C.; Krieg, T.; Hoffmann, U.; Schadendorf, D.; Pierfrancesco, Z.; Daniel, E.; Vigl, E.; Böttjer, J.; Hartig, C.; Stadler, R.; Nashan, D.; Luger, T.; Pelzer, P.; Hölzle, E.; Coras, B.; Stolz, W.; Landthaler, M.; Ebisch, M.A.; Zimmerma 2008: Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group. Melanoma Research 18(5): 353-358
Gouin, F.; Rochwerger, A.R.; Di Marco, A.; Rosset, P.; Bonnevialle, P.; Fiorenza, F.; Anract, P. 2014: Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone. European Journal of Cancer 50(14): 2425-2431
Zaffanello, M.; Brugnara, M.; Franchini, M.; Fanos, V. 2009: Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: a systematic review. Current Therapeutic Research 70(3): 254-265
Bouvier, A.Marie.; Créhange, G.; Azélie, C.; Cheynel, N.; Jouve, J.Louis.; Bedenne, L.; Faivre, J.; Lepage, Côme.; Maingon, P. 2014: Adjuvant treatments for gastric cancer: from practice guidelines to clinical practice. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 46(1): 72-75
Horwich, A. 2011: Adjuvant treatments for locally advanced prostate cancer. European Journal of Cancer 47(Suppl 3): S317-S318
Ishii, H.; Yamamoto, J.; Ikari, T. 2008: Adjuvant treatments for resectable hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 15(5): 459-462
Ueno, H.; Kosuge, T. 2008: Adjuvant treatments for resectable pancreatic cancer. Journal of Hepato-Biliary-Pancreatic Surgery 15(5): 468-472
Liao, W.-C.; Chien, K.-L.; Lin, Y.-L.; Wu, M.-S.; Lin, J.-T.; Wang, H.-P.; Tu, Y.-K. 2013: Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. LANCET. Oncology 14(11): 1095-1103
Joensuu, H.; Gligorov, J. 2012: Adjuvant treatments for triple-negative breast cancers. Annals of Oncology: Official Journal of the European Society for Medical Oncology 23(Suppl 6): Vi40-Vi45
Schmitt, C.; Bouteille, C.; Faure, C.; Mignotte, Hé.; Tredan, O.; Bachelot, T.; Guastalla, J-Paul.; Arnaud, A.; Treilleux, I.; Carrabin, N. 2012: Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node. Bulletin du Cancer 99(4): 463-469
Hendlisz, A.; Golfinopoulos, V. 2009: Adjuvant trials design in colon cancer. Current Opinion in Oncology 21(4): 367-368
Cohen, R.L. 2012: Adjuvant trials of targeted agents: the newest battleground in the war on cancer. Current Topics in Microbiology and Immunology 355: 217-232
Mignogna, M.D.; Fortuna, G.; Leuci, S.; Adamo, D.; Dell'Aversana Orabona, G.; Ruoppo, E. 2010: Adjuvant triamcinolone acetonide injections in oro-pharyngeal pemphigus vulgaris. Journal of the European Academy of Dermatology and Venereology: Jeadv 24(10): 1157-1165
Cole, P.S.; Quisberg, J.; Melin, M.Mark. 2009: Adjuvant use of acoustic pressure wound therapy for treatment of chronic wounds: a retrospective analysis. Journal of Wound Ostomy and Continence Nursing: Official Publication of Wound Ostomy and Continence Nurses Society 36(2): 171-177
Dizdar, O.; Harputluoglu, H.; Dede, D.S.; Altundag, K. 2007: Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2(12): 1136
Franco, A.éi.C.B.F.; Torrico, A.C.; Moreira, F.áb.T.; Sá, F.P.; D'Elia, H.V.; Bernardo, W.M. 2012: Adjuvant use of intravenous immunoglobulin in the treatment of neonatal sepsis: a systematic review with a meta-analysis. Jornal de Pediatria 88(5): 377-383
Yener, M.; Gultekin, E.; Ozdemir, I. 2009: Adjuvant use of liquid alginate suspension for post-tonsillectomy morbidity: double-blind randomized clinical trial of efficacy. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 140(5): 652-656
Hussain, S.A.-R.; Al-Khalifa, I.I.; Jasim, N.A.; Gorial, F.I. 2011: Adjuvant use of melatonin for treatment of fibromyalgia. Journal of Pineal Research 50(3): 267-271
Sarris, J.; Kavanagh, D.J.; Byrne, G. 2010: Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. Journal of Psychiatric Research 44(1): 32-41
Morelli, M.; Rocca, M.Luigia.; Venturella, R.; Di Cello, A.; Del Negro, S.; Condorelli, M.; Dominijanni, A.; Zullo, F. 2013: Adjuvant use of platelet gel for wound breakdown prevention in advanced vulvar cancer surgery: a retrospective study. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23(8): 1490-1494
Carson, W.E.; Unger, J.M.; Sosman, J.A.; Flaherty, L.E.; Tuthill, R.J.; Porter, M.J.; Thompson, J.A.; Kempf, R.A.; Othus, M.; Ribas, A.; Sondak, V.K. 2014: Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class i antigen expression on overall survival. Cancer Immunology Research 2(10): 981-987
McCloskey, S.A.; Tchabo, N.E.; Malhotra, H.K.; Odunsi, K.; Rodabaugh, K.; Singhal, P.; Lele, S.; Jaggernauth, W. 2010: Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecologic Oncology 116(3): 404-407
Kellas-Ślęczka, S.; Wojcieszek, P.; Białas, B. 2012: Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer. Journal of Contemporary BrachyTherapy 4(4): 247-252
Eldredge-Hindy, H.B.; Eastwick, G.; Anne, P.R.; Rosenblum, N.G.; Schilder, R.J.; Chalian, R.; Zibelli, A.M.; Kim, C.H.; Den, R. 2014: Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer. Journal of Contemporary BrachyTherapy 6(3): 262-270
Liu, C.-C. 2014: Adjuvant valproate therapy for patients with suspected mixed-depressive features. Therapeutic Advances in Psychopharmacology 4(4): 143-148
D'Amico, A.V. 2013: Adjuvant versus salvage post-prostatectomy radiation therapy: a critical review of the evidence. Journal of Urology 190(2): 450-451
D'Amico, A.V.; Chen, M.-H.; Sun, L.; Lee, W.R.; Mouraviev, V.; Robertson, C.N.; Walther, P.J.; Polascik, T.J.; Albala, D.M.; Moul, J.W. 2010: Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. Bju International 106(11): 1618-1622
Mishra, M.V.; Scher, E.D.; Andrel, J.; Margules, A.C.; Hegarty, S.E.; Trabulsi, E.J.; Hyslop, T.; Den, R.B.; Lallas, C.D.; Gomella, L.G.; Dicker, A.P.; Showalter, T.N. 2015: Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes. American Journal of Clinical Oncology 38(1): 55-60
King, C.R. 2012: Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orange. International Journal of Radiation Oncology Biology Physics 82(3): 1045-1046
Su, M.Z.; Kneebone, A.B.; Woo, H.H. 2014: Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?. Expert review of anticancer therapy 14(11): 1265-1270
Pepe, C.; Hasan, B.; Winton, T.L.; Seymour, L.; Graham, B.; Livingston, R.B.; Johnson, D.H.; Rigas, J.R.; Ding, K.; Shepherd, F.A. 2007: Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25(12): 1553-1561
Macchia, G.; Cilla, S.; Morganti, A.G.; Deodato, F.; Legge, F.; Piermattei, A.; Chiantera, V.; Scambia, G.; Valentini, V.; Ferrandina, G. 2014: Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison. Acta Oncologica 53(2): 251-258
Strauss, G.M. 2009: Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question?. Oncology 23(6): 534-6 538
McVey, G.P.; Parker, C. 2010: Adjuvant vs. salvage radiotherapy for pathologically advanced prostate cancer. Current Opinion in Urology 20(3): 229-233
Rochet, N.; Jensen, A.D.; Sterzing, F.; Munter, M.W.; Eichbaum, M.H.; Schneeweiss, A.; Sohn, C.; Debus, J.; Harms, W. 2007: Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO IIi patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/Ii study: study protocol. Bmc Cancer 7: 227
Larson, D.; Sahgal, A. 2008: Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). International Journal of Radiation Oncology Biology Physics 72(3): 959
Cikes, M.; Claggett, B.; Shah, A.M.; Desai, A.S.; Lewis, E.F.; Shah, S.J.; Anand, I.S.; O'Meara, E.; Rouleau, J.L.; Sweitzer, N.K.; Fang, J.C.; Saksena, S.; Pitt, B.; Pfeffer, M.A.; Solomon, S.D. 2018: Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction: the TOPCAT Trial. JACC. Heart Failure 6(8): 689-697
Borghesi, S.; Scotti, V.; Petrucci, A.; Paoletti, L.; Rossi, F.; Galardi, A.; Biti, G. 2010: Adjuvant whole pelvic radiotherapy in 43 patients with uterine serous cancer: outcome and patterns of failure. Tumori 96(1): 54-59
McPherson, C.M.; Suki, D.; Feiz-Erfan, I.; Mahajan, A.; Chang, E.; Sawaya, R.; Lang, F.F. 2010: Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases. Neuro-Oncology 12(7): 711-719
Mekhail, T.; Sombeck, M.; Sollaccio, R. 2011: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. Current oncology reports 13(4): 255-258
Kunzmann, V.; Wilhelm, M. 2011: Adjuvant zoledronic acid for breast cancer: mechanism of action?. LANCET. Oncology 12(11): 991-992
Coleman, R.; Cameron, D.; Dodwell, D.; Bell, R.; Wilson, C.; Rathbone, E.; Keane, M.; Gil, M.; Burkinshaw, R.; Grieve, R.; Barrett-Lee, P.; Ritchie, D.; Liversedge, V.; Hinsley, S.; Marshall, H. 2014: Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. LANCET. Oncology 15(9): 997-1006
He, M.; Fan, W.; Zhang, X. 2013: Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis. Journal of Hematology and Oncology 6(1): 80
Stiggelbout, A.M. 2010: Adjuvant! and other prediction models in the clinical encounter with cancer patients. Medical Decision Making: An International Journal of the Society for Medical Decision Making 30(4): 422-423
Agarwal, V.; O'Neill, P. 2011: Adjuvant! Online as a decision-making tool in early breast cancer--a UK national survey. Clinical Oncology ) 23(2): 159-160
Balakrishnan, A.; Haysom, S.A.; Ravichandran, D. 2011: Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of a breast cancer multidisciplinary team (MDT): a prospective study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(6): 1461-1462
Paridaens, R.J.; Gelber, S.; Cole, B.F.; Gelber, R.D.; Thürlimann, B.; Price, K.N.; Holmberg, S.B.; Crivellari, D.; Coates, A.S.; Goldhirsch, A. 2010: Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. Breast Cancer Research and Treatment 123(1): 303-310
Bhoo-Pathy, N.; Yip, C.-H.; Hartman, M.; Saxena, N.; Taib, N.A.; Ho, G.-F.; Looi, L.-M.; Bulgiba, A.M.; van der Graaf, Y.; Verkooijen, H.M. 2012: Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. European Journal of Cancer 48(7): 982-989
Kraft Rovere, R.; Colchon, P.H.; Rebello, J.R. 2013: Adjuvant! Online: mind the gap!. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 26(2): 110-113
Huober, J.; Thürlimann, B. 2009: Adjuvant! when the new world meets the old world. LANCET. Oncology 10(11): 1028-1029
Hess, V. 2008: Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer. Therapeutische Umschau. Revue Therapeutique 65(4): 201-205
Sun, H.; He, S.; Shi, M. 2014: Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection. International Immunopharmacology 22(2): 346-355
Ilyinskii, P.O.; Roy, C.J.; O'Neil, C.P.; Browning, E.A.; Pittet, L.A.; Altreuter, D.H.; Alexis, F.; Tonti, E.; Shi, J.; Basto, P.A.; Iannacone, M.; Radovic-Moreno, A.F.; Langer, R.S.; Farokhzad, O.C.; von Andrian, U.H.; Johnston, L.P.M.; Kishimoto, T.Kei. 2014: Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 32(24): 2882-2895
Anonymous 2011: Adjuvant-containing H1N1 influenza vaccine pandemrix: narcolepsy in children. Prescrire International 20(117): 154
Nakada, E.M.; Shan, J.; Kinyanjui, M.W.; Fixman, E.D. 2014: Adjuvant-dependent regulation of interleukin-17 expressing γδ T cells and inhibition of Th2 responses in allergic airways disease. Respiratory Research 15: 90
Loureiro, S.; Ren, J.; Phapugrangkul, P.; Colaco, C.A.; Bailey, C.R.; Shelton, H.; Molesti, E.; Temperton, N.J.; Barclay, W.S.; Jones, I.M. 2011: Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. Journal of Virology 85(6): 3010-3014
Carter, J.L.; Lubahn, C.; Lorton, D.; Osredkar, T.; Der, T.C.; Schaller, J.; Evelsizer, S.; Flowers, S.; Ruff, N.; Reese, B.; Bellinger, D.L. 2011: Adjuvant-induced arthritis induces c-Fos chronically in neurons in the hippocampus. Journal of Neuroimmunology 230(1-2): 85-94
Wang, Y.; Bhattacharya, D. 2014: Adjuvant-specific regulation of long-term antibody responses by ZBTB20. Journal of Experimental Medicine 211(5): 841-856
Madarnas, Y.; Trudeau, M.; Franek, J.A.; McCready, D.; Pritchard, K.I.; Messersmith, H. 2008: Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review. Cancer Treatment Reviews 34(6): 539-557
de Vries, L.; van Hunsel, F.; Cuppers-Maarschalkerweerd, B.; van Puijenbroek, Eène.; van Grootheest, K. 2014: Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands. Birth Defects Research. Part A Clinical and Molecular Teratology 100(10): 731-738
Galli, G.; Medini, D.; Borgogni, E.; Zedda, L.; Bardelli, M.; Malzone, C.; Nuti, S.; Tavarini, S.; Sammicheli, C.; Hilbert, A.K.; Brauer, V.; Banzhoff, A.; Rappuoli, R.; Del Giudice, G.; Castellino, F. 2009: Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proceedings of the National Academy of Sciences of the United States of America 106(10): 3877-3882
Anonymous 2008: Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed. Prescrire international 17(98): 234-236
Ann, J.; Samant, M.; Rheaume, C.; Dumas, C.; Beaulieu, E.; Morasse, A.; Mallett, C.; Hamelin, M.-E.; Papadopoulou, B.; Boivin, G. 2014: Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines. Vaccine 32(43): 5730-5739
Cherif, H.; Höglund, M.; Pauksens, K. 2013: Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients. European Journal of Haematology 90(5): 413-419
Dooley, M.; Goa, K.L. 2000: Adjuvanted influenza vaccine. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(1): 61-69
Martin, M.d.P.; Seth, S.; Koutsonanos, D.G.; Jacob, J.; Compans, R.W.; Skountzou, I. 2010: Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge. Plos one 5(5): E10897
Park, C.L. 2000: Adjuvanted influenza vaccine: a viewpoint by C. L. Park. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(1): 70-71
Even-Or, O.; Samira, S.; Ellis, R.; Kedar, E.; Barenholz, Y. 2013: Adjuvanted influenza vaccines. Expert Review of Vaccines 12(9): 1095-1108
El-Kamary, S.S.; Pasetti, M.F.; Mendelman, P.M.; Frey, S.E.; Bernstein, D.I.; Treanor, J.J.; Ferreira, J.; Chen, W.H.; Sublett, R.; Richardson, C.; Bargatze, R.F.; Sztein, M.B.; Tacket, C.O. 2010: Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. Journal of Infectious Diseases 202(11): 1649-1658
Barrett, P.Noel.; Ehrlich, H.J. 2011: Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1). Lancet. Infectious diseases 11(7): 496-7; author reply 497-8
Fox, C.B.; Barnes V, L.; Evers, T.; Chesko, J.D.; Vedvick, T.S.; Coler, R.N.; Reed, S.G.; Baldwin, S.L. 2013: Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy. Influenza and other Respiratory Viruses 7(5): 815-826
Binjawadagi, B.; Dwivedi, V.; Manickam, C.; Ouyang, K.; Wu, Y.; Lee, L.James.; Torrelles, J.B.; Renukaradhya, G.J. 2014: Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. International Journal of Nanomedicine 9: 679-694
Ansaldi, F.; Canepa, P.; Parodi, V.; Bacilieri, S.; Orsi, A.; Compagnino, F.; Icardi, G.; Durando, P. 2009: Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. Vaccine 27(25-26): 3345-3348
Dwivedi, V.; Vasco, A.; Vedi, S.; Dangi, A.; Arif, K.; Bhattacharya, S.M.; Owais, M. 2009: Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome. Vaccine 27(3): 473-482
Cho, W-Seob.; Dart, K.; Nowakowska, D.J.; Zheng, X.; Donaldson, K.; Howie, S.E.M. 2012: Adjuvanticity and toxicity of cobalt oxide nanoparticles as an alternative vaccine adjuvant. Nanomedicine 7(10): 1495-1505
Dobakhti, F.; Naghibi, T.; Taghikhani, M.; Ajdary, S.; Rafinejad, A.; Bayati, K.; Rafiei, S.; Rafiee-Tehrani, M. 2009: Adjuvanticity effect of sodium alginate on subcutaneously injected BCG in BALB/c mice. Microbes and Infection 11(2): 296-301
Li, W.-J.; Long, K.; Dong, H.-L.; Gao, X.-M. 2013: Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice. Clinical and Vaccine Immunology: Cvi 20(4): 582-589
Werninghaus, K.; Babiak, A.; Gross, O.; Hölscher, C.; Dietrich, H.; Agger, E.M.; Mages, J.ör.; Mocsai, A.; Schoenen, H.; Finger, K.; Nimmerjahn, F.; Brown, G.D.; Kirschning, C.; Heit, A.; Andersen, P.; Wagner, H.; Ruland, J.ür.; Lang, R. 2009: Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. Journal of Experimental Medicine 206(1): 89-97
Chen, X.; Chen, X.; Qiu, S.; Hu, Y.; Wang, D.; Liu, X.; Zhao, X.; Liu, C.; Chen, X. 2013: Adjuvanticity of compound astragalus polysaccharide and sulfated epimedium polysaccharide per os. International Journal of Biological Macromolecules 62: 248-253
Fan, Y.; Wang, D.; Liu, J.; Hu, Y.; Zhao, X.; Han, G.; Nguyen, T.L.; Chang, S. 2012: Adjuvanticity of epimedium polysaccharide-propolis flavone on inactivated vaccines against Ai and ND virus. International Journal of Biological Macromolecules 51(5): 1028-1032
Padovan, E. 2007: Adjuvanticity of microbial-derived particles and synthetic analogs in vitro. Altex 24 Spec No: 96-97
Inoue, K-ichiro.; Takano, H. 2010: Adjuvanticity of nanoparticles on Th immunity. Basic and Clinical Pharmacology and Toxicology 106(6): 445
Hannesdottir, S.G.; Olafsdottir, T.A.; Giudice, G.D.; Jonsdottir, I. 2008: Adjuvants LT-K63 and CpG enhance the activation of dendritic cells in neonatal mice. Scandinavian Journal of Immunology 68(5): 469-475
Durando, P.; Iudici, R.; Alicino, C.; Alberti, M.; de Florentis, D.; Ansaldi, F.; Icardi, G. 2011: Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Human Vaccines 7 Suppl: 29-40
Israeli, E.; Agmon-Levin, N.; Blank, M.; Shoenfeld, Y. 2009: Adjuvants and autoimmunity. Lupus 18(13): 1217-1225
Portuondo, D.L.F.; Ferreira, L.S.; Urbaczek, A.C.; Batista-Duharte, A.; Carlos, I.Z. 2015: Adjuvants and delivery systems for antifungal vaccines: current state and future developments. Medical Mycology 53(1): 69-89
Heegaard, P.M.H.; Dedieu, L.; Johnson, N.; Le Potier, M.-F.éd.ér.; Mockey, M.; Mutinelli, F.; Vahlenkamp, T.; Vascellari, M.; Sørensen, N.S. 2011: Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Archives of Virology 156(2): 183-202
Killeen, K.P. 2009: Adjuvants and delivery technologies. Human Vaccines 5(10): 667-670
Virelizier, J.-L. 2009: Adjuvants and formulations: how to make an immunogen from an antigen. Biologicals: Journal of the International Association of Biological Standardization 37(3): 139-140
Goff, P.H.; Eggink, D.; Seibert, C.W.; Hai, R.; Martínez-Gil, L.; Krammer, F.; Palese, P. 2013: Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. Plos one 8(11): E79194
Moingeon, P.; Bodo, V.ér.; Airouche, S.; Mascarell, L.; Batard, T. 2013: Adjuvants and vector systems for the sublingual route. Arbeiten aus dem Paul-Ehrlich-Institut Langen/Hessen 97: 164-167
Pérez, O.; Romeu, B.; Cabrera, O.; González, E.; Batista-Duharte, A.; Labrada, A.; Pérez, R.; Reyes, L.M.; Ramírez, W.; Sifontes, S.; Fernández, N.; Lastre, M. 2013: Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform. Frontiers in Immunology 4: 407
Ireton, G.C.; Reed, S.G. 2013: Adjuvants containing natural and synthetic Toll-like receptor 4 ligands. Expert Review of Vaccines 12(7): 793-807
Ishida, W.; Fukuda, K.; Sumi, T.; Ebihara, N.; Kajisako, M.; Matsuda, H.; Yagita, H.; Fukushima, A. 2011: Adjuvants determine the contribution of basophils to antigen sensitization in vivo. Immunology Letters 136(1): 49-54
Archambault, D.; Morin, G. 1988: Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium. Canadian Veterinary Journal 29(1): 51-58
Raman, V.S.; Duthie, M.S.; Fox, C.B.; Matlashewski, G.; Reed, S.G. 2012: Adjuvants for Leishmania vaccines: from models to clinical application. Frontiers in Immunology 3: 144
Moingeon, P. 2012: Adjuvants for allergy vaccines. Human Vaccines and Immunotherapeutics 8(10): 1492-1498
Dubensky, T.W.; Reed, S.G. 2010: Adjuvants for cancer vaccines. Seminars in Immunology 22(3): 155-161
Chiang, C.L.-L.; Kandalaft, L.E.; Coukos, G. 2011: Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines. International Reviews of Immunology 30(2-3): 150-182
Cao, Y. 2014: Adjuvants for foot-and-mouth disease virus vaccines: recent progress. Expert Review of Vaccines 13(11): 1377-1385
Alving, C.R.; Peachman, K.K.; Rao, M.; Reed, S.G. 2012: Adjuvants for human vaccines. Current Opinion in Immunology 24(3): 310-315
Pfaar, O.; Cazan, D.; Klimek, L.; Larenas-Linnemann, D.; Calderon, M.A. 2012: Adjuvants for immunotherapy. Current Opinion in Allergy and Clinical Immunology 12(6): 648-657
van Hemelen, D.; van Oosterhout, A.J.M. 2009: Adjuvants for immunotherapy: lost in translation?. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 39(12): 1783-1785
Coler, R.N.; Carter, D.; Friede, M.; Reed, S.G. 2009: Adjuvants for malaria vaccines. Parasite Immunology 31(9): 520-528
Atmar, R.L.; Keitel, W.A. 2009: Adjuvants for pandemic influenza vaccines. Current Topics in Microbiology and Immunology 333: 323-344
Norman, J.; Hartikka, J.; Strauch, P.; Manthorpe, M. 2000: Adjuvants for plasmid DNA vaccines. Methods in Molecular Medicine 29: 185-196
Charerntantanakul, W. 2009: Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Veterinary Immunology and Immunopathology 129(1-2): 1-13
Alving, C.R.; Matyas, G.R.; Torres, O.; Jalah, R.; Beck, Z. 2014: Adjuvants for vaccines to drugs of abuse and addiction. Vaccine 32(42): 5382-5389
Tetsutani, K.; Ishii, K.J. 2012: Adjuvants in influenza vaccines. Vaccine 30(52): 7658-7661
Kozlov, V.G.; Ozherelkov, S.V.; Sanin, A.V.; Kozhevnikova, T.N. 2014: Adjuvants in modern medicine and veterinary. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 91
Sittel, C. 2008: Adjuvants in operative laryngology. Hno 56(12): 1173-1174
Sittel, C. 2008: Adjuvants in operative laryngology: corticosteroids, fibrin adhesives, Mitomycin C. Hno 56(12): 1175-1182
Bosenberg, A. 2012: Adjuvants in pediatric regional anesthesia. Pain Management 2(5): 479-486
Moreno-Mendieta, S.A.; Rocha-Zavaleta, L.; Rodriguez-Sanoja, R. 2010: Adjuvants in tuberculosis vaccine development. Fems Immunology and Medical Microbiology 58(1): 75-84
Chiarella, P.; Massi, E.; De Robertis, M.; Signori, E.; Fazio, V.M. 2007: Adjuvants in vaccines and for immunisation: current trends. Expert Opinion on Biological Therapy 7(10): 1551-1562
Vordermeier, H.M.; Dean, G.S.; Rosenkrands, I.; Agger, E.M.; Andersen, P.; Kaveh, D.A.; Hewinson, R.G.; Hogarth, P.J. 2009: Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clinical and Vaccine Immunology: Cvi 16(10): 1443-1448
Verdeil, G.ég.; Marquardt, K.; Surh, C.D.; Sherman, L.A. 2008: Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy. Proceedings of the National Academy of Sciences of the United States of America 105(43): 16683-16688
Perret, R.; Sierro, S.R.; Botelho, N.K.; Corgnac, S.ép.; Donda, A.; Romero, P. 2013: Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity. Cancer Research 73(22): 6597-6608
Ravdin, I.S.; Zintel, H.A.; Bender, D.H. 1947: Adjuvants to Surgical Therapy in Large Bowel Malignancy. Annals of Surgery 126(4): 439-447
Zhang, Y.; Siebenaler, K.; Brown, K.; Dohmeier, D.; Hansen, K. 2012: Adjuvants to prolong the local anesthetic effects of coated microneedle products. International Journal of Pharmaceutics 439(1-2): 187-192
Shmakov, A.N.; Kasymov, V.A.; Kokhno, V.N. 2011: Adjuvants to the treatment of acute cerebral insufficiency in newborns. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(2): 60-63
Arakawa, T. 2011: Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future. Expert Review of Vaccines 10(1): 1-5
Glenn, G.M.; O'Hagan, D.T. 2007: Adjuvants: progress, regress and pandemic preparedness. Expert Review of Vaccines 6(5): 651-652
Aichinger, M.C.; Ginzler, M.; Weghuber, J.; Zimmermann, L.; Riedl, K.; Schütz, G.; Nagy, E.; von Gabain, A.; Schweyen, R.; Henics, T.ás. 2011: Adjuvating the adjuvant: facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells. Vaccine 29(3): 426-436
Miller, T.L.; Bray, R.A.; Goiran, C.; Justine, J.-L.; Cribb, T.H. 2009: Adlardia novaecaledoniae n. g., n. sp. (Digenea: Cryptogonimidae) from the fork-tailed threadfin bream Nemipterus furcosus (Val.) (Perciformes: Nemipteridae) off new Caledonia. Systematic Parasitology 73(2): 151-160
Kuo, C-Chuan.; Chen, H-Hui.; Chiang, W. 2012: Adlay ( yì yĭ; "soft-shelled job's tears"; the seeds of Coix lachryma-jobi L. var. ma-yuen Stapf) is a Potential Cancer Chemopreventive Agent toward Multistage Carcinogenesis Processes. Journal of Traditional and Complementary Medicine 2(4): 267-275
Ha, D.T.; Nam Trung, T.; Bich Thu, N.; Van On, T.; Hai Nam, N.; Van Men, C.; Thi Phuong, T.; Bae, K. 2010: Adlay seed extract (Coix lachryma-jobi L.) decreased adipocyte differentiation and increased glucose uptake in 3T3-L1 cells. Journal of Medicinal Food 13(6): 1331-1339
Matera, S.; Meskine, H.; Reuter, K. 2011: Adlayer inhomogeneity without lateral interactions: rationalizing correlation effects in CO oxidation at RuO2(110) with first-principles kinetic Monte Carlo. Journal of Chemical Physics 134(6): 064713
Bubnis, G.J.; Mayne, H.R. 2011: Adlayer morphologies and free energy landscapes of clusters of bis-fullerenes on model gold surfaces. Journal of Physical Chemistry. a 115(25): 7044-7054
Wang, L.; Ou-Yang, L.; Yau, S.-L. 2008: Adlayer structure of octa-alkoxy-substituted copper(II) phthalocyanine on Au(111) by electrochemical scanning tunneling microscopy. Microscopy Research and Technique 71(1): 20-25
Yan, C.-J.; Yan, H.-J.; Xu, L.-P.; Song, W.-G.; Wan, L.-J.; Wang, Q.-Q.; Wang, M.-X. 2007: Adlayer structures of aza- and/or oxo-bridged calix[2]arene[2]triazines on Au(111) investigated by scanning tunneling microscopy (STM). Langmuir: the Acs Journal of Surfaces and Colloids 23(15): 8021-8027
Kuhn, S.; Jung, U.; Ulrich, S.; Herges, R.; Magnussen, O. 2011: Adlayers based on molecular platforms of trioxatriangulenium. Chemical Communications 47(31): 8880-8882
Cometto, F.P.; Ruano, G.; Ascolani, H.; Zampieri, G. 2013: Adlayers of alkanedithiols on Au(111): effect of disulfide reducing agent. Langmuir: the Acs Journal of Surfaces and Colloids 29(5): 1400-1406
Dietrich, P.M.; Horlacher, T.; Girard-Lauriault, P.-L.; Gross, T.; Lippitz, A.; Min, H.; Wirth, T.; Castelli, R.; Seeberger, P.H.; Unger, W.E.S. 2011: Adlayers of dimannoside thiols on gold: surface chemical analysis. Langmuir: the Acs Journal of Surfaces and Colloids 27(8): 4808-4815
Volkov, V.V.; Lebedeva, V.I.; Petrova, I.V.; Bobyl, A.V.; Konnikov, S.G.; Roldughin, V.I.; van Erkel, J.; Tereshchenko, G.F. 2011: Adlayers of palladium particles and their aggregates on porous polypropylene hollow fiber membranes as hydrogenization contractors/reactors. Advances in Colloid and Interface Science 164(1-2): 144-155
Remadevi, R.; Szallisi, A. 2008: Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief. Idrugs: the Investigational Drugs Journal 11(2): 120-132
Plottke, P.; Adler, A. 1947: Adler and the others. Individual Psychology Bulletin 6: 130-136
Baikov, P.A.; Chetyrkin, K.G.; Kühn, J.H. 2010: Adler function, Bjorken sum rule, and the Crewther relation to order alpha(s)(4) in a general gauge theory. Physical Review Letters 104(13): 132004
Paulau, P.V.; McIntyre, C.; Noblet, Y.; Radwell, N.; Firth, W.J.; Colet, P.; Ackemann, T.; Oppo, G.-L. 2012: Adler synchronization of spatial laser solitons pinned by defects. Physical Review Letters 108(21): 213904
Lindenfeld, E.; MacDONALD, M.; Adler, A. 1947: Adler's contribution to social adjustment. Individual Psychology Bulletin 6(1-2): 22-26
Mandell, S.; Adler, A. 1947: Adler's contribution to the varying functions of a psychologist. Individual Psychology Bulletin 6(1-2): 65-68
Ansbacher, H.L.; Adler, A. 1947: Adler's place today in the psychology of memory. Individual Psychology Bulletin 6(1-2): 32-40
Amianto, F.; Bertorello, A.; Spalatro, A.; Milazzo, M.; Signa, C.; Cavarero, S.; Abbate Daga, G.; Fassino, S. 2014: Adlerian parental counseling in eating disorders: preliminary data of a controlled clinical trial. Eating and Weight Disorders: Ewd 19(3): 303-314
Bruck, A.; Adler, A. 1947: Adlerian philosophy. Individual Psychology Bulletin 6(1-2): 80-87
Pratt, A.B. 1985: Adlerian psychology as an intuitive operant system. Behavior Analyst 8(1): 39-51
Iranshahy, M.; Javidi-Shirazi, H.; Pham, N.B.; Quinn, R.J.; Sadeghian, H.; Iranshahi, M. 2014: Adlumiceine methyl ester, a new alkaloid from Fumaria vaillantii. Journal of Asian Natural Products Research 16(12): 1148-1152
Richardson, G.S. 1946: Admantinoma of the maxillary sinus; report of two cases. Annals of Otology Rhinology and Laryngology 55(4): 914-931
Karlsson, P.M.; Esbjörnsson, N.B.; Holmberg, K. 2009: Admicellar polymerization of methyl methacrylate on aluminum pigments. Journal of Colloid and Interface Science 337(2): 364-368
Saitoh, T.; Itoh, H.; Hiraide, M. 2009: Admicelle-enhanced synchronous fluorescence spectrometry for the selective determination of polycyclic aromatic hydrocarbons in water. Talanta 79(2): 177-182
Rayhan, R.U.; Zheng, Y.; Uddin, E.; Timbol, C.; Adewuyi, O.; Baraniuk, J.N. 2013: Administer and collect medical questionnaires with Google documents: a simple, safe, and free system. Applied Medical Informatics 33(3): 12-21
Lane-Krebs, K.; Reid-Searl, K.; Heidke, P. 2012: Administer one puppet PRN. Australian Nursing Journal 19(8): 43
Gruen, R.L.; Reade, M.C. 2012: Administer tranexamic acid early to injured patients at risk of substantial bleeding. Bmj 345: E7133
Watson, L. 2010: Administer vaccines? how to decide. Radiologic Technology 81(4): 390-392
Cheng, Q.; Xu, C.; Zhang, L.; Li, J.; Cao, T.; Zhang, M. 2010: Administered CpG oligodeoxynucleotide induces mRNA expression of CXC and CC chemokines at the intestinal mucosa and PBMCs in piglets. International Immunopharmacology 10(5): 611-618
Al-Sughayir, M.A. 2014: Administered antipsychotic pro re nata medications in psychiatric inpatients. Pre- and post-accreditation comparison. Saudi Medical Journal 35(2): 172-177
Honda, S.; Kawamoto, S.; Tanaka, H.; Kishida, H.; Kitagawa, M.; Nakai, Y.; Abe, K.; Hirata, D. 2014: Administered chrysanthemum flower oil attenuates hyperuricemia: mechanism of action as revealed by DNA microarray analysis. Bioscience Biotechnology and Biochemistry 78(4): 655-661
Federico, G.; Focosi, D.; Marchi, B.; Randazzo, E.; De Donno, M.; Vierucci, F.; Bugliani, M.; Campi, F.; Scatena, F.; Saggese, G.; Mathieu, C.; Marchetti, P. 2014: Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens. Clinical Nutrition 33(6): 1153-1156
Podicheti, R.; Dong, Q. 2011: Administering GBrowse sites with WebGBrowse. Current Protocols in Bioinformatics Chapter 9: Unit 9.14
Reed, M.J. 2007: Administering a glyceryl trinitrate infusion: big is not always best. Emergency Medicine Journal: Emj 24(6): 423-424
Reed, M. 2008: Administering a glyceryl trinitrate infusion: faster is better than slower. Emergency Medicine Journal: Emj 25(9): 620
Stevens, S. 2009: Administering a subconjunctival injection. Community Eye Health 22(69): 15
Higgins, D. 2007: Administering a suppository. Nursing Times 103(10): 26-27
Pullen, R.L. 2008: Administering a transdermal drug. Nursing 38(5): 14
Heidgerken, L. 1949: Administering an audio-visual education program. Hospital Progress 30(2): 35-38
Rushing, J. 2008: Administering an enoxaparin injection. Nursing 38(3): 19
Fahmi, A.; Bowman, R. 2008: Administering an eye anaesthetic: principles, techniques, and complications. Community Eye Health 21(65): 14-17
Pullen, R.L. 2008: Administering an orally disintegrating tablet. Nursing 38(1): 18
Kohler, F.D.; Harvey, D.L. 1970: Administering and managing the u.s. And soviet space programs. Science 169(3950): 1049-1056
Wilson, E.; Morbey, H.; Brown, J.; Payne, S.; Seale, C.; Seymour, J. 2015: Administering anticipatory medications in end-of-life care: a qualitative study of nursing practice in the community and in nursing homes. Palliative Medicine 29(1): 60-70
Fulco, P.P. 2013: Administering antiretroviral medication through enteral tubes. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(12): 1016-1017
Mello, Sônia.A.; Marese, Aélica.C.M.; Brancalhão, R.M.C.; Zanoni, J.N.; Natali, M.Raquel.M. 2013: Administering ascorbic acid to rats undergoing ageing processes: effects on myosin-V immunoreactive myenteric neurons. Anais da Academia Brasileira de Ciencias 85(1): 337-347
Zou, Y.; Tian, S.; Wang, Y.; Sun, K. 2014: Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 25(7): 660-664
Smith, N. 2011: Administering chemotherapy in nononcology settings: a case study. Clinical Journal of Oncology Nursing 15(4): 433-435
Morrisey, F.Frank. 2009: Administering church goods. Health Progress 90(4): 11-13
Hurks, P.P.M. 2013: Administering design fluency tests in school-aged children: analyses of design productivity over time, clustering, and switching. Clinical Neuropsychologist 27(7): 1131-1149
Williams, T. 2012: Administering enteral tube medications - room for improvement?. Evidence-Based Nursing 15(4): 126-127
Watkinson, S.; Seewoodhary, R. 2008: Administering eye medications. Nursing Standard: 1987) 22(18): 42-48
Rushing, J. 2007: Administering eyedrops. Nursing 37(5): 18
Berlepsch-Schreiner, H.; Glienke, S.; Staudacher, D. 2014: Administering eyedrops--no so simple at all. Krankenpflege. Soins Infirmiers 107(7): 21-23
Chiasson, A.M.; Rowe, P. 2000: Administering influenza vaccine in a Canadian emergency department: is there a role?. Cjem 2(2): 90-94
Greenhawt, M.J.; Li, J.T.; Bernstein, D.I.; Blessing-Moore, J.; Cox, L.; Khan, D.; Lang, D.M.; Nicklas, R.A.; Oppenheimer, J.; Portnoy, J.M.; Randolph, C.; Schuller, D.E.; Spector, S.L.; Tilles, S.A.; Wallace, D. 2011: Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 106(1): 11-16
Kelso, J.M. 2014: Administering influenza vaccine to egg-allergic persons. Expert Review of Vaccines 13(8): 1049-1057
Khan, S.; Abuzakouk, M.; Doré, P.C.; Sewell, W.A.C. 2011: Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients. Irish Journal of Medical Science 180(1): 125-128
Nielsen, S.Bjerregaard.; Wells, J.C.K.; Slater, C.; Fewtrell, M.S.; Reilly, J.J. 2011: Administering labelled water to exclusively breast-fed infants in studies involving stable isotope dilution techniques. Isotopes in Environmental and Health Studies 47(1): 18-25
Kelly, J.; Wright, D. 2009: Administering medication to adult patients with dysphagia. Nursing Standard: 23(29): 62-68
Kelly, J.; Wright, D. 2010: Administering medication to adult patients with dysphagia: part 2. Nursing Standard: 24(26): 61-68
Anonymous 2008: Administering medication: not so fast. Nursing 38(7): 54
Kovosi, S.; Freeman, M. 2011: Administering medications for Parkinson disease on time. Nursing 41(3): 66
Macleod, S. 2014: Administering medicines when water is unavailable. Archives of Disease in Childhood 99(3): 257
Timmis, E. 1946: Administering penicillin. Public Health Nursing 38: 20-23
Pullen, R.L.; Hayes, D.D. 2007: Administering pneumococcal vaccine. Nursing 37(9): 59
Salvatori, M.; Mansi, L. 2007: Administering radioiodine treatment; alternative to nuclear medicine prescribing. European Journal of Nuclear Medicine and Molecular Imaging 34(9): 1512-1513
Moore, P.A. 2007: Administering sedation: the controversy continues. General dentistry 55(4): 273-4; author reply 274
Neraal, T. 2014: Administering shortages. Deutsches Arzteblatt International 111(20): 364
Puckett, C. 2010: Administering social security: challenges yesterday and today. Social security bulletin 70(3): 27-78
Weinert, C.R. 1989: Administering steroids in unicameral bone cysts. Western Journal of Medicine 150(6): 684-685
Mitchell, G.A. 1988: Administering sulfamethazine to food-producing animals. Canadian Veterinary Journal 29(4): 327-329
Waters, A.J.; Miller, E.K.; Li, Y. 2010: Administering the Implicit Association Test in an ecological momentary assessment study. Psychological Reports 106(1): 31-43
Moawad, E.Y. 2014: Administering the Optimum Dose of l-Arginine in Regional Tumor Therapy. Indian Journal of Clinical Biochemistry: Ijcb 29(4): 442-451
Floyd, S. 2010: Administering the influenza vaccine. Nursing New Zealand 16(4): 20-21
Shaffer, C.; Aymong, L. 2014: Administering vaccines. Nursing 44(10): 46-50
Mitchell, A.A.; Sapienza-Crawford, A.J.; Hanley, K.L.; Lokey, K.J.; Wells, L.; McDowell, G.C.; Stanton-Hicks, M. 2013: Administering ziconotide and monitoring patients treated with ziconotide: expert opinions. Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses 14(3): E84-E94
He, Z.-X.; Wang, H.-W.; Shang, F.; Yan, H.; Yang, Y. 2009: Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats. Zhonghua Yi Xue Za Zhi 89(30): 2110-2115
Haggard, A. 2008: Administration. Journal for Nurses in Staff Development: Jnsd: Official Journal of the National Nursing Staff Development Organization 24(4): 187-188
Tedaldi, M.; Ramieri, V.; Foresta, E.; Cascone, P.; Iannetti, G. 2010: Experience in the management of frontal sinus fractures. Journal of Craniofacial Surgery 21(1): 208-210
McCalmont, T.H. 2012: Administration. Journal of Cutaneous Pathology 39(9): 819-820
Walsh, J. 1984: Administration Announces Intent to Leave UNESCO. Science 223(4632): 150-151
Panzarini, E.; Dwikat, M.; Mariano, S.; Vergallo, C.; Dini, L. 2014: Administration Dependent Antioxidant Effect of Carica papaya Seeds Water Extract. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 281508
Branch, A. 1930: Administration of Iodides by Inhalation. Canadian Medical Association Journal 23(6): 829
Forbes, T.R. 1938: Administration of Oestrone to Young Alligators. Science 87(2256): 282-283
Cumberlege, G.I. 1911: Administration of Serum by the Mouth. British Medical Journal 2(2637): 108
Smith, R.J. 1983: Administration Resists Demands for ASAT Ban: Arguments for a ban on antisatellite weapons gain an increasingly sympathetic hearing in Congress, but Reagan's appointees show little enthusiasm. Science 222(4622): 394-396
Land, E.H.; Daw, N.W. 1962: Binocular Combination of Projected Images. Science 138(3540): 589-590
Hagland, M. 2010: Administration Tech Trends 2010. Trend: data infrastructure. Healthcare Informatics: the Business Magazine for Information and Communication Systems 27(2): 12; 14
Koutsaki, S.; Koutelekos, I.; Gerogianni, G.; Koutsaki, M.; Koukouzeli, A.; Fouka, G.; Polikandrioti, M. 2018: Atrial Fibrillation in Hypertension: Patients' Characteristics. Materia Socio-Medica 30(1): 4-9
Tasic, I.; Lazarevic, G.; Kostic, S.; Djordjevic, D.; Simonovic, D.; Rihter, M.; Vulic, D.; Stefanovic, V. 2010: Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk. Acta Cardiologica 65(4): 407-414
Rahman-Filipiak, A.A.M.; Woodard, J.L. 2013: Administration and environment considerations in computer-based sports-concussion assessment. Neuropsychology Review 23(4): 314-334
Luo, L.; Wang, W.Z.; Song, W.L. 2001: Administration and evaluation nutrition support of live related intestinal transplantation during perioperation. Zhongguo Ying Yong Sheng Li Xue Za Zhi 17(1): 102-103
Bostock, J. 1949: Administration and mental invalidity; a historical introduction to a recurring problem. Medical Journal of Australia 1(4): 96-98
Sahinovic, M.M.; Absalom, A.R.; Struys, M.M.R.F. 2010: Administration and monitoring of intravenous anesthetics. Current Opinion in Anaesthesiology 23(6): 734-740
Perez, E. 1983: Administration and physicians. Canadian Medical Association Journal 128(2): 104
Connor, D.J.; Sabbagh, M.N. 2008: Administration and scoring variance on the ADAS-Cog. Journal of Alzheimer's Disease: Jad 15(3): 461-464
Mayes, D.; Janzen, S.K.; Quigley, P.A. 2009: Administration and union partnership: one Magnet hospital's story. Nursing Administration Quarterly 33(2): 105-108
Abdeen, A.Z. 1982: Administration angst. Canadian Family Physician Medecin de Famille Canadien 28: 598
Popov, N.; Heruti, I.; Levy, S.; Lulav-Grinwald, D.; Bar-Sela, G. 2014: Illness perception differences between Russian- and Hebrew-speaking Israeli oncology patients. Journal of Clinical Psychology in Medical Settings 21(1): 33-40
Smith, R.J. 1985: Administration at Odds over Soviet Cheating: Some allegations, listed as "probable" or "likely" in Administration reports, are disputed by government experts. Science 228(4700): 695-696
Walsh, J. 1979: Administration backs plan for technology foundation. Science 203(4379): 423
Mageshwaran, L. 2013: Administration by Gavage is the rule. Cardiovascular Drugs and Therapy 27(5): 481
Seymour, R.A. 1948: Administration by nurses of intramuscular and intravenous therapy. Canadian Hospital 25(9): 41
Soini, E.J.; Leussu, M.; Hallinen, T. 2013: Administration costs of intravenous biologic drugs for rheumatoid arthritis. Springerplus 2: 531
Kruse, G.B.; Potashman, M.H.; Stavrakas, S.; Wong, B.J. 2014: Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma. Journal of Medical Economics 17(7): 446-458
Sun, M. 1985: Administration drafts biotech plan for OECD. Science 230(4728): 925
Ryan, J.J.; Glass, L.A.; Tree, H.A. 2008: Administration frequencies of WAIS-III supplementary and optional subtests of board-certified clinical neuropsychologists. Applied Neuropsychology 15(3): 205-207
Norman, C. 1983: Administration grapples with export controls. Science 220(4601): 1021-1024
Scott, E.H. 1945: Administration in a hospital in China. Australian Hospital 12(10): 16
Millward, R.C. 1948: Administration in our hospitals; improvements which might be made. Hospital and Health Management 11(128): 201-204
Sbrana, F.; Di Paolo, A.; Pasanisi, E.M.; Tagliaferri, E.; Arvia, C.; Puntoni, M.; Leonildi, A.; Bigazzi, F.; Danesi, R.; Rovai, D.; Tascini, C.; Menichetti, F. 2010: Administration interval and daptomycin toxicity: a case report of rhabdomyolysis. Journal of ChemoTherapy 22(6): 434-435
Curtis, J.; Capp, K. 2003: Administration of 'as needed' psychotropic medication: a retrospective study. International Journal of Mental Health Nursing 12(3): 229-234
Lourbopoulos, A.; Grigoriadis, N.; Lagoudaki, R.; Touloumi, O.; Polyzoidou, E.; Mavromatis, I.; Tascos, N.; Breuer, A.; Ovadia, H.; Karussis, D.; Shohami, E.; Mechoulam, R.; Simeonidou, C. 2011: Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Research 1390: 126-141
Schöffski, P.; Cerbone, L.; Wolter, P.; De Wever, I.; Samson, I.; Dumez, H.; Clement, P.; Wildiers, H.; Stas, M. 2012: Administration of 24-h intravenous infusions of trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: an effective and patient-friendly palliative treatment option. Onkologie 35(1-2): 14-17
Padron, A.S.; Neto, R.A.L.; Pantaleão, T.U.; de Souza dos Santos, M.C.; Araujo, R.L.; de Andrade, B.M.; da Silva Leandro, M.; de Castro, J.ão.P.S.W.; Ferreira, A.C.F.; de Carvalho, D.P. 2014: Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues. Journal of Endocrinology 221(3): 415-427
Hofmeyr, G.J.; Fawole, B.; Mugerwa, K.; Godi, N.P.; Blignaut, Q.; Mangesi, L.; Singata, M.; Brady, L.; Blum, J. 2011: Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 112(2): 98-102
Viganó, F.; Perissinotto, L.; Bosco, V.R.F. 2010: Administration of 5% human serum albumin in critically ill small animal patients with hypoalbuminemia: 418 dogs and 170 cats (1994-2008). Journal of Veterinary Emergency and Critical Care 20(2): 237-243
Ju, S.-A.; Park, S.-M.; Lee, Y.-S.; Bae, J.-H.; Yu, R.; An, W.G.; Suh, J.-H.; Kim, B.-S. 2012: Administration of 6-gingerol greatly enhances the number of tumor-infiltrating lymphocytes in murine tumors. International Journal of Cancer 130(11): 2618-2628
Stechman, M.J.; Charlwood, N.; Gray, D.W.R.; Handa, A. 2007: Administration of 75 mg of aspirin daily for 28 days is sufficient prophylaxis against renal transplant vein thrombosis. Phlebology 22(2): 83-85
Hoschler, K.; Andrews, N.J.; Faust, S.N.; Finn, A.; Pollard, A.J.; Snape, M.D.; Walker, W.T.; Zambon, M.; Miller, E. 2014: Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58(2): 181-187
Mori, H.; Yamanaka, K.; Matsuo, K.; Kurokawa, I.; Yasutomi, Y.; Mizutani, H. 2009: Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. Archives of Dermatological Research 301(2): 151-157
Anonymous 1948: Administration of Anaesthetics. Canadian Medical Association Journal 58(3): 293
Wang, L.; Kisaalita, W.S. 2011: Administration of BDNF/ginsenosides combination enhanced synaptic development in human neural stem cells. Journal of Neuroscience Methods 194(2): 274-282
Shim, J.-H.; Greenblatt, M.B.; Singh, A.; Brady, N.; Hu, D.; Drapp, R.; Ogawa, W.; Kasuga, M.; Noda, T.; Yang, S.-H.; Lee, S.-K.; Rebel, V.I.; Glimcher, L.H. 2012: Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice. Journal of Clinical Investigation 122(1): 91-106
Liu, P.; Feng, Y.; Dong, C.; Yang, D.; Li, B.; Chen, X.; Zhang, Z.; Wang, Y.; Zhou, Y.; Zhao, L. 2014: Administration of BMSCs with muscone in rats with gentamicin-induced AKi improves their therapeutic efficacy. Plos one 9(5): E97123
Ripamonti, B.; Agazzi, A.; Baldi, A.; Balzaretti, C.; Bersani, C.; Pirani, S.; Rebucci, R.; Savoini, G.; Stella, S.; Stenico, A.; Domeneghini, C. 2009: Administration of Bacillus coagulans in calves: recovery from faecal samples and evaluation of functional aspects of spores. Veterinary Research Communications 33(8): 991-1001
Zokaeifar, H.; Babaei, N.; Saad, C.R.; Kamarudin, M.S.; Sijam, K.; Balcazar, J.L. 2014: Administration of Bacillus subtilis strains in the rearing water enhances the water quality, growth performance, immune response, and resistance against Vibrio harveyi infection in juvenile white shrimp, Litopenaeus vannamei. Fish and Shellfish Immunology 36(1): 68-74
Taipale, T.; Pienihäkkinen, K.; Alanen, P.; Jokela, J.; Söderling, E. 2013: Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age. Caries research 47(5): 364-372
Anonymous 1961: Administration of Blood By Registered Nurses-Joint Statement by California Medical Association, California Hospital Association and California Nurses' Association. California Medicine 95(6): 409-410
Ruiu, L.; Satta, A.; Floris, I. 2014: Administration of Brevibacillus laterosporus spores as a poultry feed additive to inhibit house fly development in feces: a new eco-sustainable concept. Poultry Science 93(3): 519-526
Marek-Trzonkowska, N.; Mysliwiec, M.; Dobyszuk, A.; Grabowska, M.; Techmanska, I.; Juscinska, J.; Wujtewicz, M.A.; Witkowski, P.; Mlynarski, W.; Balcerska, A.; Mysliwska, J.; Trzonkowski, P. 2012: Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children. Diabetes Care 35(9): 1817-1820
Jiang, Y.; Brody, D.L. 2012: Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice. Journal of Neurotrauma 29(13): 2332-2341
Shlieout, G.; Koerner, A.; Maffert, M.; Forssmann, K.; Caras, S. 2011: Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study. Clinical Drug Investigation 31(7): E1-E7
Rother, C. 2013: Administration of Cardiodoron® in patients with functional cardiovascular disorders and/or sleep disorders--results of a prospective, non-interventional study. Forschende Komplementarmedizin 20(5): 334-344
Von Allmen, E.P. 1942: Administration of Case Finding in Industry. California and Western Medicine 57(1): 51-52
Bedirli, A.; Kerem, M.; Ofluoglu, E.; Salman, B.; Katircioglu, H.; Bedirli, N.; Yilmazer, D.; Alper, M.; Pasaoglu, H. 2009: Administration of Chlorella sp. microalgae reduces endotoxemia, intestinal oxidative stress and bacterial translocation in experimental biliary obstruction. Clinical Nutrition 28(6): 674-678
Joyner, J.; Neves, L.; Ferrario, C.; Brosnihan, K. 2008: Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation. Journal of the American Society of Hypertension: Jash 2(6): 425-430
Ohkubo, T.; Tanaka, Y. 2010: Administration of DHA-PS to aged mice was suitable for increasing hippocampal PS and DHA ratio. Journal of Oleo Science 59(5): 247-253
Weissman, A.; Horowitz, E.; Ravhon, A.; Levran, D. 2014: Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue. Journal of Assisted Reproduction and Genetics 31(11): 1565
Parashar, D.; Paingankar, M.S.; Kumar, S.; Gokhale, M.D.; Sudeep, A.B.; Shinde, S.B.; Arankalle, V.A. 2013: Administration of E2 and NS1 si RNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus. Plos Neglected Tropical Diseases 7(9): E2405
Pashnin, A.G.; Lebedeva, N.N.; Avakian, G.N. 2007: Administration of EHF-therapy in patients with drug-resistant epilepsy. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2: 12-14
Maddox, M.L.; DeBoer, E.C.; Hammerquist, R.J. 2014: Administration of Extended Infusion Piperacillin-TazobactamWith the use of Smart Pump Technology. Hospital Pharmacy 49(5): 444-448
Miller, M.M.; Fogle, J.E. 2012: Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection. Viruses 4(6): 954-962
Voigt, R.M.; Herrold, A.A.; Riddle, J.L.; Napier, T.Celeste. 2011: Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behavioural Brain Research 216(1): 419-423
Best, S.R.; Peng, S.; Juang, C.-M.; Hung, C.-F.; Hannaman, D.; Saunders, J.R.; Wu, T.-C.; Pai, S.I. 2009: Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 27(40): 5450-5459
Cornely, P.B. 1936: Administration of Health Education and Health Supervision in Negro Colleges. American Journal of Public Health and the Nation's Health 26(9): 888-896
Memos, N.; Betrosian, A.; Messaris, E.; Boutsikou, M.; Kataki, A.; Chatzigianni, E.; Nikolopoulou, M.; Leandros, E.; Konstadoulakis, M. 2009: Administration of Human Protein-C concentrate prevents apoptotic brain cell death after experimental sepsis. Brain Research 1264: 119-126
DeBoer, M.D.; Scarlett, J.M.; Levasseur, P.R.; Grant, W.F.; Marks, D.L. 2009: Administration of IL-1beta to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract. Peptides 30(2): 210-218
Hung, A.M.; Limkunakul, C.; Placido, J.S.; Siew, E.D.; Ellis, C.D.; Shintani, A.; Ikizler, T.A. 2014: Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients. Journal of Nephrology 27(6): 681-688
Vilskersts, R.; Kuka, J.; Svalbe, B.; Cirule, H.; Liepinsh, E.; Grinberga, S.; Kalvinsh, I.; Dambrova, M. 2011: Administration of L-carnitine and mildronate improves endothelial function and decreases mortality in hypertensive Dahl rats. Pharmacological Reports: Pr 63(3): 752-762
Sergeyeva, T.N.; Sergeyev, V.G. 2011: Administration of LPS-stimulated autologous macrophages induces α-synuclein aggregation in dopaminergic neurons of rat brain. Bulletin of Experimental Biology and Medicine 150(4): 406-408
Meadows-Oliver, M. 2011: Administration of Lactobacillus GG to hospitalised children reduces the risk of gastrointestinal and respiratory tract infections. Evidence-Based Nursing 14(1): 8-9
Lv, L.-X.; Hu, X.-J.; Qian, G.-R.; Zhang, H.; Lu, H.-F.; Zheng, B.-W.; Jiang, L.; Li, L.-J. 2014: Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats. Applied Microbiology and Biotechnology 98(12): 5619-5632
Waters, T.C. 1939: Administration of Laws for the Prevention and Control of Occupational Diseases. American Journal of Public Health and the Nation's Health 29(7): 728-737
Vargas-Guerrero, B.; García-López, P.M.; Martínez-Ayala, A.L.; Domínguez-Rosales, J.é A.; Gurrola-Díaz, C.M. 2014: Administration of Lupinus albus gamma conglutin (Cγ) to n5 STZ rats augmented Ins-1 gene expression and pancreatic insulin content. Plant Foods for Human Nutrition 69(3): 241-247
Golubtsova, E.N.; Veliev, E.I. 2011: Administration of M-cholinoblockers after prostatic surgery. Urologiia 5: 46-49
Marengo, E.B.; de Moraes, L.V.; Faria, M.; Fernandes, B.L.; Carvalho, L.V.; Tambourgi, D.V.; Rizzo, L.V.; Portaro, F.C.V.; Camargo, A.ôn.C.M.; Sant'anna, O.A. 2008: Administration of M. leprae Hsp65 interferes with the murine lupus progression. Plos one 3(8): E3025
Seckinger, D.L. 1941: Administration of Medical Services as Part of a Health Department Program. American Journal of Public Health and the Nation's Health 31(9): 905-911
Taplin, G.V.; Bryan, F.A. 1947: Administration of Micronized Therapeutic Agents by Inhalation or Topical Application. Science 105(2732): 502-503
Marengo, E.B.; Commodaro, A.G.ça.; Peron, J.P.S.; de Moraes, L.V.; Portaro, F.C.V.; Belfort, R.; Rizzo, L.V.; Sant'Anna, O.A. 2009: Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice. Plos one 4(11): E7912
Suman, S.; Maniar, M.; Fornace, A.J.; Datta, K. 2012: Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response. Radiation Oncology 7: 6
Kawata, E.; Ashihara, E.; Kimura, S.; Takenaka, K.; Sato, K.; Tanaka, R.; Yokota, A.; Kamitsuji, Y.; Takeuchi, M.; Kuroda, J.; Tanaka, F.; Yoshikawa, T.; Maekawa, T. 2008: Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Molecular Cancer Therapeutics 7(9): 2904-2912
Penitente, R.; Nicolò, C.; Van den Elzen, P.; Di Sante, G.; Agrati, C.; Aloisi, F.; Sercarz, E.E.; Ria, F. 2008: Administration of PLP139-151 primes T cells distinct from those spontaneously responsive in vitro to this antigen. Journal of Immunology 180(10): 6611-6622
Sanchez-Siles, A.A.; Ishimura, N.; Rumi, M.A.K.; Tamagawa, Y.; Ito, S.; Ishihara, S.; Nabika, T.; Kinoshita, Y. 2011: Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice. Journal of clinical biochemistry and nutrition 49(1): 42-49
Yang, X.; Teoh, S.-H.; DasDe, S.; Lee, T. 2013: Administration of PTH and ibandronate increases ovariectomized rat compact bone viscoelasticity. Journal of the Mechanical Behavior of Biomedical Materials 22: 51-58
Lessard, M.; Dupuis, M.; Gagnon, N.; Nadeau, E.; Matte, J.J.; Goulet, J.; Fairbrother, J.M. 2009: Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. Journal of Animal Science 87(3): 922-934
Lee, Y.; Kim, J.; Jang, S.; Oh, S. 2013: Administration of Phytoceramide Enhances Memory and Upregulates the Expression of pCREB and BDNF in Hippocampus of Mice. Biomolecules and Therapeutics 21(3): 229-233
Mountin, J.W. 1940: Administration of Public Medical Service by Health Departments. American Journal of Public Health and the Nation's Health 30(2): 138-144
Bondo, T.; Jensen, S.K. 2011: Administration of RRR-α-tocopherol to pregnant mares stimulates maternal IgG and IgM production in colostrum and enhances vitamin e and IgM status in foals. Journal of Animal Physiology and Animal Nutrition 95(2): 214-222
Gifondorwa, D.J.; Jimenz-Moreno, R.; Hayes, C.D.; Rouhani, H.; Robinson, M.B.; Strupe, J.L.; Caress, J.; Milligan, C. 2012: Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Neurology Research International 2012: 170426
Hosseinzadeh, H.; Eydi, M.; Ghaffarlou, M.; Ghabili, K.; Golzari, S.E.; Bazzazi, A.M. 2012: Administration of Remifentanil in Establishing a more Stable Post-anesthesia Cardiovascular Status in Neurosurgical Procedures. Journal of Cardiovascular and Thoracic Research 4(1): 21-24
Nishikawa, K.; Iwase, K.; Fujii, M.; Matsuda, C.; Shimada, K.; Hirota, M.; Kimura, T.; Wada, D.; Nasu, S.; Tanaka, Y. 2009: Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(4): 595-598
Lu, A.; Wagner, K.R.; Broderick, J.P.; Clark, J.F. 2014: Administration of S-methyl-L-thiocitrulline protects against brain injuries after intracerebral hemorrhage. Neuroscience 270: 40-47
Khan, M.; Im, Y.-B.; Shunmugavel, A.; Gilg, A.G.; Dhindsa, R.K.; Singh, A.K.; Singh, I. 2009: Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. Journal of Neuroinflammation 6: 32
Genovese, K.J.; Lowry, V.K.; Stanker, L.H.; Kogut, M.H. 1998: Administration of Salmonella enteritidis-immune lymphokine to day-old turkeys by subcutaneous, oral, and nasal routes: A comparison of effects on Salmonella enteritidis liver invasion, peripheral blood heterophilia and heterophil activation. Avian Pathology: Journal of the W.V.P.A 27(6): 597-604
Cary, W.H. 1930: Administration of Swimming Pool Standards in Detroit. American Journal of Public Health and the Nation's Health 20(7): 727-733
Murillo-Rodríguez, E.; Palomero-Rivero, M.; Millán-Aldaco, D.; Arias-Carrión, O.; Drucker-Colín, R.é 2011: Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. Plos one 6(7): E20766
Sasaki, T.; Tanno, S.; Shibukawa, K.; Osanai, S.; Kawabe, J.; Ohsaki, Y. 2008: Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts. International Journal of Oncology 33(3): 525-532
Byun, S.Hye.; Jeon, Y. 2011: Administration of Vitamin C in a Patient with Herpes Zoster - A case report -. Korean Journal of Pain 24(2): 108-111
Edwards, H.R. 1933: Administration of a Bureau of Tuberculosis in a City Department of Health. American Journal of Public Health and the Nation's Health 23(6): 591-599
Baumbauer, K.M.; Young, E.E.; Hoy, K.C.; Abood, A.; Joynes, R.L. 2007: Administration of a Ca-super(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibitor prevents the learning deficit observed in spinal rats after noncontingent shock administration. Behavioral Neuroscience 121(3): 570-578
Leonardo, C.C.; Hall, A.A.; Collier, L.A.; Green, S.M.; Willing, A.E.; Pennypacker, K.R. 2010: Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury. Translational Stroke Research 1(2): 135-145
Winckelmann, A.A.; Munk-Petersen, L.ær.V.; Rasmussen, T.A.; Melchjorsen, J.; Hjelholt, T.J.; Montefiori, D.; Østergaard, L.; Søgaard, O.S.; Tolstrup, M. 2013: Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients. Plos one 8(4): E62074
Juan, Y-Chen.; Kuo, Y-Haur.; Chang, C-Chuan.; Zhang, L-Jie.; Lin, Y-Yu.; Hsu, C-Yun.; Liu, H-Kang. 2011: Administration of a decoction of sucrose- and polysaccharide-rich radix astragali (huang qi) ameliorated insulin resistance and Fatty liver but affected Beta-cell function in type 2 diabetic rats. Evidence-Based Complementary and Alternative Medicine: Ecam 2011: 349807
Arai, T.; Moriyama, H.; Shimizu, M.; Sasaki, H.; Kishi, M.; Okumachi, Y.; Yasuda, H.; Hara, K.; Yokono, K.; Nagata, M. 2010: Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice. Clinical Immunology 136(1): 74-82
Rondanelli, M.; Opizzi, A.; Solerte, S.Bruno.; Trotti, R.; Klersy, C.; Cazzola, R. 2009: Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. British Journal of Nutrition 101(3): 457-464
Scotti, L.; Irusta, G.; Abramovich, D.; Tesone, M.; Parborell, F. 2011: Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. Molecular and Cellular Endocrinology 335(2): 116-125
Blockeel, C.; Riva, A.; De Vos, M.; Haentjens, P.; Devroey, P. 2011: Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. a pilot study. Fertility and Sterility 95(5): 1714-9.E1-2
Beecher, C.; Daly, M.éa.; Berry, D.P.; Klostermann, K.; Flynn, J.; Meaney, W.; Hill, C.; McCarthy, T.V.; Ross, R.P.; Giblin, L. 2009: Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression. Journal of Dairy Research 76(3): 340-348
Caiazzo, G.; De Rosa, S.; Torella, D.; Spaccarotella, C.; Mongiardo, A.; Giampà, S.; Micieli, M.; Palella, E.; Gulletta, E.; Indolfi, C. 2014: Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. CIRCULATION. Cardiovascular Interventions 7(1): 104-112
Mavrogianni, V.S.; Papadopoulos, E.; Fragkou, I.A.; Gougoulis, D.A.; Valasi, I.; Orfanou, D.C.; Ptochos, S.; Gallidis, E.; Fthenakis, G.C. 2011: Administration of a long-acting antiparasitic to pre-pubertal ewe-lambs in Greece results in earlier reproductive activity and improved reproductive performance. Veterinary Parasitology 177(1-2): 139-144
Lee, K.-C.; Yang, Y.-Y.; Huang, Y.-T.; Lee, F.-Y.; Hou, M.-C.; Lin, H.-C.; Lee, S.-D. 2010: Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability. Clinical Science 119(1): 45-55
Dancik, D. 1949: Administration of a medical rehabilitation service in a neuropsychiatric hospital. Archives of Physical Medicine and Rehabilitation 30(10): 657-664
Brini, E.; Ruffini, F.; Bergami, A.; Brambilla, E.; Dati, G.; Greco, B.; Cirillo, R.; Proudfoot, A.E.I.; Comi, G.; Furlan, R.; Zaratin, P.; Martino, G. 2009: Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. Journal of Neuroimmunology 209(1-2): 33-39
Li, Z.; Zhao, B.; Kim, Y.S.; Hu, C.Y.; Yang, J. 2010: Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth. Molecular Reproduction and Development 77(1): 76-82
Sklavos, M.M.; Coudriet, G.M.; Delmastro, M.; Bertera, S.; Coneybeer, J.T.; He, J.; Trucco, M.; Piganelli, J.D. 2013: Administration of a negative vaccination induces hyporesponsiveness to islet allografts. Cell Transplantation 22(7): 1147-1155
Ceriello, A.; Lansink, M.; Rouws, C.H.F.C.; van Laere, K.M.J.; Frost, G.S. 2009: Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. Diabetes Research and Clinical Practice 84(3): 259-266
Tancred, L.; Telepnev, M.V.; Golovliov, I.; Andersson, B.; Andersson, H.; Lindgren, H.; Sjöstedt, A. 2011: Administration of a nitric oxide donor inhibits mglA expression by intracellular Francisella tularensis and counteracts phagosomal escape and subversion of TNF-α secretion. Journal of Medical Microbiology 60(Part 11): 1570-1583
Nihei, J.; Cardillo, F.; Dos Santos, W.L.C.; Pontes-de-Carvalho, L.; Mengel, J. 2014: Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi. European Journal of Microbiology and Immunology 4(2): 128-137
Zhang, Q-Ye.; Ma, S.; Xi, D.; Zhang, W-Tong.; Li, A-Wu. 2011: Administration of a novel penicillamine-bound membrane: a preventive and therapeutic treatment for abdominal adhesions. Bmc Surgery 11: 5
Bontempo, V.; Jiang, X.R.; Cheli, F.; Lo Verso, L.; Mantovani, G.; Vitari, F.; Domeneghini, C.; Agazzi, A. 2014: Administration of a novel plant extract product via drinking water to post-weaning piglets: effects on performance and gut health. Animal: An International Journal of Animal Bioscience 8(5): 721-730
Chand, D.H. 2010: Administration of a pediatric dialysis unit: the basics. Renal Failure 32(1): 10-13
Hamahata, A.; Enkhbaatar, P.; Lange, M.; Yamaki, T.; Nakazawa, H.; Nozaki, M.; Sakurai, H.; Traber, L.D.; Traber, D.L. 2012: Administration of a peroxynitrite decomposition catalyst into the bronchial artery attenuates pulmonary dysfunction after smoke inhalation and burn injury in sheep. Shock 38(5): 543-548
Gomes, C.M.; Serafini, P.C.; Motta, E.L.A.; Rocha, A.M.; Yadid, I.M.; Baracat, E.C. 2010: Administration of a pharmacophysiologic dose of recombinant human chorionic gonadotropin at menses promotes corpus luteum rescue. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 108(2): 158-159
Lucansky, V.; Krmencikova-Fliegl, M.; Stanek, L.; Vonka, V. 2014: Administration of a plasmid that expresses SDF-1α affects the oncogenic potential of mouse bcr-abl-transformed cells. Molecular Medicine Reports 10(4): 2116-2122
Matuskova, Z.; Anzenbacherova, E.; Vecera, R.; Tlaskalova-Hogenova, H.; Kolar, M.; Anzenbacher, P. 2014: Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. Plos one 9(2): E87150
Jarosz, K.; Czupryńska, M.; Andrzejewska, J.; Wasilewicz, M.P.; Post, M.; Lubikowski, J.; Wójcicki, M.; Milkiewicz, P. 2009: Administration of a recombinant factor Vlla in patients undergoing liver transplantation for fulminant hepatic failure. Transplantation Proceedings 41(8): 3088-3090
Branca, C.; Wisely, E.V.; Hartman, L.K.; Caccamo, A.; Oddo, S. 2014: Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease. Neurobiology of Aging 35(12): 2726-2735
Mallet, E.; Philippe, F.; Castanet, M.; Basuyau, J.-P. 2010: Administration of a single Winter oral dose of 200,000 IU of vitamin D3 in adolescents in Normandy: evaluation of the safety and vitamin D status obtained. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 17(7): 1042-1046
Cadena, S.M.; Tomkinson, K.N.; Monnell, T.E.; Spaits, M.S.; Kumar, R.; Underwood, K.W.; Pearsall, R.S.; Lachey, J.L. 2010: Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. Journal of Applied Physiology 109(3): 635-642
Fakhfakh, R.; Lee, S.-J.; Tremblay, J.P. 2012: Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Cell Transplantation 21(7): 1419-1430
Fujino, N.; Kubo, H.; Suzuki, T.; He, M.; Suzuki, T.; Yamada, M.; Takahashi, T.; Ota, C.; Yamaya, M. 2012: Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice. Experimental Lung Research 38(1): 28-36
Olearczyk, J.J.; Quigley, J.E.; Mitchell, B.C.; Yamamoto, T.; Kim, I.-H.; Newman, J.W.; Luria, A.; Hammock, B.D.; Imig, J.D. 2009: Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clinical Science 116(1): 61-70
Vrioni, G.; Bourdakis, A.; Pappas, G.; Pitiriga, V.; Mavrouli, M.; Pournaras, S.; Tsakris, A. 2014: Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Antimicrobial Agents and ChemoTherapy 58(12): 7541-7544
Ghilardi, J.R.; Freeman, K.T.; Jimenez-Andrade, J.M.; Mantyh, W.G.; Bloom, A.P.; Kuskowski, M.A.; Mantyh, P.W. 2010: Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain. Molecular Pain 6: 87
De Costa, A-Maria.A.; Justis, D.N.; Schuyler, C.A.; Young, M.Rita.I. 2012: Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response. International Immunopharmacology 13(3): 322-330
Shen, B.; Remzi, F.H.; Lavery, I.C.; Lopez, R.; Queener, E.; Shen, L.; Goldblum, J.; Fazio, V.W. 2009: Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Alimentary Pharmacology and Therapeutics 29(5): 519-526
Dietlein, M.; Moka, D.; Reinholz, U.; Schmidt, M.; Schomäcker, K.; Schicha, H.; Wellner, U. 2007: Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?. NUKLEARMEDIZIN. Nuclear Medicine 46(3): 77-84
Wang, C.; Wang, M.; Liu, Y.; Zeng, P. 2011: Administration of adenovirus encoding anti-CD20 antibody gene induces B-cell deletion and alleviates lupus in the BWF1 mouse model. International Immunopharmacology 11(6): 693-697
Van Erning, F.N.; Bernards, N.; Creemers, G.-J.; Vreugdenhil, A.; Lensen, C.J.P.A.; Lemmens, V.E.P.P. 2014: Administration of adjuvant oxaliplatin to patients with stage IIi colon cancer is affected by age and hospital. Acta Oncologica 53(7): 975-980
Gao, Y.; Li, X.-Q. 2009: Administration of adrenomedullin into subfornical organ inhibits Na(+),K(+)-ATPase activity in single proximal renal tubule of rats. Sheng Li Xue Bao: 61(1): 94-98
Neĭmark, A.I.; Isaenko, V.I.; Iakovets, I.V.; Simashkevich, A.V.; Aliev, R.T. 2009: Administration of afala preparation in urological practice. Urologiia 3: 67-70
Oreshko, L.S. 2008: Administration of afobasol for correction of mental disorders in celiac disease patients. Terapevticheskii Arkhiv 80(10): 13-16
Gorin, N.-C.; Isnard, F.ço.; Garderet, L.; Ikhlef, S.; Corm, S.; Quesnel, B.; Legrand, O.; Cachanado, M.; Rousseau, A.; Laporte, J.-P. 2013: Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase Ii study. European Journal of Haematology 91(4): 315-321
Sugiura, S.; Inaguma, D.; Kitagawa, A.; Murata, M.; Kamimura, Y.; Sendo, S.; Hamaguchi, K.; Nagaya, H.; Tatematsu, M.; Kurata, K.; Yuzawa, Y.; Matsuo, S. 2010: Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events. Clinical and Experimental Nephrology 14(1): 43-50
Aliaev, I.G.; Rapoport, L.M.; Tsarichenko, D.G.; Bushuev, V.O. 2010: Administration of alpha-blockers to prevent postoperative acute urinary retention after urogenital operations. Urologiia 2010(5): 27-29
Simkins, H.M.A.; Hyde, E.; Farrand, K.J.; Ong, M.L.; Degli-Esposti, M.A.; Hermans, I.F.; Ronchese, F. 2011: Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo. Journal of Leukocyte Biology 89(5): 753-762
Youngquist, S.T.; Niemann, J.T.; Shah, A.P.; Thomas, J.L.; Rosborough, J.P. 2013: Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 33(6): 292-296
Eppert, H.D.; Goddard, K.B. 2010: Administration of amiodarone during resuscitation of ventricular arrhythmias. Journal of Emergency Nursing 36(1): 26-28
Tempe, D.K.; Gandhi, A.; Mehta, V.; Banerjee, A.; Datt, V.; Ramamurthy, P.; Goyal, G. 2007: Administration of amiodarone into the aortic root for persistent ventricular fibrillation after aortic valve replacement. Journal of Cardiothoracic and Vascular Anesthesia 21(3): 414-416
Miyata, M.; Takamatsu, Y.; Kuribayashi, H.; Yamazoe, Y. 2009: Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. Journal of Pharmacology and Experimental Therapeutics 331(3): 1079-1085
Zhang, Y.; He, J.-S.; Wang, X.; Wang, J.; Bao, F.-X.; Pang, S.-Y.; Yin, F.; Hu, H.-G.; Peng, X.-L.; Sun, W.-M.; Zheng, Y.-P.; Hou, L.-L.; Hong, T. 2011: Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice. Journal of Alzheimer's Disease: Jad 23(3): 551-561
Sarner, H. 1963: Administration of an Anesthetic. Journal of the American Dental Society of Anesthesiology 10(5): 138-139
Gault, V.A.; Kerr, B.D.; Harriott, P.; Flatt, P.R. 2011: Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Clinical Science 121(3): 107-117
Shell, W.E.; Charuvastra, M.; Breitstein, M.; Pavlik, S.L.; Charuvastra, A.; May, L.; Silver, D.S. 2014: Administration of an amino Acid-based regimen for the management of autonomic nervous system dysfunction related to combat-induced illness. Journal of Central Nervous System Disease 6: 93-98
Olivares, E.L.; Silveira, A.L.B.; Fonseca, F.V.; Silva-Almeida, C.; Côrtes, R.S.; Pereira-Junior, P.P.; Nascimento, J.H.M.; Reis, L.C. 2014: Administration of an anabolic steroid during the adolescent phase changes the behavior, cardiac autonomic balance and fluid intake in male adult rats. Physiology and Behavior 126: 15-24
Fife, G.L. 1946: Administration of an anesthesia department. Journal of the American Association of Nurse Anesthetists 14: 7-16
Watanabe, Y.; Takasugi, E.; Shitakura, K.; Okajima, K.; Hota, N.; Kubo, Y.; Nunoda, S.; Otsuka, K. 2011: Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect. Clinical and Experimental Hypertension 33(4): 246-254
Yamanashi, H.; Hashizume, O.; Yonekawa, H.; Nakada, K.; Hayashi, J-Ichi. 2014: Administration of an antioxidant prevents lymphoma development in transmitochondrial mice overproducing reactive oxygen species. Experimental Animals 63(4): 459-466
Scott, E.G. 1946: Administration of an effective pharmacy requires a sound policy. Hospitals 20(1): 58-61
Goodhart, R.S. 1948: Administration of an industrial nutrition program. Occupational Medicine 5(3): 252-255
Ayoade, B.A.; Tade, A.O.; Salami, B.A.; Oladapo, O. 2009: Administration of analgesics in patients with acute abdominal pain: a survey of the practice of doctors in a developing country. International Journal of Emergency Medicine 2(4): 211-215
Ozer, A.B.; Erhan, O.L.; Sumer, C.; Yildizhan, O. 2012: Administration of anesthesia in a patient with allgrove syndrome. Case Reports in Anesthesiology 2012: 109346
Ballou, M.A.; Sutherland, M.A.; Brooks, T.A.; Hulbert, L.E.; Davis, B.L.; Cobb, C.J. 2013: Administration of anesthetic and analgesic prevent the suppression of many leukocyte responses following surgical castration and physical dehorning. Veterinary Immunology and Immunopathology 151(3-4): 285-293
Tzafalia, M.; Sixou, J.-L. 2011: Administration of anesthetics using metal syringes. An ex vivo study. Anesthesia Progress 58(2): 61-65
Valdés, G.; Schneider, D.; Corthorn, J.; Ortíz, R.; Acuña, S.; Padilla, O. 2014: Administration of angiotensin Ii and a bradykinin B2 receptor blocker in midpregnancy impairs gestational outcome in guinea pigs. Reproductive Biology and Endocrinology: Rb&e 12: 49
Hongo, M.; Ishizaka, N.; Furuta, K.; Yahagi, N.; Saito, K.; Sakurai, R.; Matsuzaki, G.; Koike, K.; Nagai, R. 2009: Administration of angiotensin II, but not catecholamines, induces accumulation of lipids in the rat heart. European Journal of Pharmacology 604(1-3): 87-92
Watanabe, Y.; Kikuchi, T.; Mitsuhashi, T.; Kimura, H.; Tsuchida, Y.; Otsuka, K. 2013: Administration of angiotensin receptor Ii blockade improves vascular function, urinary albumin excretion, and left ventricular hypertrophy in low-risk essential hypertensive patients receiving antihypertensive treatment with calcium channel blockers. Clinical and Experimental Hypertension 35(2): 87-94
Oliva, S.; Cioffi, G.; Frattini, S.; Simoncini, E.L.; Faggiano, P.; Boccardi, L.; Pulignano, G.; Fioretti, A.M.; Giotta, F.; Lestuzzi, C.; Maurea, N.; Sabatini, S.; Tarantini, L. 2012: Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?. Oncologist 17(7): 917-924
Wakabayashi, K.; Tsujino, T.; Naito, Y.; Ezumi, A.; Lee-Kawabata, M.; Nakao, S.; Goda, A.; Sakata, Y.; Yamamoto, K.; Daimon, T.; Masuyama, T. 2011: Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients. Heart and Vessels 26(3): 252-257
Brown, J.P. 2010: Administration of annual oral high-dose vitamin D to community-dwelling older women in autumn and winter months increases risk of falls and fractures. Evidence-Based Medicine 15(6): 175-176
Liu, D.; Huang, Y.; Jia, C.; Li, Y.; Liang, F.; Fu, Q. 2015: Administration of antagomir-223 inhibits apoptosis, promotes angiogenesis and functional recovery in rats with spinal cord injury. Cellular and Molecular Neurobiology 35(4): 483-491
Johnston, H.F.; Xu, Y.; Racine, J.J.; Cassady, K.; Ni, X.; Wu, T.; Chan, A.; Forman, S.; Zeng, D. 2014: Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(8): 1089-1103
Viterbo, D.; Callender, G.E.; DiMaio, T.; Mueller, C.M.; Smith-Norowitz, T.; Zenilman, M.E.; Bluth, M.H. 2009: Administration of anti-Reg i and anti-PAPIi antibodies worsens pancreatitis. Jop: Journal of the Pancreas 10(1): 15-23
Mashayekhi, F.; Gholizadeh, L. 2011: Administration of anti-c-kit antibody into the cerebrospinal fluid leads to increased cell death in the developing cerebral cortex. Saudi Journal of Biological Sciences 18(3): 261-266
Ishizuka, S.; Inafune, A.; Hira, T.; Izumi, H.; Ozawa, K.; Takase, M.; Hara, H. 2009: Administration of anti-glucagon-like peptide-2 serum suppresses epithelial cell proliferation of the distal small intestine in weanling rats. Biomedical Research 30(4): 259-261
Lei, J.; He, F.; Wu, M.; Zheng, X.; Chen, X.; Chen, Z. 2010: Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival. Transplant International: Official Journal of the European Society for Organ Transplantation 23(12): 1271-1281
Kasuya, K.; Suzuki, M.; Nagakawa, Y.; Suzuki, Y.; Kikuchi, S.; Kyo, B.; Matsudo, T.; Itoi, T.; Tsuchida, A.; Aoki, T. 2012: Administration of anti-vascular endothelial growth factor antibody following hepatectomy does not inhibit remnant liver regeneration or growth of remnant metastases. Experimental and Therapeutic Medicine 3(2): 347-350
Watanabe, J.; Fujiwara, R.; Sasajima, N.; Ito, S.; Sonoyama, K. 2010: Administration of antibiotics during infancy promoted the development of atopic dermatitis-like skin lesions in NC/Nga mice. Bioscience Biotechnology and Biochemistry 74(2): 358-363
Anonymous 2008: Administration of antibiotics for treatment of nosocomial pneumonia in elderly patients or patients with kidney dysfunction. Nihon Kokyuki Gakkai Zasshi 69-72
Petridis, I.G.; Fthenakis, G.C. 2014: Administration of antibiotics to ewes at the beginning of the dry-period. Journal of Dairy Research 81(1): 9-15
Falagas, M.E.; Agrafiotis, M.; Athanassa, Z.; Siempos, I.I. 2008: Administration of antibiotics via the respiratory tract as monotherapy for pneumonia. Expert Review of AntI-Infective Therapy 6(4): 447-452
Rioufol, C.; Ranchon, F.; Schwiertz, V.ér.; Vantard, N.; Joue, E.; Gourc, C.é; Gauthier, N.ém.; Guedat, M.G.; Salles, G.; Souquet, P.-J.; Favier, B.; Gilles, L.; Freyer, G.; You, B.ît.; Trillet-Lenoir, V.ér.; Guitton, J.ér.ôm. 2014: Administration of anticancer drugs: exposure in hospital nurses. Clinical Therapeutics 36(3): 401-407
Prohaska, E.S.; King, A.R. 2012: Administration of antiretroviral medication via enteral tubes. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(24): 2140-2146
Ishitobi, Y.; Akiyoshi, J.; Honda, S.; Ninomiya, T.; Kanehisa, M.; Tanaka, Y.; Tsuru, J.; Isogawa, K.; Kitamura, H.; Fujikura, Y. 2012: Administration of antisense DNA for GPR39-1b causes anxiolytic-like responses and appetite loss in rats. Neuroscience Research 72(3): 257-262
Wakatsuki, M.; Akiyoshi, J.; Ichioka, S.; Tanaka, Y.; Tsuru, J.; Matsushita, H.; Hanada, H.; Isogawa, K. 2007: Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in rats. Neuropeptides 41(6): 477-483
Ryerson, L.M.; Bruce, A.K.; Lequier, L.; Kuhle, S.; Massicotte, M.P.; Bauman, M.E. 2014: Administration of antithrombin concentrate in infants and children on extracorporeal life support improves anticoagulation efficacy. Asaio Journal 60(5): 559-563
Kurian, G.A.; Paddikkala, J. 2009: Administration of aqueous extract of Desmodium gangeticum (L) root protects rat heart against ischemic reperfusion injury induced oxidative stress. Indian Journal of Experimental Biology 47(2): 129-135
Lockhart, W.T.; Atkinson, J.R. 1919: Administration of arsenic in syphilis. Canadian Medical Association Journal 9(2): 129-135
Balto, K. 2011: Administration of articaine anesthesia may lead to superior profound pulpal anesthesia compared with lidocaine in adult patients. Journal of Evidence-Based Dental Practice 11(4): 183-184
de Paula, E.A.; Kossatz, S.; Fernandes, D.; Loguercio, A.D.; Reis, A. 2014: Administration of ascorbic acid to prevent bleaching-induced tooth sensitivity: a randomized triple-blind clinical trial. Operative Dentistry 39(2): 128-135
Geffner, L.F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A.H.; Montenegro, X.; Gonzalez, R.; Silva, F. 2008: Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplantation 17(12): 1277-1293
Sharma, A.; Gokulchandran, N.; Chopra, G.; Kulkarni, P.; Lohia, M.; Badhe, P.; Jacob, V.C. 2012: Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplantation 21(Suppl 1): S79-S90
Rasouli, M.R.; Moini, M.; Eghtesadi-Araghi, P. 2009: Administration of beta-blockers in patients undergoing vascular operations. Journal of the American College of Surgeons 208(6): 1147-8; author reply 1148-9
Livovsky, D.M.; Lalazar, G.; Ben Ya'acov, A.; Pappo, O.; Preston, S.; Zolotaryova, L.; Ilan, Y. 2008: Administration of beta-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution. International Immunopharmacology 8(9): 1298-1305
Hudelist, G.; Huber, A.; Auer, M.; Knöfler, M.; Saleh, L.; Hrachowitz, C.; Huber, J.C.; Kubista, E.; Manavi, M.; Bilban, M.; Singer, C.F. 2010: Administration of betaHCG leads to dose-dependent changes of gene expression signature of endometriotic stromal cells. Reproductive Biomedicine Online 20(5): 699-706
Sasaki, Y.; Sone, H.; Kamiyama, S.; Shimizu, M.; Shirakawa, H.; Kagawa, Y.; Komai, M.; Furukawa, Y. 2012: Administration of biotin prevents the development of insulin resistance in the skeletal muscles of Otsuka Long-Evans Tokushima Fatty rats. Food and Function 3(4): 414-419
Mendoza-Rodríguez, C.A.; García-Guzmán, M.; Baranda-Avila, N.í; Morimoto, S.; Perrot-Applanat, M.; Cerbón, M. 2011: Administration of bisphenol a to dams during perinatal period modifies molecular and morphological reproductive parameters of the offspring. Reproductive Toxicology 31(2): 177-183
Venkataramana, V.; Kumar, S.S.; Reddy, B.V.; Cherukuri, A.S.; Sigamani, K.R.; Chandrasekhar, G. 2014: Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: a radiographic assessment. Journal of Pharmacy and Bioallied Sciences 6(Suppl 1): S165-S170
Oida, T.; Mimatsu, K.; Kano, H.; Kawasaki, A.; Kuboi, Y.; Fukino, N.; Kida, K.; Amano, S. 2012: Administration of bisphosphonates for malignant hepatic tumor with hypercalcemia. Hepato-Gastroenterology 59(114): 444-447
Egger, C.; Cannet, C.; Gérard, C.; Jarman, E.; Jarai, G.; Feige, A.ès.; Suply, T.; Micard, A.; Dunbar, A.; Tigani, B.; Beckmann, N. 2013: Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRi and histology. Plos one 8(5): E63432
Jiang, Q.; Takahagi, S.; Uitto, J. 2012: Administration of bone marrow derived mesenchymal stem cells into the liver: potential to rescue pseudoxanthoma elasticum in a mouse model (Abcc6-/-). Journal of Biomedicine and Biotechnology 2012: 818937
Kong, Q.-F.; Sun, B.; Bai, S.-S.; Zhai, D.-X.; Wang, G.-Y.; Liu, Y.-M.; Zhang, S.-J.; Li, R.; Zhao, W.; Sun, Y.-Y.; Li, N.; Wang, Q.; Peng, H.-S.; Jin, L.-H.; Li, H.-L. 2009: Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta. Journal of Neuroimmunology 207(1-2): 83-91
Wang, Y.; Hu, F.; Wang, Z.-j.; Wang, G.-x.; Zhang, Z.-h.; Xie, P.; Cui, S.-p. 2008: Administration of bone marrow-derived stem cells suppresses cellular necrosis and apoptosis induced by reperfusion of ischaemic kidneys in rats. Chinese Medical Journal 121(3): 268-271
Smith, N.N.; Kelly, M.J.; Pell, J.M.; Hill, R.A. 2010: Administration of bovine anti-IGF-1 immunoglobulin to dietary protein deficient rats alters dietary intake and plasma IGF-1 binding profiles, but does not affect change in body mass. Animal: An International Journal of Animal Bioscience 4(9): 1553-1560
Rempf, C.; Standl, T.; Schenke, K.; Chammas, K.; Gottschalk, A.; Burmeister, M.-A.; Gottschalk, A. 2009: Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits. British Journal of Anaesthesia 103(4): 496-504
Efendiev, M.E.; Ali-Zade, F. 1949: Administration of bromides in internal diseases. Klinicheskaia Meditsina 27(2): 48-52
Ponce Castro, H.; Rodríguez Espino, S.; Rodríguez Orozco, A.R. 2009: Administration of budesonide (inhaled steroid) to children to control intermittent asthma. Revista Alergia Mexico 56(1): 9-12
Bauters, T.; Rayner, P.; Therrien, R.; Van Lancker, S.; Bordon, V.; Robays, H.; Benoit, Y.; Dhooge, C. 2014: Administration of budesonide in children with graft-versus-host disease. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 20(4): 316-318
Xiong, T.; Zhao, Y.; Hu, D.; Meng, J.; Wang, R.; Yang, X.; Ai, J.; Qian, K.; Zhang, H. 2012: Administration of calcitonin promotes blastocyst implantation in mice by up-regulating integrin β3 expression in endometrial epithelial cells. Human Reproduction 27(12): 3540-3551
Tewari, M.; Shukla, H.S. 2007: Administration of cancer chemotherapeutic drugs through the enhanced peripheral veins by creating a radiocephalic fistula. American Journal of Surgery 194(2): 240-242
Zelmer, A.; Martin, M.J.; Gundogdu, O.; Birchenough, G.; Lever, R.; Wren, B.W.; Luzio, J.P.; Taylor, P.W. 2010: Administration of capsule-selective endosialidase e minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1. Microbiology 156(Part 7): 2205-2215
Chugh, A.R.; Beache, G.M.; Loughran, J.H.; Mewton, N.; Elmore, J.B.; Kajstura, J.; Pappas, P.; Tatooles, A.; Stoddard, M.F.; Lima, J.A.C.; Slaughter, M.S.; Anversa, P.; Bolli, R. 2012: Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126(11 Suppl 1: S54-S64
Dale, B.ør.; Hvalvik, S. 2013: Administration of care to older patients in transition from hospital to home care services: home nursing leaders' experiences. Journal of Multidisciplinary Healthcare 6: 379-389
Feng, Y.; Ni, L.; Wang, Q. 2013: Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis. Journal of Dermatological Science 72(2): 158-167
Tabernero, J.; Pfeiffer, P.; Cervantes, A.és. 2008: Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?. Oncologist 13(2): 113-119
Stein, A.; Hiemer, S.; Jordan, K.; Arnold, D.; Schmoll, H.-J. 2012: Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option for patients without possibility of peripheral or central venous access. Onkologie 35(7-8): 440-442
Yoshida, Y.; Hoshino, S.; Aisu, N.; Naito, M.; Tanimura, S.; Mogi, A.; Tanaka, T.; Hirata, K.; Tamura, K.; Yamashita, Y. 2015: Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients. International Journal of Clinical Oncology 20(2): 332-337
Anonymous 1951: Administration of child-care services, and problems for research. Bulletin of the World Health Organization 3(3): 500-506
Sato, N.; Seiwa, C.; Uruse, M.; Yamamoto, M.; Tanaka, K.; Kawakita, T.; Komatsu, Y.; Yasukawa, A.; Takao, M.; Kudo, C.; Hasegawa, A.; Ishige, A.; Watanabe, K.; Asou, H. 2011: Administration of chinpi, a component of the herbal medicine ninjin-youei-to, reverses age-induced demyelination. Evidence-Based Complementary and Alternative Medicine: Ecam 2011: 617438
Tom, V.J.; Kadakia, R.; Santi, L.; Houlé, J.D. 2009: Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity. Journal of Neurotrauma 26(12): 2323-2333
Liu, Y.; Wang, D. 2013: Administration of chromium(III) and manganese(II) as a potential protective approach against daunorubicin-induced cardiotoxicity: in vitro and in vivo experimental evidence. Biological Trace Element Research 156(1-3): 253-261
Abe, A.; Nishiyama, Y.; Hagiwara, H.; Okubo, S.; Ueda, M.; Katsura, K.-i.; Katayama, Y. 2013: Administration of cilostazol, an antiplatelet, to patients with acute-stage cerebral infarction and its effects on plasma substance P level and latent time of swallowing reflex. Journal of Nippon Medical School 80(1): 50-56
Fidaleo, M.; Sartori, C. 2008: Administration of ciprofibrate to lactating mothers induces PPARalpha-signaling pathway in the liver and kidney of suckling rats. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 60(1): 33-41
Syrigou, E.; Makrilia, N.; Vassias, A.; Nikolaidis, I.; Xyla, V.; Manolopoulos, L.; Syrigos, K. 2010: Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?. Anti-Cancer Drugs 21(3): 333-338
Sonpavde, G.; Watson, D.; Tourtellott, M.; Cowey, C.L.; Hellerstedt, B.; Hutson, T.E.; Zhan, F.; Vogelzang, N.J. 2012: Administration of cisplatin-based chemotherapy for advanced urothelial carcinoma in the community. Clinical Genitourinary Cancer 10(1): 1-5
Wilson, W.L. 1949: Administration of civilian medical care in total war. Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department 9(2): 107-110
Farhi, J.; Orvieto, R.; Homburg, R. 2010: Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome. Fertility and Sterility 93(6): 2077-2079
Kim, J.-W.; Ahn, H.-S.; Baik, J.-H.; Yoon, B.-J. 2013: Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice. Journal of Psychopharmacology 27(2): 171-180
Kontoangelos, K.; Economou, M.; Kiriaki, P.; Michalis, V.; Papadimitriou, G.N. 2014: Administration of clozapine and excessive elevated serum triglycerides: a case report. Journal of Clinical Psychopharmacology 34(3): 387-388
Li, M.; He, W.; Heupel, K. 2011: Administration of clozapine to a mother rat potentiates pup ultrasonic vocalization in response to separation and re-separation: contrast with haloperidol. Behavioural Brain Research 222(2): 385-389
Matthews, A.L.; O'Conner-Von, S. 2008: Administration of comfort medication at end of life in neonates: effects of weight. Neonatal Network: Nn 27(4): 223-227
Sanz, M.G.; Oliveira, A.F.; Page, A.; Horohov, D.W. 2014: Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals. Veterinary Record 175(19): 485
Nagar, H.; Boothe, D.; Parikh, A.; Yondorf, M.; Parashar, B.; Gupta, D.; Holcomb, K.; Caputo, T.; Chao, K.S.C.; Nori, D.; Wernicke, A.G. 2013: Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer. International Journal of Radiation Oncology Biology Physics 87(4): 665-669
Kawalec, P.ł; Holko, P.ła.; Paszulewicz, A.; Obtułowicz, K. 2013: Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results. Pneumonologia i Alergologia Polska 81(2): 95-104
Bose, S.; Leclerc, G.M.; Vasquez-Martinez, R.; Boockfor, F.R. 2010: Administration of connexin43 siRNA abolishes secretory pulse synchronization in GnRH clonal cell populations. Molecular and Cellular Endocrinology 314(1): 75-83
Kodera, T.; Yamada, S.; Yamamoto, Y.; Hara, A.; Tanaka, Y.; Seno, M.; Umezawa, K.; Takei, I.; Kojima, I. 2009: Administration of conophylline and betacellulin-delta4 increases the beta-cell mass in neonatal streptozotocin-treated rats. Endocrine Journal 56(6): 799-806
De Berti, G.; Maggi, M.; Conigliaro, R.; Levrini, G.; Salzano, S.; Ghadirpour, R.; Servadei, F. 2012: Administration of conscious sedation by a neuroradiology team during percutaneous vertebroplasty and spinal biopsy procedures. Neuroradiology 54(3): 231-237
Sendur, M.A.N.; Aksoy, S.; Yaman, S.; Arik, Z.; Tugba Kos, F.; Akinci, M.B.; Civelek, B.; Yildirim Ozdemir, N.; Uncu, D.; Zengin, N. 2013: Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity. Journal of Buon: Official Journal of the Balkan Union of Oncology 18(1): 274-280
Burke, J.M.; Soli, F.; Miller, J.E.; Terrill, T.H.; Wildeus, S.; Shaik, S.A.; Getz, W.R.; Vanguru, M. 2010: Administration of copper oxide wire particles in a capsule or feed for gastrointestinal nematode control in goats. Veterinary Parasitology 168(3-4): 346-350
Blockeel, C.; Polyzos, N.P.; Derksen, L.; De Brucker, M.; Vloeberghs, V.; van de Vijver, A.; De Vos, M.; Tournaye, H. 2014: Administration of corifollitropin alfa on day 2 versus day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study. Human Reproduction 29(7): 1500-1507
Lee, S.; Rivier, C. 1992: Administration of corticosterone to pregnant adrenalectomized dams does not alter the hypothalamic-pituitary-adrenal axis' activity of the offspring. Molecular and Cellular Neurosciences 3(2): 118-123
Saito, F.; Nakatani, T.; Iwase, M.; Maeda, Y.; Murao, Y.; Suzuki, Y.; Fukushima, M.; Ide, C. 2012: Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study. Restorative Neurology and Neuroscience 30(2): 127-136
Liu, P.; Jaffar, J.; Hellstrom, I.; Hellstrom, K.E. 2010: Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. Journal of ImmunoTherapy 33(1): 53-59
Tsuji, Y.; Kato, Y.; Tsunoda, Y. 2012: Administration of cyclosporin a to recipients improves the potential of mouse somatic cell nuclear-transferred oocytes to develop to fetuses. Zygote 20(3): 261-267
Uchikawa, Y.; Ikegami, T.; Masuda, Y.; Ohno, Y.; Mita, A.; Urata, K.; Nakazawa, Y.; Terada, M.; Miyagawa, S. 2009: Administration of dalteparin based on the activated clotting time for prophylaxis of hepatic vessel thrombosis in living donor liver transplantation. Transplantation Proceedings 41(9): 3784-3790
Pokrovskiĭ, A.V.; Gontarenko, V.N.; Titova, M.I. 2011: Administration of dalteparin in reconstructive vascular surgery. Angiologiia i Sosudistaia Khirurgiia 17(2): 17-22
Tan, X.-D.; Dou, Y.-C.; Shi, C.-W.; Duan, R.-S.; Sun, R.-P. 2009: Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats. Journal of Neuroimmunology 207(1-2): 39-44
Li, Q.; Ge, C.; Liu, R.; Zhang, K.; Wu, G.; Huo, W. 2010: Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantation. Vaccine 28(52): 8300-8305
Cámara, Y.; González-Vioque, E.; Scarpelli, M.; Torres-Torronteras, J.; Caballero, A.; Hirano, M.; Martí, R. 2014: Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. Human Molecular Genetics 23(9): 2459-2467
Neustein, S. 2009: Administration of desflurane with bistrectal index monitoring in a patient with narcolepsy undergoing anesthesia. Acta Anaesthesiologica Belgica 60(4): 247-249
Zhang, J.; Yao, Y.; Xiao, F.; Lan, X.; Yu, C.; Zhang, Y.; Jiang, C.; Yang, J.; Pei, G.; Li, Y.; Rong, S.; Hu, S.; Li, J.; Xu, G. 2013: Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling. International Journal of Clinical and Experimental Pathology 6(11): 2366-2375
Kim, J.-W.; Kim, Y.J.; Chang, Y.P. 2013: Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors. Comparative Medicine 63(1): 48-54
Koroleva, I.A.; Mochalova, A.S. 2011: Administration of dicarbamin in the course of taxotere-assisted chemotherapy. Voprosy Onkologii 57(2): 250 252-4
Watanabe, N.; Watanabe, Y.; Kumagai, M.; Fujimoto, K. 2009: Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. International Journal of Food Sciences and Nutrition 60 Suppl. 5: 136-142
Sierra, S.; Alfaro, J.M.; Sánchez, S.; Burgos, J.S. 2012: Administration of docosahexaenoic acid before birth and until aging decreases kainate-induced seizures in adult zebrafish. Brain Research Bulletin 88(5): 467-470
Wurtman, R.J.; Cansev, M.; Sakamoto, T.; Ulus, I.H. 2009: Administration of docosahexaenoic acid, uridine and choline increases levels of synaptic membranes and dendritic spines in rodent brain. World Review of Nutrition and Dietetics 99: 71-96
Sabbagh, J.J.; Heaney, C.F.; Bolton, M.M.; Murtishaw, A.S.; Ure, J.A.; Kinney, J.W. 2012: Administration of donepezil does not rescue galanin-induced spatial learning deficits. International Journal of Neuroscience 122(12): 742-747
Hutchinson, J.A.; Gövert, F.; Riquelme, P.; Bräsen, J.H.; Brem-Exner, B.G.; Matthäi, M.; Schulze, M.; Renders, L.; Kunzendorf, U.; Geissler, E.K.; Fändrich, F. 2009: Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible. Clinical Transplantation 23(1): 140-145
Brodskii, V.Y.; Mal'chenko, L.A.; Dubovaya, T.K.; Konchenko, D.S.; Zvezdina, N.D. 2014: Administration of dopamine to rats disorganizes the rhythm of protein synthesis in hepatocytes. Bulletin of Experimental Biology and Medicine 157(2): 220-223
Misawa, E.; Tanaka, M.; Nabeshima, K.; Nomaguchi, K.; Yamada, M.; Toida, T.; Iwatsuki, K. 2012: Administration of dried Aloe vera gel powder reduced body fat mass in diet-induced obesity (DIO) rats. Journal of Nutritional Science and Vitaminology 58(3): 195-201
Valtcheva-Sarker, R.V.; O'Reilly, J.D.; Sarker, D.K. 2007: Administration of drug and nutritional components in nano-engineered form to increase delivery ratio and reduce current inefficient practice. Recent Patents on Drug Delivery and Formulation 1(2): 147-159
Shepherd, M. 2011: Administration of drugs 1: Oral route. Nursing Times 107(32-33): 18
Shepherd, M. 2011: Administration of drugs 3: parenteral. Nursing Times 107(36): 16
Shepherd, M. 2011: Administration of drugs 4: by patients. Nursing Times 107(37): 16
Nacimento, M.él. 2011: Administration of drugs derived from blood. Revue de l'Infirmiere 169: 43-44
Vasseur, R. 2014: Administration of drugs to the elderly and the nursing role. Soins. Gerontologie 109: 13-15
Kimura, K.; Aoki, J.; Sakamoto, Y.; Kobayashi, K.; Sakai, K.; Inoue, T.; Iguchi, Y.; Shibazaki, K. 2012: Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study. Journal of the Neurological Sciences 313(1-2): 132-136
Dong, W.; Du, J.; Shen, H.; Gao, D.; Li, Z.; Wang, G.; Mu, X.; Liu, Q. 2010: Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load. Cancer Immunology Immunotherapy: Cii 59(11): 1697-1705
Massin-Short, S.; Fisher, V.Scott.; Bakker, G.; Nieratko, J.; Morgan, S.; Herrmann, J.; Savoia, E. 2013: Administration of emergency preparedness Department of Health And Human Service funds: the experience of state and local health departments. Journal of public health management and practice: JPHMP 19(2): 192-195
Liu, F.; Chu, X.; Huang, J.; Tian, K.; Hua, J.; Tong, P. 2014: Administration of enoxaparin 24 h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention. Archives of Orthopaedic and Trauma Surgery 134(5): 679-683
Linn, D.D.; Beckett, R.D.; Foellinger, K. 2015: Administration of enteral nutrition to adult patients in the prone position. Intensive and Critical Care Nursing 31(1): 38-43
Mahmoud, M.; McAuliffe, J.; Donnelly, L.F. 2011: Administration of enteric contrast material before abdominal CT in children: current practices and controversies. Pediatric Radiology 41(4): 409-412
Sedat, J.; Chau, Y.; Gaudard, J.; Suissa, L.; Lachaud, S.; Lonjon, M. 2015: Administration of eptifibatide during endovascular treatment of ruptured cerebral aneurysms reduces the rate of thromboembolic events. Neuroradiology 57(2): 197-203
Aquilina, M.; Varani, E.; Balducelli, M.; Vecchi, G.; Frassineti, V.; Maresta, A. 2009: Administration of eptifibatide during transfer for primary PCi in patients with STEMI: effect on Pre-PCi TIMi flow and its correlation with pain-to-therapy time. Journal of Invasive Cardiology 21(3): 115-120
Theivanayagam, S.; Lim, R.G.; Cobell, W.J.; Gowda, J.T.; Matteson, M.L.; Choudhary, A.; Bechtold, M.L. 2013: Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 19(5): 205-210
Chen, S.; Li, J.; Peng, H.; Zhou, J.; Fang, H. 2014: Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats. International Journal of Molecular Medicine 33(4): 840-848
Chung, K.Y.; Baxa, T.J.; Parr, S.L.; Luqué, L.D.; Johnson, B.J. 2011: Administration of estradiol (E2), trenbolone acetate (TBA), and TBA/E2 implants alters adipogenic and myogenic gene expression in bovine skeletal muscle. Journal of Animal Science: -
Emadi, S.R.; Rezaei, A.; Bolourchi, M.; Hovareshti, P.; Akbarinejad, V. 2014: Administration of estradiol benzoate before insemination could skew secondary sex ratio toward males in Holstein dairy cows. Domestic Animal Endocrinology 48: 110-118
Nahata, M.; Saegusa, Y.; Sadakane, C.; Yamada, C.; Nakagawa, K.; Okubo, N.; Ohnishi, S.; Hattori, T.; Sakamoto, N.; Takeda, H. 2014: Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 26(6): 821-831
Fink, M.P. 2007: Administration of exogenous cytochrome c as a novel approach for the treatment of cytopathic hypoxia. Critical Care Medicine 35(9): 2224-2225
He, M.; Moochhala, S.M.; Adhikari, S.; Bhatia, M. 2009: Administration of exogenous fractalkine, a CX3C chemokine, is capable of modulating inflammatory response in cecal ligation and puncture-induced sepsis. Shock 31(1): 33-39
Foster, P.S.; Campbell, R.W.; Williams, M.R.; Branch, K.K.; Roosa, K.M.; Orman, C.; Drago, V. 2014: Administration of exogenous melatonin increases spreading activation in lexical memory networks. Human Psychopharmacology 29(4): 397-404
Wafaisade, A.; Lefering, R.; Maegele, M.; Brockamp, T.; Mutschler, M.; Lendemans, S.; Banerjee, M.; Bouillon, B.; Probst, C. 2013: Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. Journal of Trauma and Acute Care Surgery 74(2): 387-383; Discussion: 393-395
Gardiner, M. 2013: Administration of fluids per rectum in horses. Veterinary Record 172(16): 430
Langsdorf, G.C. 1946: Administration of fluids, including plasma and blood, in prolonged surgery. Surgery 19: 874
Holguín-Hernández, E.; Orozco-Díaz, J.é G. 2013: Administration of folic acid and other micronutrients to pregnant women in Colombia. Revista Panamericana de Salud Publica 34(2): 99-106
Mazón, M.ía.J.é; Gómez, A.; Yilmaz, O.; Carrillo, M.; Zanuy, S. 2014: Administration of follicle-stimulating hormone in vivo triggers testicular recrudescence of juvenile European sea bass (Dicentrarchus labrax). Biology of Reproduction 90(1): 6
Agostinetto, R. 2009: Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment. Reproductive Biology and Endocrinology: Rb&e 7: 48
Yang, J.-Y.; Lee, W.I.; Shin, W.-K.; Kim, C.H.; Baik, S.-W.; Kim, K.-H. 2013: Administration of four different doses of gabapentin reduces awakening from breakthrough pain and adverse effects in outpatients with neuropathic pain during the initial titration. Korean Journal of Anesthesiology 65(1): 48-54
Mishina, M.; Komaba, Y.; Kobayashi, S.; Kominami, S.; Fukuchi, T.; Mizunari, T.; Teramoto, A.; Katayama, Y. 2008: Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism. Neurologia Medico-Chirurgica 48(7): 292-297
Lin, K. 2009: Administration of gadolinium-based contrast agents in MR angiography. Ajr. American Journal of Roentgenology 192(4): W193; Author Reply W194
Chang, P.-Y.; Dai, M.-S.; Ho, C.-L.; Yao, N.-S. 2013: Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis. Journal of Buon: Official Journal of the Balkan Union of Oncology 18(4): 1058-1061
Ozer, A.B.; Erhan, O.L.; Demirel, I.; Ozcan, S. 2012: Administration of general anaesthesia to a paediatric patient with osteopetrosis. BMJ Case Reports
Cangemi, C.F. 2011: Administration of general anesthesia for outpatient orthognathic surgical procedures. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 69(3): 798-807
Amouyal, M.èl. 2013: Administration of genetic expression by multi-task proteins and long-range action. Frontiers in Genetics 4: 52
Gutierrez, A.; England, J.D. 2013: Administration of glucocorticoids in boys with Duchenne muscular dystrophy. Continuum 19(6 Muscle Disease): 1703-1708
Melhem, A.; Yamada, S.D.; Fleming, G.F.; Delgado, B.; Brickley, D.R.; Wu, W.; Kocherginsky, M.; Conzen, S.D. 2009: Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(9): 3196-3204
Calder, W.A. 1973: Administration of grant funds. Science 182(4117): 1085
Li, N.; Zhang, L.; Li, H.; Fang, B. 2010: Administration of granulocyte colony-stimulating factor ameliorates radiation-induced hepatic fibrosis in mice. Transplantation Proceedings 42(9): 3833-3839
Naito, T.; Goto, K.; Morioka, S.; Matsuba, Y.; Akema, T.; Sugiura, T.; Ohira, Y.; Beppu, M.; Yoshioka, T. 2009: Administration of granulocyte colony-stimulating factor facilitates the regenerative process of injured mice skeletal muscle via the activation of Akt/GSK3alphabeta signals. European Journal of Applied Physiology 105(4): 643-651
Vasconcelos, J.F.; Souza, B.S.F.; Lins, T.F.S.; Garcia, Lícia.M.S.; Kaneto, C.M.; Sampaio, G.P.; de Alcântara, A.C.; Meira, Cássio.S.; Macambira, S.G.; Ribeiro-dos-Santos, R.; Soares, M.B.P. 2013: Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(12): 4691-4702
Yun, Y.-R.; Jang, J.H.; Jeon, E.; Kang, W.; Lee, S.; Won, J.-E.; Kim, H.W.; Wall, I. 2012: Administration of growth factors for bone regeneration. Regenerative Medicine 7(3): 369-385
Grönbladh, A.; Johansson, J.; Nyberg, F.; Hallberg, M. 2014: Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 24(2-3): 60-66
Ammann, P.; Brennan, T.C.; Mekraldi, S.; Aubert, M.L.; Rizzoli, Ré. 2010: Administration of growth hormone in selectively protein-deprived rats decreases BMD and bone strength. Bone 46(6): 1574-1581
Dabrowski, K. 1991: Administration of gulonolactone does not evoke ascorbic acid synthesis in teleost fish. Fish Physiology and Biochemistry 9(3): 215-221
Hoffman, A.N.; Cheng, J.P.; Zafonte, R.D.; Kline, A.E. 2008: Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sciences 83(17-18): 602-607
Yang, J.; Xie, Y.; Wang, H.; Yao, Y.; Hou, J.; Ma, Y.; Zhang, Q.; Xing, Y.; Wu, J.; Li, T.; Zheng, J.; Liu, J.; Cao, R. 2013: Administration of heat shock protein 65 inhibits murine melanoma growth in vivo. Molecular Medicine Reports 7(1): 171-176
Choudhary, A.K.; Rennie, J.; Cairns, C.; Borthwick, G.; Hughes, J.; Morton, N.M.; Kluth, D.; Conway, B.R. 2013: Administration of heme arginate ameliorates murine type 2 diabetes independently of heme oxygenase activity. Plos one 8(10): E78209
Zarifkar, A.; Habibi, H.; Namazi, M.R.; Hosseininasab, S.J.; Mosavat, S.H.; Khatibi, A.; Habibi, H. 2009: Administration of heparanase-IIi improves the survival and angiogenesis of rat skin autografts. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 144(2): 195-198
Stojanov, S.; Liese, J.G.; Belohradsky, B.H.; Vandermeulen, C.; Hoppenbrouwers, K.; Van der Wielen, M.; Van Damme, P.; Georges, B.; Dupuy, M.; Scemama, M.; Watson, M.; Fiquet, A.; Stek, J.E.; Golm, G.T.; Schödel, F.P.; Kuter, B.J. 2007: Administration of hepatitis a vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine. Vaccine 25(43): 7549-7558
Mashayekhi, F.; Gholizadeh, L. 2011: Administration of hepatocyte growth factor increases reelin and disabled 1 expression in the mouse cerebral cortex: an in vivo study. Cellular and Molecular Neurobiology 31(8): 1267-1270
Liu, J.; Pan, B.; Zeng, L.-Y.; Xu, K.-L. 2013: Administration of high dose dexamethasone impairs the function of thymus cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(5): 1271-1274
Araya, M.; Núñez, H.éc.; Pavez, L.; Arredondo, M.; Méndez, M.; Cisternas, F.; Pizarro, F.; Sierralta, W.; Uauy, R.; González, M. 2012: Administration of high doses of copper to capuchin monkeys does not cause liver damage but induces transcriptional activation of hepatic proliferative responses. Journal of Nutrition 142(2): 233-237
Bernhardt, M.B.; Hicks, M.J.; Pappo, A.S. 2009: Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma. Pediatric Blood and Cancer 53(7): 1346-1348
Lloyd, S.A.; Yuan, Y.Y.; Simske, S.J.; Riffle, S.E.; Ferguson, V.L.; Bateman, T.A. 2009: Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction. Journal of Bone and Mineral Metabolism 27(5): 546-554
Najmeddin, F.; Ahmadi, A.; Mahmoudi, L.; Sadeghi, K.; Khalili, H.; Ahmadvand, A.; Najafi, A.; Mojtahedzadeh, M. 2014: Administration of higher doses of amikacin in early stages of sepsis in critically ill patients. Acta Medica Iranica 52(9): 703-709
Sasaki, J.; Miwa, T.; Odawara, M. 2012: Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function. Endocrine Journal 59(4): 297-304
Rojas, D.B.; Gemelli, T.; de Andrade, R.B.; Campos, A.G.ãe.; Dutra-Filho, C.S.; Wannmacher, C.óv.M.D. 2012: Administration of histidine to female rats induces changes in oxidative status in cortex and hippocampus of the offspring. Neurochemical Research 37(5): 1031-1036
Burenkova, O.V.; Aleksandrova, E.A.; Zaraiskaya, I.Y. 2014: Administration of histone deacetylase inhibitor during neonatal period changes emotionality of adult male 129Sv mice. Bulletin of Experimental Biology and Medicine 156(5): 620-623
Yuzbasioglu, M.Fatih.; Kurutas, E.Belge.; Bulbuloglu, E.; Goksu, M.; Atli, Y.; Bakan, V.; Kale, I.Taner. 2009: Administration of honey to prevent peritoneal adhesions in a rat peritonitis model. International Journal of Surgery 7(1): 54-57
Dahlen, C.R.; Bird, S.L.; Martel, C.A.; Olson, K.; Stevenson, J.S.; Lamb, G.C. 2010: Administration of human chorionic gonadotropin 7 days after fixed-time artificial insemination of suckled beef cows. Journal of Animal Science 88(7): 2337-2345
Wallace, L.D.; Breiner, C.A.; Breiner, R.A.; Spell, A.R.; Carter, J.A.; Lamb, G.C.; Stevenson, J.S. 2011: Administration of human chorionic gonadotropin at embryo transfer induced ovulation of a first wave dominant follicle, and increased progesterone and transfer pregnancy rates. Theriogenology 75(8): 1506-1515
Takahashi, K.; Oharaseki, T.; Yokouchi, Y.; Miura, N.N.; Ohno, N.; Okawara, A.I.; Murata, H.; Naoe, S.; Suzuki, K. 2010: Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease. Modern Rheumatology 20(2): 160-167
Collura, L.A.; Hoffman, J.B.; Wilson, M.E. 2009: Administration of human leptin differentially affects parameters of cortisol secretion in socially housed female rhesus monkeys. Endocrine 36(3): 530-537
Fontenele, M.d.F.át.M. 2010: Administration of human performance: a case study in a General Hospital of Fortaleza, Ceará State. Ciencia and Saude Coletiva 15(Suppl 1): 1315-1324
Sasaki, H.; Ishikawa, M.; Tanaka, N.; Nakanishi, K.; Kamei, N.; Asahara, T.; Ochi, M. 2009: Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine 34(3): 249-254
Messaris, E.; Betrosian, A.P.; Memos, N.; Chatzigianni, E.; Boutsikou, M.; Economou, V.; Dontas, I.; Theodossiades, G.; Konstadoulakis, M.M.; Douzinas, E.E. 2010: Administration of human protein C improves survival in an experimental model of sepsis. Critical Care Medicine 38(1): 209-216
Jamdar, S.; Babu, B.I.; Nirmalan, M.; Jeziorska, M.; McMahon, R.F.T.; Siriwardena, A.K. 2013: Administration of human recombinant activated protein C is not associated with pancreatic parenchymal haemorrhage in L-arginine-induced experimental acute pancreatitis. Jop: Journal of the Pancreas 14(6): 610-617
Latzman, J.M.; Kong, L.; Liu, C.; Samadani, U. 2010: Administration of human recombinant bone morphogenetic protein-2 for spine fusion may be associated with transient postoperative renal insufficiency. Spine 35(7): E231-E237
Zhang, X.-J.; Meng, X.-Y.; Huang, X.-L.; Dai, H.-Y.; Wei, P.; Ling, Y.-L. 2011: Administration of hydrogen sulfide intraperitoneally reverses the hyporesponsiveness of rat pulmonary artery induced by lipopolysaccharide and its relationship with carbon monoxide. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23(4): 200-203
Derwall, M.; Francis, R.C.E.; Kida, K.; Bougaki, M.; Crimi, E.; Adrie, C.; Zapol, W.M.; Ichinose, F. 2011: Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects. Critical Care 15(1): R51
Qian, L.; Mei, K.; Shen, J.; Cai, J. 2013: Administration of hydrogen-rich saline protects mice from lethal acute graft-versus-host disease (aGVHD). Transplantation 95(5): 658-662
Greenberg, C.S.; Bowden, V.R. 2009: Administration of hypotonic solutions vs. isotonic solutions in hospitalized children. Pediatric Nursing 35(1): 62-63
Ilardi, D. 2008: Obesity wars continue. Home-based pediatric weight management. School Nurse News 25(2): 22-24
Chen, H.; Liu, K-yan.; Xu, L-ping.; Liu, D-hong.; Chen, Y-hong.; Zhao, X-yu.; Han, W.; Zhang, X-hui.; Wang, Y.; Zhang, Y-yuan.; Qin, Y-zhen.; Liu, Y-rong.; Huang, X-jun. 2012: Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia. Journal of Hematology and Oncology 5: 29
Chen, H.; Liu, K.-Y.; Xu, L.-P.; Liu, D.-H.; Chen, Y.-H.; Shi, H.-X.; Han, W.; Zhan, X.-H.; Wang, Y.; Zhao, T.; Huang, X.-J. 2011: Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Chinese Medical Journal 124(2): 246-252
Yamazaki, R.; Aisa, Y.; Mori, T.; Iketani, O.; Ikeda, Y.; Okamoto, S. 2009: Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel. Leukemia and Lymphoma 50(4): 670-672
Fung, I.; Spergel, J.M. 2012: Administration of influenza vaccine to pediatric patients with egg-induced anaphylaxis. Journal of Allergy and Clinical Immunology 129(4): 1157-1159
Kelso, J.M. 2010: Administration of influenza vaccines to patients with egg allergy. Journal of Allergy and Clinical Immunology 125(4): 800-802
Kelso, J.M. 2010: Administration of influenza vaccines to patients with egg allergy: Update for the 2010-2011 season. Journal of allergy and clinical immunology 126(6): 1302-1304
Kontoangelos, K.; Vaidakis, N.; Zervas, I.; Thomadaki, O.; Christaki, S.; Stavrianeas, N.G.; Papadimitriou, G.N. 2010: Administration of inositol to a patient with bipolar disorder and psoriasis: a case report. Cases Journal 3: 69
Vidal, M.è; Colungo, C.; Jansá, M. 2011: Administration of insulin. new recommendations. Revista de Enfermeria 34(6): 50
Ikeda, K.; Kobayashi, M.; Seko, Y.; Imai, N.; Hirakawa, M.; Kawamura, Y.; Sezaki, H.; Hosaka, T.; Akuta, N.; Saitoh, S.; Suzuki, F.; Suzuki, Y.; Arase, Y.; Kumada, H. 2010: Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer. Hepatology Research: the Official Journal of the Japan Society of Hepatology 40(12): 1168-1175
Orsal, A.S.; Blois, S.M.; Bermpohl, D.; Schaefer, M.; Coquery, N. 2008: Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. Neuropsychobiology 58(3-4): 211-222
Rusai, K.; Huang, H.; Sayed, N.; Strobl, M.; Roos, M.; Schmaderer, C.; Heemann, U.; Lutz, J. 2008: Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury. Transplant International: Official Journal of the European Society for Organ Transplantation 21(6): 572-580
Cornelius, D.C.; Hogg, J.P.; Scott, J.; Wallace, K.; Herse, F.; Moseley, J.; Wallukat, G.; Dechend, R.; LaMarca, B. 2013: Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62(6): 1068-1073
Ruiz-Bailén, M.; Rucabado-Aguilar, L.; Galindo-Rodríguez, S.; Castillo-Rivera, A.; Brea Salvago, F.; Pola Gallego de Guzmán, M.ía.D.; Ramos Cuadra, J.é Án. 2011: Administration of intrapericardial tissue adhesive after cardiac rupture and cardiac tamponade. International Journal of Cardiology 147(3): E50-E52
Fernández Cañabate, E.; Longoni Merino, M.; Garriga Biosca, R.; Navas Vinagre, I. 2008: Administration of intrathecal hyaluronidase in a patient diagnosed with adhesive arachnoiditis. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(1): 58-60
Jee, B.Chul.; Suh, C.Suk.; Kim, Y.Beom.; Kim, S.Hyun.; Choi, Y.Min.; Kim, J.Gu.; Moon, S.Yong. 2010: Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis. Gynecologic and Obstetric Investigation 70(1): 47-54
Beirne, O.R. 2008: Administration of intravenous antibiotics immediately before extraction of wisdom teeth lowers the rate of postsurgical infections. Journal of Evidence-Based Dental Practice 8(1): 26-27
Golombek, S.G.; Navarro, M.; Negre, S.; Matoses, M.L.; Ledo, A.; Saénz, P.; Vento, M. 2010: Administration of intravenous immunoglobulin is not free of risk in the neonatal period. Archives de pediatrie: organe officiel de la Societe francaise de pediatrie 17(3): 298; author reply 299
Lieberman, P.; Rachid, R. 2013: Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies. Journal of Allergy and Clinical Immunology. in Practice 1(6): 704
Stangel, M.; Gold, R. 2011: Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010. Der Nervenarzt 82(4): 415-6 418 420 Passim
Janus, N.; Scotte, F.; Rey, J.-B.; Amet, S.; Rouillon, L.; Zakin, L.; Mahi, L.; Deray, G.; Launay-Vacher, V. 2013: Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 21(10): 2743-2748
Grzegorzewska, A.E. 2007: Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease. Polskie Archiwum Medycyny Wewnetrznej 117(4): 52-57
Gumbinger, C.; Hametner, C.; Wildemann, B.; Veltkamp, R.; Bösel, J. 2013: Administration of isoflurane-controlled dyskinetic movements caused by anti-NMDAR encephalitis. Neurology 80(21): 1997-1998
Duraj, J.; Hunakova, L.; Bodo, J.; Jakubikova, J.; Chovancova, J.; Sedlak, J. 2009: Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells. Neoplasma 56(3): 208-214
Franco, M.C.; Golowczyc, M.A.; De Antoni, G.L.; Pérez, P.F.; Humen, M.ín.; Serradell, M.ía.d.L.A. 2013: Administration of kefir-fermented milk protects mice against Giardia intestinalis infection. Journal of Medical Microbiology 62(Part 12): 1815-1822
Colombani, S.; Kabbani, Y.; Mathoulin-Pélissier, S.; Gékière, J-P.; Dixmérias, F.; Monnin, D.; Lakdja, F. 2008: Administration of ketamine during induction and maintenance of anaesthesia in postoperative pain prevention. Annales Francaises d'Anesthesie et de Reanimation 27(3): 202-207
Murakoshi, F.; Takeuchi, M.; Inomata, A.; Horimoto, T.; Ito, M.; Suzuki, Y.; Kato, K. 2014: Administration of lasalocid-NA is preventive against cryptosporidiosis of newborn calves. Veterinary Record 175(14): 353
Ghasemi, A.; Saberi, M.; Ghasemi, M.; Shafaroodi, H.; Moezi, L.; Bahremand, A.; Montaser-Kouhsari, L.; Ziai, P.; Dehpour, A.R. 2010: Administration of lithium and magnesium chloride inhibited tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice. Epilepsy and Behavior: E&b 19(4): 568-574
Anderson, S.; Cockrell, J.; Beller, P.; Murphy, E.; Nelson, P.; Hawkins, M.; Cederna-Moss, J. 2010: Administration of local anesthetic agents to decrease pain associated with peripheral vascular access. Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society 33(6): 353-361
Gibbs, J. 2008: Administration of local anesthetic while positioning the needle during inferior alveolar nerve blocks did not affect patients' reported pain on injection. Journal of Evidence-Based Dental Practice 8(4): 251-252
Molist Gasa, F.; Ywazaki, M.; Gómez de Segura Ugalde, A.; Hermes, R.G.; Gasa Gasó, J.; Pérez Hernández, J.é F. 2010: Administration of loperamide and addition of wheat bran to the diets of weaner pigs decrease the incidence of diarrhoea and enhance their gut maturation. British Journal of Nutrition 103(6): 879-885
Kulay, L.; Hagemann, C.C.; Nakamura, M.U.; Simões, R.S.; de Carvalho, A.Moreira.; Oliveira-Filho, R.M.; Espiridião, S. 2013: Administration of lopinavir/ritonavir association during rat pregnancy: maternal and fetal effects. Clinical and Experimental Obstetrics and Gynecology 40(1): 151-154
Rau, T.F.; Kothiwal, A.S.; Rova, A.R.; Brooks, D.M.; Rhoderick, J.F.; Poulsen, A.J.; Hutchinson, J.; Poulsen, D.J. 2014: Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats. Experimental Neurology 253: 31-40
Pilon, C.B.; Petillon, S.; Naserian, S.; Martin, G.H.; Badoual, C.; Lang, P.; Azoulay, D.; Piaggio, E.; Grimbert, P.; Cohen, J.L. 2014: Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(12): 2874-2882
Helewski, K.J.; Kowalczyk-Ziomek, G.I.; Czecior, E.; Swietochowska, E.; Wielkoszynski, T.; Czuba, Z.P.; Szliszka, E.; Krol, W. 2010: Administration of low doses of tumor necrosis factor-alpha protects rat liver from ischaemic damage and reperfusion injury. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 61(3): 273-278
Rustemeyer, J.; van de Wal, R.; Keipert, C.; Dicke, U. 2010: Administration of low-dose FK 506 accelerates histomorphometric regeneration and functional outcomes after allograft nerve repair in a rat model. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 38(2): 134-140
Kawamura, M.; Nakano, S.; Kyoda, S.; Tabei, I.; Yoshida, K.; Takeyama, H. 2013: Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 909-912
Ishida, H.; Sakane, S.; Toyama, T.; Fukutomi, K.; Kimura, K.; Sugimoto, A.; Hibino, K.; Tamura, T.; Iwasaki, T.; Iwasaki, R.; Hasegawa, H.; Sakakibara, Y.; Yamada, T.; Nakazuru, S.; Mita, E. 2014: Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir. Hepatology Research: the Official Journal of the Japan Society of Hepatology 44(10): E84-E91
Tang, J.; Li, X-Hong.; Wang, H.; Xiong, Y.; Mu, D-Zhi. 2009: Administration of low-dose heparin in total nutrient admixture prevents central venous catheter-related infections in neonates. Zhongguo Dang Dai Er Ke Za Zhi 11(12): 983-985
Borjeson, T.M.; Pang, J.; Fox, J.G.; García, A. 2014: Administration of luteinizing hormone releasing hormone agonist for synchronization of estrus and generation of pseudopregnancy for embryo transfer in rats. Journal of the American Association for Laboratory Animal Science: Jaalas 53(3): 232-237
Duxbury, J.A.; Wright, K.; Bradley, D.; Barnes, P. 2010: Administration of medication in the acute mental health ward: perspective of nurses and patients. International Journal of Mental Health Nursing 19(1): 53-61
Estrela, K.d.S.R.; Loyola, C.M.D. 2014: Administration of medication to use when needed and the care of psychiatric nursing. Revista Brasileira de Enfermagem 67(4): 563-567
Fernandez, R.S.; Griffiths, R.; Aguilar, V.; Tran, D.; Chester, R. 2008: Administration of medications by enrolled nurses: perceptions of metropolitan and non-metropolitan registered nurses and nursing unit managers. Contemporary Nurse 27(2): 237-245
Boland, E.R. 1948: Administration of medicine. British Medical Journal 2(4565): 9-19
Alexis, O.; Caldwell, J. 2013: Administration of medicines - the nurse role in ensuring patient safety. British Journal of Nursing 22(1): 32-35
Haw, C.; Stubbs, J. 2010: Administration of medicines in food and drink: a study of older inpatients with severe mental illness. International Psychogeriatrics 22(3): 409-416
Bedwani, S.; Baverstock, A.; Finlay, F. 2008: Administration of medicines to children using sports and leisure facilities: a survey of the South West of England. Child: Care Health and Development 34(2): 230-233
Wilson, N.; Best, C. 2011: Administration of medicines via an enteral feed tube. Nursing Times 107(41): 18-20
Noyes, J.; Lewis, M. 2007: Compiling, costing and funding complex packages of home-based health care. Paediatric Nursing 19(5): 28-32
Idrus, N.M.; McGough, N.N.H.; Riley, E.P.; Thomas, J.D. 2011: Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss. Alcoholism Clinical and Experimental Research 35(2): 355-364
Idrus, N.M.; McGough, N.N.H.; Riley, E.P.; Thomas, J.D. 2014: Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats. Alcoholism Clinical and Experimental Research 38(2): 529-537
Kaengkan, P.; Baek, S.E.; Kim, J.Y.; Kam, K.-Y.; Do, B.-R.; Lee, E.S.; Kang, S.G. 2013: Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats. Molecules and Cells 36(6): 534-541
Fitzgerald, J. 2009: Administration of micotil. Veterinary Record 165(12): 355-356
Ujigo, S.; Kamei, N.; Hadoush, H.; Fujioka, Y.; Miyaki, S.; Nakasa, T.; Tanaka, N.; Nakanishi, K.; Eguchi, A.; Sunagawa, T.; Ochi, M. 2014: Administration of microRNA-210 promotes spinal cord regeneration in mice. Spine 39(14): 1099-1107
Lo Monte, G.; Soave, I.; Marci, R. 2013: Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results. Minerva Ginecologica 65(4): 453-463
Xu, H.; Liu, Z.-Q.; Liu, Y.; Zhang, W.-S.; Xu, B.; Xiong, Y.-C.; Deng, X.-M. 2009: Administration of midazolam in infancy does not affect learning and memory of adult mice. Clinical and Experimental Pharmacology and Physiology 36(12): 1144-1148
Bianciardi, P.; Brovida, C.; Valente, M.; Aresu, L.; Cavicchioli, L.; Vischer, C.; Giroud, L.; Castagnaro, M. 2009: Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys. Toxicologic Pathology 37(6): 770-775
Xia, D.; Shen, K.; Zhong, W.; Pan, H. 2011: Administration of minocycline ameliorates damage in a renal ischemia/reperfusion injury model. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 34(2): E55-E63
Mammen, C.; Sharma, M. 2011: Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in home births in Pakistan: randomised placebo-controlled trial. Bjog: An International Journal of Obstetrics and Gynaecology 118(8): 1018; Author Reply 1018-9
Mobeen, N.; Durocher, J.; Zuberi, N.; Jahan, N.; Blum, J.; Wasim, S.; Walraven, G.; Hatcher, J. 2011: Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. Bjog: An International Journal of Obstetrics and Gynaecology 118(3): 353-361
Nasonov, E.L.; Lukina, G.V.; Sigidin, I.A.; Bazevich, L.A.; Zlobina, T.I.; Kamalova, R.G.; Kniazeva, L.A.; Mazurov, V.I.; Men'shikova, L.V.; Sizikov, A.E.; Smirnova, E.A.; Fofonova, N.A.; Shabalina, T.V.; Shkil', N.V.; Iakushin, S.S. 2008: Administration of monoclonal antibodies to B-lymphocytes (rituximab) in rheumatoid arthritis in Russia. Terapevticheskii Arkhiv 80(8): 57-62
Shaiova, L.; Mori, M.; Anderson, K.; Loewen, G.; Ghalie, R.; Homel, P.; Portenoy, R. 2007: Administration of morphine sulfate extended-release capsules via gastrostomy: dissolution study and case reports. Journal of Palliative Medicine 10(5): 1063-1067
Semon, J.A.; Zhang, X.; Pandey, A.C.; Alandete, S.M.; Maness, C.; Zhang, S.; Scruggs, B.A.; Strong, A.L.; Sharkey, S.A.; Beuttler, M.M.; Gimble, J.M.; Bunnell, B.A. 2013: Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis. Stem Cells Translational Medicine 2(10): 789-796
Jin, R.; Guo, S.; Wang, M.-y.; Li, Y.-h.; Wu, L.-X.; Ma, H.; Lowrie, D.B.; Fan, X.-y.; Zhang, J.-h. 2013: Administration of mycobacterial Ag85A and IL-17A fusion protein attenuates airway inflammation in a murine model of asthma. International Immunopharmacology 17(4): 1067-1074
Sakaguchi, K.; Mizuta, N.; Imai, A.; Nakatsukasa, K.; Morita, M.; Soushi, M.; Taguchi, T. 2012: Administration of nab-paclitaxel for 9 metastatic breast cancer patients. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(7): 1081-1085
Yoshida, H.; Yanai, H.; Ito, K.; Tomono, Y.; Koikeda, T.; Tsukahara, H.; Tada, N. 2010: Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 209(2): 520-523
Wang, P.H.M.; Schwindt, T.T.; Barnabé, G.F.; Motta, F.L.T.; Semedo, P.; Beraldo, F.C.; Mazzali, M.; Dos Reis, M.A.; Teixeira, V.d.P.A.; Pacheco-Silva, A.; Mello, L.E.ên.A.d.; Câmara, N.O.S. 2009: Administration of neural precursor cells ameliorates renal ischemia-reperfusion injury. NEPHRON. Experimental Nephrology 112(1): E20-E28
Ohnishi, K.; Nakamura-Uchiyama, F. 2010: Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza a (H1N1). Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 16(1): 62-63
Miller, D.I.; Talbot, V.; Gagnon, M.èl.; Messier, C. 2013: Administration of neuropsychological tests using interactive voice response technology in the elderly: validation and limitations. Frontiers in Neurology 4: 107
Izco, M.ía.; Gutierrez-Lopez, M.D.; Marchant, I.; O'Shea, E.; Colado, M.I. 2010: Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum. Psychopharmacology 207(4): 671-679
Samal, A.A.; Honavar, J.; Brandon, A.; Bradley, K.M.; Doran, S.; Liu, Y.; Dunaway, C.; Steele, C.; Postlethwait, E.M.; Squadrito, G.L.; Fanucchi, M.V.; Matalon, S.; Patel, R.P. 2012: Administration of nitrite after chlorine gas exposure prevents lung injury: effect of administration modality. Free Radical Biology and Medicine 53(7): 1431-1439
Bishop, J.T. 2007: Administration of nitrous oxide in labor: expanding the options for women. Journal of Midwifery and Women's Health 52(3): 308-309
Schell, W. 2010: Administration of nonprescription drugs is and remains a nursing care service--the Federal Social Court has supported the right of home nursing care. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 29(2): 71
Goto, T.; Shinoda, Y.; Okuma, T.; Ogura, K.; Tsuda, Y.; Yamakawa, K.; Hozumi, T. 2011: Administration of nonsteroidal anti-inflammatory drugs accelerates spontaneous healing of osteoid osteoma. Archives of Orthopaedic and Trauma Surgery 131(5): 619-625
Hu, Q.; Zuo, P.; Shao, B.; Yang, S.; Xu, G.; Lan, F.; Lu, X.; Xiong, W.; Xu, Y.; Xiong, S. 2010: Administration of nonviral gene vector encoding rat beta-defensin-2 ameliorates chronic Pseudomonas aeruginosa lung infection in rats. Journal of Gene Medicine 12(3): 276-286
Sosa, Z.Y.; Palmada, M.N.; Fóscolo, M.R.; Capani, F.; Conill, A.; Cavicchia, J.C. 2009: Administration of noradrenaline in the autonomic ganglia modifies the testosterone release from the testis using an ex vivo system. International Journal of Andrology 32(4): 391-398
Chen, J.; Li, J.-M.; Yang, R.; Zhao, L.-H.; Feng, L.; Chen, Y.-J.; Zhou, D. 2009: Administration of nursing services in a newly built traumatic infection ward after an 8.0-magnitude earthquake in Wenchuan. Journal of Emergency Nursing 35(6): 532-535
Dembiński, A.; Warzecha, Z.; Ceranowicz, P.; Cieszkowski, J.; Dembiński, M.; Ptak-Belowska, A.; Kuwahara, A.; Kato, I. 2011: Administration of obestatin accelerates the healing of chronic gastric ulcers in rats. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(8): Br196-Br200
Larsen, K.A.; Kelly, S.E.; Stern, T.A.; Bode, R.H.; Price, L.Lyn.; Hunter, D.J.; Gulczynski, D.; Bierbaum, B.E.; Sweeney, G.A.; Hoikala, K.A.; Cotter, J.J.; Potter, A.W. 2010: Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 51(5): 409-418
Abut, E.; Guveli, H.; Yasar, B.; Bolukbas, C.; Bolukbas, F.Fusun.; Ince, A.Tuzun.; Kendir, T.; Dalay, A.Remzi.; Kurdas, O.Ovunc. 2009: Administration of olive oil followed by a low volume of polyethylene glycol-electrolyte lavage solution improves patient satisfaction with right-side colonic cleansing over administration of the conventional volume of polyethylene glycol-electrolyte lavage solution for colonoscopy preparation. Gastrointestinal Endoscopy 70(3): 515-521
Kane, D.L. 1997: Administration of omeprazole (prilosec) in the atypical patient. International Journal of Pharmaceutical Compounding 1(1): 12-13
Bartkó, G.ör. 2007: Administration of once-daily extended release quetiapine in schizophrenic disorders. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 9(4): 189-195
Gener, B.; Burns, J.M.; Griffin, S.; Boyer, E.W. 2010: Administration of ondansetron is associated with lethal outcome. Pediatrics 125(6): E1514-E1517
Décarie, S. 2009: Naznin Hébert. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 6(2): 13-14
Otsuki, K.; Tokunaka, M.; Oba, T.; Nakamura, M.; Shirato, N.; Okai, T. 2014: Administration of oral and vaginal prebiotic lactoferrin for a woman with a refractory vaginitis recurring preterm delivery: appearance of lactobacillus in vaginal flora followed by term delivery. Journal of Obstetrics and Gynaecology Research 40(2): 583-585
Lopatkin, N.A.; Kamalov, A.A.; Mazo, E.B.; Dorofeev, S.D.; Efremov, E.A.; Kozdoba, A.S.; Popov, S.V.; Mel'nik, I.I.; Okhobotov, D.A. 2009: Administration of oral vitaprost for prevention of exacerbations of chronic abacterial prostatitis. Urologiia 2009(1): 29-35
Anderson, C.; Rolfe, P.; Brennan-Hunter, A. 2013: Administration of over-the-counter medication to children at home--a survey of parents from community health centers. Journal of Community Health Nursing 30(3): 143-154
Gensheimer, M.; Jones, C.A.; Graves, C.R.; Merchant, N.B.; Lockhart, A.C. 2009: Administration of oxaliplatin to a pregnant woman with rectal cancer. Cancer ChemoTherapy and Pharmacology 63(2): 371-373
McGloin, S. 2008: Administration of oxygen therapy. Nursing Standard: 22(21): 46-48
Davenport, A.; Stearns, M.P. 2007: Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome. Nephrology 12(4): 386-390
Levi, G.S.; Feldman, A.I. 1950: Administration of pediatric clinics in Krasna Slobodka. Voprosy Pediatrii 18(3): 51-55
Grimson, T.A. 1945: Administration of penicillin by intramuscular drip. British Medical Journal 2: 849
Goldberg, Y.H.; Ginelli, P.; Siegel, R.; Ostfeld, R.J.; Schaefer, M.; Spevack, D.M. 2012: Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk. Cardiology 122(2): 119-125
Adachi, T.; Yanaka, H.; Kanai, H.; Nozaki, M.; Takahara, Y.; Tsuda, M.; Jonouchi, T.; Tsuda, K.; Hirasawa, A.; Tsujimoto, G. 2008: Administration of perilla oil coated with Calshell increases glucagon-like peptide secretion. Biological and Pharmaceutical Bulletin 31(5): 1021-1023
Busk, P.; Jacobsen, S.; Martinussen, T. 2010: Administration of perioperative penicillin reduces postoperative serum amyloid a response in horses being castrated standing. Veterinary Surgery: Vs 39(5): 638-643
Misawa, E.; Tanaka, M.; Nomaguchi, K.; Yamada, M.; Toida, T.; Takase, M.; Iwatsuki, K.; Kawada, T. 2008: Administration of phytosterols isolated from Aloe vera gel reduce visceral fat mass and improve hyperglycemia in Zucker diabetic fatty (ZDF) rats. Obesity Research and Clinical Practice 2(4): I-Ii
Fujimura, T.; Yamagishi, S.-i.; Ueda, S.; Fukami, K.; Shibata, R.; Matsumoto, Y.; Kaida, Y.; Hayashida, A.; Koike, K.; Matsui, T.; Nakamura, K.-i.; Okuda, S. 2009: Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(5): 1397-1406
Yu, H.; Chen, L.; Jiang, J. 2010: Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats. Molecular Vision 16: 2384-2394
Ueda, S.-i.; Yamagishi, S.-i.; Matsui, T.; Jinnouchi, Y.; Imaizumi, T. 2011: Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction. American Journal of Pathology 178(2): 591-598
Yamagishi, S.; Matsui, T.; Nakamura, K.; Takenaka, K. 2009: Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats. Clinical and Experimental Medicine 9(1): 73-76
Cummings, B.P.; Bettaieb, A.; Graham, J.L.; Stanhope, K.; Haj, F.G.; Havel, P.J. 2014: Administration of pioglitazone alone or with alogliptin delays diabetes onset in UCD-T2DM rats. Journal of Endocrinology 221(1): 133-144
Kim, C.-H.; Park, C.D.; Lee, A.-Y. 2012: Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance. Vaccine 30(14): 2405-2410
Dar, A.; Lai, K.; Dent, D.; Potter, A.; Gerdts, V.; Babiuk, L.A.; Mutwiri, G.K. 2012: Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs. Veterinary Immunology and Immunopathology 146(3-4): 289-295
Ishibashi, K.; Ishiguro, T.; Kuwabara, K.; Ohsawa, T.; Okada, N.; Miyazaki, T.; Yokoyama, M.; Matsuki, M.; Ishida, H. 2008: Administration of polysaccharide K (PSK) for stage IIi colorectal cancer in clinical practice. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(12): 2283-2285
Ishibashi, K.; Hokama, N.; Ishiguro, T.; Kuwabara, K.; Okada, N.; Ohsawa, T.; Miyazaki, T.; Yokoyama, M.; Ishida, H. 2009: Administration of polysaccharide K (PSK) for stage IIi rectal cancer in clinical practice. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 1975-1978
Morris, K.R.; Bean, A.G.D.; Bruce, M.P.; Broadway, M.M.; O'Neil, T.E.; Andrew, M.E.; Emmins, J.J.; Strom, D.G. 2008: Administration of porcine interleukin-3 induces increased levels of blood eosinophils. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 28(7): 435-444
Simon, E.; Bánk, J.; Gál, J.; Siró, Péter.; Novák, László.; Fülesdi, Béla.; Molnár, C. 2012: Administration of preemptive analgesia by diclofenac to prevent acute postcraniotomy headache. Ideggyogyaszati Szemle 65(9-10): 302-306
Komatsubara, K.; Miyoshi, K.; Kogure, Y.; Matsuhisa, T.; Eguchi, H. 2010: Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 107-110
Daudelin, J.-F.ço.; Lessard, M.; Beaudoin, F.éd.ér.; Nadeau, E.; Bissonnette, N.; Boutin, Y.; Brousseau, J.-P.; Lauzon, K.; Fairbrother, J.M. 2011: Administration of probiotics influences F4 (K88)-positive enterotoxigenic Escherichia coli attachment and intestinal cytokine expression in weaned pigs. Veterinary Research 42: 69
Zhou, H.-J.; Yin, L.; Chen, C.-Q.; Shi, M.-M.; Zhang, M.-J. 2010: Administration of probiotics reduces bacterial translocation after intestinal transplantation in rats. Transplantation Proceedings 42(10): 4643-4647
Biggs, T.M.; Brauer, R.O.; Wolf, L.E. 1977: Mastopexy in conjunction with subcutaneous mastectomy. Plastic and Reconstructive Surgery 60(1): 1-5
Dumonceau, J.-M.; Hovaguimian, F.éd.ér.; Bertolini, D.; Walder, B. 2010: Administration of propofol by non-anesthesiologists for digestive endoscopy. Revue Medicale Suisse 6(261): 1638-1641
Alekhin, D.I.; Fokin, A.A.; Mikhaĭlova, O.A.; Sumnaia, D.B.; Goloshchapova, Z.A. 2007: Administration of prostaglandins Ei and immunotherapy in management of various-genesis trophic ulcers. Angiologiia i Sosudistaia Khirurgiia 13(3): 27-33
Buendgens, L.; Bruensing, J.; Matthes, M.; Dückers, H.; Luedde, T.; Trautwein, C.; Tacke, F.; Koch, A. 2014: Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. Journal of Critical Care 29(4): 696.E11
Wensel, T.M. 2009: Administration of proton pump inhibitors in patients requiring enteral nutrition. P and T: a Peer-Reviewed Journal for Formulary Management 34(3): 143-160
Fedotova, I.O.; Sapronov, N.S. 2012: Administration of quinpirole with 17beta-estradiol in low doses corrects active avoidance performance in ovariectomized female rats. Eksperimental'naia i Klinicheskaia Farmakologiia 75(12): 7-10
Van de Bovenkamp, C.G.; Meij, B.P.; Stassen, Q.E.M.; Nijsen, J.F.W.; Kirpensteijn, J. 2009: Administration of radioactive holmium-166 microsphere in domestic animals with inoperable tumors. Tijdschrift Voor Diergeneeskunde 134(12): 532-533
Bogojević, D.; Poznanović, G.; Grdović, N.; Grigorov, I.; Vidaković, M.; Dinić, S.; Mihailović, M. 2011: Administration of rat acute-phase protein α(2)-macroglobulin before total-body irradiation initiates cytoprotective mechanisms in the liver. Radiation and Environmental Biophysics 50(1): 167-179
Li, Z.; Xu, X.; Huang, L.; Wu, J.; Lu, Q.; Xiang, Z.; Liao, J.; Weng, S.; Yu, X.; He, J. 2010: Administration of recombinant IFN1 protects zebrafish (Danio rerio) from ISKNV infection. Fish and Shellfish Immunology 29(3): 399-406
Schmid, S.; Friesenecker, B.; Lorenz, I.; Innerhofer, P.; Koscielny, J.ür.; Velik-Salchner, C.; Mutz, N.; Fries, D. 2007: Administration of recombinant activated factor VIi (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(3): 313-317
Alavi, A-Asghar.; Jalali, S.Mahdi.; Rasouli, M.R.; Eghtesadi-Araghi, P. 2008: Administration of recombinant activated factor VII in major thoracic operations. Archives of Surgery 143(10): 1021; Author Reply 1021
Uber, W.E.; Toole, J.M.; Stroud, M.R.; Haney, J.S.; Lazarchick, J.; Crawford, F.A.; Ikonomidis, J.S. 2011: Administration of recombinant activated factor VIi in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. Journal of Thoracic and Cardiovascular Surgery 141(6): 1469-77.E2
Valdenegro-Vega, V.A.; Crosbie, P.B.B.; Cook, M.T.; Vincent, B.N.; Nowak, B.F. 2014: Administration of recombinant attachment protein (r22C03) of Neoparamoeba perurans induces humoral immune response against the parasite in Atlantic salmon (Salmo salar). Fish and Shellfish Immunology 38(2): 294-302
Leitner, G.C.; Faschingbauer, M.; Wenda, S.; Weigel, G.ün.; Fischer, G. 2014: Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors. Transfusion 54(12): 3121-3126
Cathelin, D.; Placier, S.; Ploug, M.; Verpont, M.-C.; Vandermeersch, S.; Luque, Y.; Hertig, A.; Rondeau, E.; Mesnard, L. 2014: Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice. Journal of the American Society of Nephrology: Jasn 25(8): 1662-1668
Takeuchi, S.; Takasato, Y.; Masaoka, H.; Otani, N. 2009: Administration of recombinant tissue plasminogen activator to a case of cerebral infarction in the setting of painless aortic dissection. Neurology India 57(6): 808-809
Cavalcanti, E.; Vadrucci, E.; Delvecchio, F.R.; Addabbo, F.; Bettini, S.; Liou, R.; Monsurrò, V.; Huang, A.Y.-C.; Pizarro, T.T.; Santino, A.; Chieppa, M. 2014: Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation. Plos one 9(2): E88898
Milla, P.; Airoldi, M.; Weber, G.ün.; Drescher, A.; Jaehde, U.; Cattel, L. 2009: Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. Anti-Cancer Drugs 20(5): 396-402
Engman, S.J.; Edwards, A.O.; Bakri, S.J. 2011: Administration of repeat intravitreal anti-VEGF drugs by retina specialists in an injection-only clinic for patients with exudative AMD: patient acceptance and safety. Seminars in Ophthalmology 26(6): 380-386
Sinisgalli, A.J. 1980: Administration of research. Science 208(4449): 1212
Gross, P.R. 1986: Administration of research. Science 232(4754): 1078
Sportès, C.; Hakim, F.T.; Memon, S.A.; Zhang, H.; Chua, K.S.; Brown, M.R.; Fleisher, T.A.; Krumlauf, M.C.; Babb, R.R.; Chow, C.K.; Fry, T.J.; Engels, J.; Buffet, R.; Morre, M.; Amato, R.J.; Venzon, D.J.; Korngold, R.; Pecora, A.; Gress, R.E.; Mackall, C.L. 2008: Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. Journal of Experimental Medicine 205(7): 1701-1714
Nasonov, E.L. 2007: Administration of rituximab in rheumatoid arthritis from the position of evidence-based medicine. Terapevticheskii Arkhiv 79(12): 76-82
Karthik, D.; Viswanathan, P.; Anuradha, C.Venkatraman. 2011: Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats. Journal of Cardiovascular Pharmacology 58(5): 514-521
Yoshimoto, K.; Ueda, S.; Kitamura, Y.; Inden, M.; Hattori, H.; Ishikawa, N.; McLean, S.; Ikegaya, H. 2012: Administration of rotenone enhanced voluntary alcohol drinking behavior in C57BL/6J mice. Legal Medicine 14(5): 229-238
Parlee, S.D.; Simon, B.R.; Scheller, E.L.; Alejandro, E.U.; Learman, B.S.; Krishnan, V.; Bernal-Mizrachi, E.; MacDougald, O.A. 2014: Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. Endocrinology 155(4): 1313-1326
Koizumi, M.; Tanjung, N.G.; Chen, A.; Dynlacht, J.R.; Garrett, J.; Yoshioka, Y.; Ogawa, K.; Teshima, T.; Yokota, H. 2012: Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells. Anticancer Research 32(9): 3667-3673
Sherman, S.; Freeman, M.L.; Tarnasky, P.R.; Wilcox, C.M.; Kulkarni, A.; Aisen, A.M.; Jacoby, D.; Kozarek, R.A. 2014: Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis. Gastroenterology 147(3): 646-654.E2
Doyle, R.E.; Hinch, G.N.; Fisher, A.D.; Boissy, A.; Henshall, J.M.; Lee, C. 2011: Administration of serotonin inhibitor p-Chlorophenylalanine induces pessimistic-like judgement bias in sheep. Psychoneuroendocrinology 36(2): 279-288
VanGilder, R.L.; Kelly, K.A.; Chua, M.D.; Ptachcinski, R.L.; Huber, J.D. 2009: Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Experimental Brain Research 197(1): 23-34
Xie, C.; Sun, J.; Qiao, W.; Lu, D.; Wei, L.; Na, M.; Song, Y.; Hou, X.; Lin, Z. 2011: Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy. Plos one 6(9): E24966
Oliveira, J.ão.B.A.; Baruffi, R.; Petersen, C.áu.G.; Mauri, A.L.; Cavagna, M.; Franco, J.é G. 2010: Administration of single-dose GnRH agonist in the luteal phase in ICSi cycles: a meta-analysis. Reproductive Biology and Endocrinology: Rb&e 8: 107
Zhang, W.; Zhang, Y.; Li, P.; Rhodesm, S.D.; Wang, Y.; Xue, X.; Dong, Y.; Ding, W.; Shen, Y.; Zhang, B. 2011: Administration of sodium ibandronate in the treatment of complicated giant cell tumor of the spine. Spine 36(17): E1166-E1172
Ruiz-Bailén, M. 2010: Administration of statins during the acute phase of acute coronary syndrome. Medicina Intensiva 34(1): 56-63
Shanks, A.; Gross, G.; Shim, T.; Allsworth, J.; Sadovsky, Y.; Bildirici, I. 2010: Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles. American Journal of Obstetrics and Gynecology 203(1): 47.E1-47.E5
Soler Mieras, A.; Santaeugenia González, S.à; Montané Esteva, E. 2007: Administration of subcutaneous antibiotics in patients on palliative care. Medicina Clinica 129(6): 236-237
Hawkins, A.S.; Yoo, D.C.; Movson, J.S.; Noto, R.B.; Powers, K.; Baird, G.L. 2014: Administration of subcutaneous buffered lidocaine prior to breast lymphoscintigraphy reduces pain without decreasing lymph node visualization. Journal of Nuclear Medicine Technology 42(4): 260-264
Passalacqua, G.; Canonica, G.W. 2008: Administration of sublingual vaccines. Clinical Allergy and Immunology 21: 333-341
Turner, P.V.; Pekow, C.; Vasbinder, M.Ann.; Brabb, T. 2011: Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. Journal of the American Association for Laboratory Animal Science: JAALAS 50(5): 614-627
Turner, P.V.; Brabb, T.; Pekow, C.; Vasbinder, M.A. 2011: Administration of substances to laboratory animals: routes of administration and factors to consider. Journal of the American Association for Laboratory Animal Science: Jaalas 50(5): 600-613
Sugawara, A.; Sasakawa, T.; Hasegawa, N.; Takahata, O.; Iwasaki, H. 2011: Administration of sugammadex to a patient with myasthenia gravis with fade of the train-of-four ratio. Masui. Japanese Journal of Anesthesiology 60(9): 1082-1085
Hamburg, A.L.; Kravec, E.M. 1948: Administration of sulfamide No. 100 in pneumonia in children and the comparative evaluation of its effects. Pediatriia 6(4): 63-65
Rhost, S.; Lofbom, L.; Mansson, J.-E.; Lehuen, A.; Blomqvist, M.; Cardell, S.L. 2014: Administration of sulfatide to ameliorate type i diabetes in non-obese diabetic mice. Scandinavian Journal of Immunology 79(4): 260-266
Mari, G.; Morganti, M.; Merlo, B.; Castagnetti, C.; Parmeggiani, F.; Govoni, N.; Galeati, G.; Tamanini, C. 2009: Administration of sulpiride or domperidone for advancing the first ovulation in deep anestrous mares. Theriogenology 71(6): 959-965
Hinz, M.; Stein, A.; Cole, T.; Ryan, P. 2014: Administration of supplemental L-tyrosine with phenelzine: a clinical literature review. Clinical Pharmacology: Advances and Applications 6: 107-110